Please wait...
| ID | PMID | YEAR | Sequence | MAP | Name | C-ter MOD | N-ter MOD | Linear/Cyclic | Stereo-Chemistry | Modified | Length | Fuction | Activity | RBCs Source | Origin | Experimental structure | Non-Hemolytic |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18081258 | 2008 | GLPVCGETCVGGTCNTPGCTCSWPVCTRN{cyc:N-C} | Katala B1 | Free | Free | Cyclic | L | None | 29 | Anti-HIV | HD50 =11.7μM | Human | Cyclotides (Chinese herb from the Violaceae family Viola yedoensis) | NA | NA | ||
| 18081258 | 2008 | GGTIFDCGETCFLGTCYTPGCSCGNYGFCYGTN{cyc:N-C} | Cycloviolacin Y1 | Free | Free | Cyclic | L | None | 33 | Anti-HIV | Poor hemolytic | Human | Cyclotides (Chinese herb from the Violaceae family Viola yedoensis) | NA | NA | ||
| 18081258 | 2008 | GVPCGESCVFIPCITGVIGCSCSSNVCYLN{cyc:N-C} | Cycloviolacin Y4 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | HD50 =9.3μM | Human | Cyclotides (Chinese herb from the Violaceae family Viola yedoensis) | NA | NA | ||
| 18081258 | 2008 | GIPCAESCVWIPCTVTALVGCSCSDKVCYN{cyc:N-C} | Cycloviolacin Y5 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | HD50 = 8.7μM | Human | Cyclotides (Chinese herb from the Violaceae family Viola yedoensis) | NA | NA | ||
| 17114219 | 2007 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Hemolytic | 100% hemolysis at 2μM | Rat | Melittin (venom of the european honey bee, Apis mellifera) | Random coil and α Helical | NA | ||
| 17307975 | 2007 | {nnr:alK}-{nnr:l}K-{nnr:l}K-{nnr:l}K | OAK 1 | Free | Free | Linear | Mix | a = amino, l = lauric acid, alK = aminolauryl-lysine | 4 | Antiplasmodial | 24.6± 1.2% hemolysis at 100 μM | Human | Oligoacyllysine analog (Synthetic peptide) | NA | NA | ||
| 17307975 | 2007 | {nnr:l}K-{nnr:l}K-{nnr:l}K-{nnr:l}K | OAK 2 | Free | Free | Linear | Mix | l = lauric acid, alK = aminolauryl-lysine | 4 | Antiplasmodial | 26.1±4.5% hemolysis at 100 μM | Human | Oligoacyllysine analog (Synthetic peptide) | NA | NA | ||
| 17307975 | 2007 | K-{nnr:l}K-{nnr:l}K-{nnr:l}K | OAK 3 | Free | Free | Linear | Mix | l = lauric acid, alK = aminolauryl-lysine | 4 | Antiplasmodial | 2.3±1.5% hemolysis at 100 μM | Human | Oligoacyllysine analog (Synthetic peptide) | NA | NA | ||
| 17307975 | 2007 | {nnr:a}{nnr:l}K-{nnr:l}K-{nnr:l}K | OAK 4 | Free | Free | Linear | Mix | a = amino, l = lauric acid | 3 | Antiplasmodial | 3.4±0.8% hemolysis at 100 μM | Human | Oligoacyllysine analog (Synthetic peptide) | NA | NA | ||
| 17307975 | 2007 | {nnr:l}K-{nnr:l}K-{nnr:l}K | OAK 5 | Free | Free | Linear | Mix | l = lauric acid, alK = aminolauryl-lysine | 3 | Antiplasmodial | 13.3±4.3% hemolysis at 100 μM | Human | Oligoacyllysine analog (Synthetic peptide) | NA | NA | ||
| 17307975 | 2007 | K-{nnr:l}K-{nnr:l}K | OAK 6 | Free | Free | Linear | Mix | l = lauric acid, alK = aminolauryl-lysine | 3 | Antiplasmodial | <0.1% hemolysis at 100 μM | Human | Oligoacyllysine analog (Synthetic peptide) | NA | NA | ||
| 17307975 | 2007 | {nnr:alK}-{nnr:l}K | OAK 7 | Free | Free | Linear | Mix | a = amino, l = lauric acid, alK = aminolauryl-lysine | 2 | Antiplasmodial | 0.14±0.3% hemolysis at 100 μM | Human | Oligoacyllysine analog (Synthetic peptide) | NA | NA | ||
| 17307975 | 2007 | {nnr:l}K-{nnr:l}K | OAK 8 | Free | Free | Linear | Mix | l = lauric acid | 2 | Antiplasmodial | 4.9±1.7% hemolysis at 100 μM | Human | Oligoacyllysine analog (Synthetic peptide) | NA | NA | ||
| 17307975 | 2007 | K-{nnr:l}K | OAK 9 | Free | Free | Linear | Mix | l = lauric acid | 2 | Antiplasmodial | <0.1% hemolysis at 100 μM | Human | Oligoacyllysine analog (Synthetic peptide) | NA | NA | ||
| 18695936 | 2009 | GRILSFIKGLAEHL{ct:Amid} | Eumenine mastoparan-OD | Amidation | Free | Linear | L | None | 14 | Hemolytic | >40% hemolysis at 50μM | Sheep | Venom of a Vespid solitary wasp, Orancistrocerus drewseni drewseni | α-helix | NA | ||
| 18695936 | 2009 | ILGIITSLLKSL{ct:Amid} | Orancis-Protonectin | Amidation | Free | Linear | L | None | 12 | Hemolytic | ~80% hemolysis at 50μM | Sheep | Venom of a Vespid solitary wasp, Orancistrocerus drewseni drewseni | α-helix | NA | ||
| 18695936 | 2009 | INLKALAALAKKIL{ct:Amid} | Mastoparan | Amidation | Free | Linear | L | None | 14 | Hemolytic | <10% hemolysis at 50μM | Sheep | Black-bellied hornet (Vespa basalis, Vespinae) venom | α-helix | NA | ||
| 20564013 | 2010 | GTPCGESCVYIPCISGVIGCSCTDKVCYLN{cyc:N-C} | Kalata B5 | Free | Free | Cyclic | L | None | 30 | Pesticidal | HD50 =27.4±1.2μM | Human | Cyclotides (Oldenlandia affinis) | typical bracelet cyclotide fold | NA | ||
| 20728940 | 2010 | NPVLVKDATGSTQFGPVQALGAQYSMWKLK | CP2 | Free | Free | Linear | L | None | 30 | Inhibitor of complement pathway | 100% hemolysis at 0.77mM | Sheep | Coat protein derivative (human astrovirus type 1) | NA | NA | ||
| 20728940 | 2010 | PAICQRATATLGTVGSNTSGTTEIEACILL | CP1 | Free | Free | Linear | L | None | 30 | Inhibitor of complement pathway | 100% hemolysis at 0.77mM | Sheep | Coat protein derivative (human astrovirus type 1) | NA | NA | ||
| 20728940 | 2010 | PAIAQRATATLGTVGSNTSGTTEIEACILL | C04A | Free | Free | Linear | L | None | 30 | Inhibitor of complement pathway | 100% hemolysis at 0.77mM | Sheep | Coat protein derivative (human astrovirus type 1) | NA | NA | ||
| 20728940 | 2010 | PAICQRATATLGTVGSNTSGTTEIEAAILL | C27A | Free | Free | Linear | L | None | 30 | Inhibitor of complement pathway | 90% hemolysis at 0.77mM | Sheep | Coat protein derivative (human astrovirus type 1) | NA | NA | ||
| 20728940 | 2010 | PAICQRATATLGTVGSNTSGTTAIEACILL | E23A | Free | Free | Linear | L | None | 30 | Inhibitor of complement pathway | 80% hemolysis at 0.77mM | Sheep | Coat protein derivative (human astrovirus type 1) | Helix+Sheet+Loop | NA | ||
| 20728940 | 2010 | PAICQRATATLGTVGSNTSGTTEIAACILL | E25A | Free | Free | Linear | L | None | 30 | Inhibitor of complement pathway | 95% hemolysis at 0.77mM | Sheep | Coat protein derivative (human astrovirus type 1) | NA | NA | ||
| 20728940 | 2010 | PAICQRAEIEACILL | Δ8-22 | Free | Free | Linear | L | None | 15 | Inhibitor of complement pathway | 100% hemolysis at 0.77mM | Sheep | Coat protein derivative (human astrovirus type 1) | NA | NA | ||
| 14769216 | 2004 | FALLGDFFRKSKEKIGKEFKRIVQRIKDFFRNLVPRTES | FALL-39 | Free | Free | Linear | L | None | 39 | Antibiotic | >25% hemolysis at 200g/l | Human | Cathelicidin (Homo sapiens bone marrow) | α-helical | NA | ||
| 14769216 | 2004 | FALLGDFFRKSKEKIGKEFKRIVQRIKDFFRNLVPRTES | FALL-39 | Free | Free | Linear | L | None | 39 | Antibiotic | >30% hemolysis at 400g/l | Human | Cathelicidin (Homo sapiens bone marrow) | α-helical | NA | ||
| 14769216 | 2004 | FALLGDFFRKSKEKIGKEFKRIVQRIKDFFRKLVPRTES | FALL-39-lys32 | Free | Free | Linear | L | None | 39 | Antibiotic | 30% hemolysis at 200g/l | Human | Cathelicidin (Homo sapiens bone marrow) | α-helical | NA | ||
| 14769216 | 2004 | FALLGDFFRKSKEKIGKEFKRIVQRIKDFFRKLVPRTES | FALL-39-lys32 | Free | Free | Linear | L | None | 39 | Antibiotic | 40% hemolysis at 400g/l | Human | Cathelicidin (Homo sapiens bone marrow) | α-helical | NA | ||
| 14769216 | 2004 | FALLGDFFRKSKEKIGKEFKRIVKRIKDFFRNLVPRTES | FALL-39-lys24 | Free | Free | Linear | L | None | 39 | Antibiotic | >30% hemolysis at 200g/l | Human | Cathelicidin (Homo sapiens bone marrow) | α-helical | NA | ||
| 14769216 | 2004 | FALLGDFFRKSKEKIGKEFKRIVKRIKDFFRNLVPRTES | FALL-39-lys24 | Free | Free | Linear | L | None | 39 | Antibiotic | >35% hemolysis at 400g/l | Human | Cathelicidin (Homo sapiens bone marrow) | α-helical | NA | ||
| 15052574 | 2004 | I/LNWLKLGKAIIDAI/L{ct:Amid} | Agelaia-MP | Amidation | Free | Linear | L | None | 14 | Inflammatory | 75% hemolysis at 1 x10-6 M | Rat | Mastoparan (venom of the wasp Agelaia pallipes pallipes) | NA | NA | ||
| 15150833 | 2004 | INWLKLGKMVIDAL{ct:Amid} | 13a | Amidation | Free | Linear | L | None | 14 | Inflammatory | 100% hemolysis at 6.2x10-5 M | Rat | Mastoparan (venom of the social wasp Polybia paulista) | NA | NA | ||
| 15150833 | 2004 | IDWLKLGKMVMDVL{ct:Amid} | 13b | Amidation | Free | Linear | L | None | 14 | Inflammatory | 100% hemolysis at 6.2x10-5 M | Rat | Mastoparan (venom of the social wasp Polybia paulista) | NA | NA | ||
| 15225564 | 2004 | ILGTILGLLKGL{ct:Amid} | Protonectin | Amidation | Free | Linear | L | None | 12 | Chemotactic | >40% hemolysis at 10-4 M | Rat | Mastoparan (venom of the neotropical social wasp Agelaia pallipes pallipes) | NA | NA | ||
| 15225564 | 2004 | INWLKLGKAIIDAL{ct:Amid} | Agelaia-MP | Amidation | Free | Linear | L | None | 14 | Mast cell degranulating toxin | ~90% hemolysis at 10-4 M | Rat | Mastoparan (venom of the neotropical social wasp Agelaia pallipes pallipes) | NA | NA | ||
| 15328050 | 2004 | FWGALAKGALKLIPSLFSSFSKKD | Pin2 | Free | Free | Linear | L | None | 24 | Hemolytic | ~60% hemolysis at 25µM | Pig | Pandinin 2 (Pandinus imperator) | α-helical | NA | ||
| 15328050 | 2004 | FRGLAKLLKIGLKSFARVLKKVLPKAAKAGKALAKSMADENAIRQQNQ | Oxki1 | Free | Free | Linear | L | None | 48 | Hemolytic | ~100% hemolysis at 25µM | Pig | Oxyopinin (Oxyopes kitabensis) | α-helical | NA | ||
| 15581688 | 2005 | INWKKMAAATALKMI{ct:Amid} | MP | Amidation | Free | Linear | L | None | 15 | Hemolytic | 40% hemolysis at 10µM | Rat | Venom of the Neotropical social wasp Protopolybia exigua (Saussure) | α-helical | NA | ||
| 15581688 | 2005 | INWLKLGKKVSAIL{ct:Amid} | MPI | Amidation | Free | Linear | L | None | 14 | Hemolytic | 40% hemolysis at 10µM | Rat | Venom of the Neotropical social wasp Protopolybia indica (Saussure) | α-helical | NA | ||
| 15616319 | 2005 | QRSVSNAATRVCRTGRSRWRDVCRNFMRR | G8 | Free | Free | Linear | L | None | 29 | Antibiotic | >80% hemolysis 100µM | Rabbit | Granulysin-Derived Peptides | α-helical | NA | ||
| 15616319 | 2005 | QRSVSNAATRVCRTGRSRW | G13 | Free | Free | Linear | L | None | 19 | Antibiotic | 20% hemolysis 100µM | Rabbit | Granulysin-Derived Peptides | α-helical | NA | ||
| 15616319 | 2005 | GRSRWRDVCRNFMRR | G14 | Free | Free | Linear | L | None | 15 | Antibiotic | 40% hemolysis 100µM | Rabbit | Granulysin-Derived Peptides | α-helical | NA | ||
| 15616319 | 2005 | GQSQWRDVCRNFMRR | G15 | Free | Free | Linear | L | None | 15 | Antibiotic | ~40% hemolysis 100µM | Rabbit | Granulysin-Derived Peptides | α-helical | NA | ||
| 15616319 | 2005 | GRSRWRDVCRNFMRRYQSRVIQGLV | G20 | Free | Free | Linear | L | None | 25 | Antibiotic | >80% hemolysis 100µM | Rabbit | Granulysin-Derived Peptides | α-helical | NA | ||
| 15629533 | 2005 | MAQDIISTIGDLVKWIIDTVNKFTKK{nt:Formylation} | Peptide f-26 | Free | Formylation | Linear | L | None | 26 | Antibiotic | ~90% hemolysis at 30µM | Guinea-pig | Analog of delta-lysin from staphylococcus aureus (synthetic peptide) | α-helical | NA | ||
| 15629533 | 2005 | MAQDIISTIGDLVKWIIDTVNKFTKK | Peptide n-26 | Free | Free | Linear | L | None | 26 | Hemolytic | ~95% hemolysis at 30µM | Guinea-pig | Analog of delta-lysin from staphylococcus aureus (synthetic peptide) | α-helical | NA | ||
| 15629533 | 2005 | AQDIISTIGDLVKWIIDTVNKFTKK | Peptide n-25 | Free | Free | Linear | L | None | 25 | Hemolytic | >75% hemolysis at 30µM | Guinea-pig | Analog of delta-lysin from staphylococcus aureus (synthetic peptide) | α-helical | NA | ||
| 15629533 | 2005 | IISTIGDLVKWIIDTVNKFTKK | Peptide n-22 | Free | Free | Linear | L | None | 22 | Hemolytic | 100% hemolysis at 5µM | Guinea-pig | Analog of delta-lysin from staphylococcus aureus (synthetic peptide) | α-helical | NA | ||
| 15629533 | 2005 | STIGDLVKWIIDTVNKFTKK | Peptide n-20 | Free | Free | Linear | L | None | 20 | Hemolytic | ~100% hemolysis at 20µM | Guinea-pig | Analog of delta-lysin from staphylococcus aureus (synthetic peptide) | α-helical | NA | ||
| 15629533 | 2005 | IGDLVKWIIDTVNKFTKK | Peptide n-18 | Free | Free | Linear | L | None | 18 | Hemolytic | <50% hemolysis at 30µM | Guinea-pig | Analog of delta-lysin from staphylococcus aureus (synthetic peptide) | α-helical | NA | ||
| 15629533 | 2005 | DLVKWIIDTVNKFTKK | Peptide n-16 | Free | Free | Linear | L | None | 16 | Hemolytic | <25% hemolysis at 30µM | Guinea-pig | Analog of delta-lysin from staphylococcus aureus (synthetic peptide) | α-helical | NA | ||
| 15822124 | 2005 | FRKLFRVYSNFLRGKLKL{nt:Acet}{ct:Amid} | P1buy | Amidation | Acetylation | Linear | L | None | 18 | Hemolytic | 62% hemolysis at 10µM | Rat | Protein Data Bank (PDB, 1buy) | α-helical | NA | ||
| 15822124 | 2005 | WYSEMKRNVQRLERAIEE{nt:Acet}{ct:Amid} | P1c3c | Amidation | Acetylation | Linear | L | None | 18 | Hemolytic | 18% hemolysis at 10µM | Rat | Protein Data Bank (PDB, 1c3c) | α-helical | NA | ||
| 15822124 | 2005 | RDAKELVELFFEEIRRAL{nt:Acet}{ct:Amid} | P1ihf | Amidation | Acetylation | Linear | L | None | 18 | Hemolytic | 46% hemolysis at 10µM | Rat | Protein Data Bank (PDB, 1ihf) | α-helical | NA | ||
| 15822124 | 2005 | KQLIRFLKRLDRNLWGLA{nt:Acet}{ct:Amid} | P1ill | Amidation | Acetylation | Linear | L | None | 18 | Hemolytic | 48% hemolysis at 10µM | Rat | Protein Data Bank (PDB, 1ill) | α-helical | NA | ||
| 16460023 | 2006 | VSAVAKVAMKKGAALLKKMGVKISPLK | P1 | Free | Free | Linear | L | None | 27 | Hemolytic | 50% hemolysis at >900µM | Human | Peptides derived from Trialysin protein found in the saliva of Triatoma infestans | NA | NA | ||
| 16460023 | 2006 | KQLKKVSAVAKVAMKKGAALLKKMGVK | P2 | Free | Free | Linear | L | None | 27 | Hemolytic | 50% hemolysis at 450µM | Human | Peptides derived from Trialysin protein found in the saliva of Triatoma infestans | NA | NA | ||
| 16460023 | 2006 | VGKVLKQLKKVSAVAKVAMKKGAALLK | P3 | Free | Free | Linear | L | None | 27 | Hemolytic | 50% hemolysis at >900µM | Human | Peptides derived from Trialysin protein found in the saliva of Triatoma infestans | NA | NA | ||
| 16460023 | 2006 | KFGKIVGKVLKQLKKVSAVAKVAMKKG | P4 | Free | Free | Linear | L | None | 27 | Hemolytic | 50% hemolysis at 274µM | Human | Peptides derived from Trialysin protein found in the saliva of Triatoma infestans | NA | NA | ||
| 16460023 | 2006 | GKVLDKFGKIVGKVLKQLKKVSAVAKV | P5 | Free | Free | Linear | L | None | 27 | Hemolytic | 50% hemolysis at 117µM | Human | Peptides derived from Trialysin protein found in the saliva of Triatoma infestans | NA | NA | ||
| 16460023 | 2006 | FKIKPGKVLDKFGKIVGKVLKQLKKVSAVAKV | P6 | Free | Free | Linear | L | None | 32 | Hemolytic | 50% hemolysis at 90µM | Human | Peptides derived from Trialysin protein found in the saliva of Triatoma infestans | NA | NA | ||
| 16460023 | 2006 | FKIKPGKVLDKFGKIVGKVLKQLKKVS | P7 | Free | Free | Linear | L | None | 27 | Hemolytic | 50% hemolysis at 296µM | Human | Peptides derived from Trialysin protein found in the saliva of Triatoma infestans | NA | NA | ||
| 16460028 | 2006 | GASLSFKILKTVLEALGNV | EqTII11-29 | Free | Free | Linear | L | None | 19 | Hemolytic | 10% hemolysis at 25µM | Human | Actinoporin from sea anaemone Actinia equina L | NA | NA | ||
| 16730857 | 2006 | KFKLKQ{cyc:N-C} | BPC6L | Free | Free | Cyclic | L | None | 6 | Hemolytic | 11±4.6% hemolysis at 360µM | Human | Synthetic peptide | NA | NA | ||
| 16730857 | 2006 | KLKF{d}KLKQ{cyc:N-C} | BPC8D | Free | Free | Cyclic | Mix | None | 8 | Hemolytic | 37±5.2% hemolysis at 360µM | Human | Synthetic peptide | NA | NA | ||
| 16730857 | 2006 | KLKLKF{d}KLKQ{cyc:N-C} | BPC10D | Free | Free | Cyclic | Mix | None | 10 | Hemolytic | 42± 6.8% hemolysis at 360µM | Human | Synthetic peptide | NA | NA | ||
| 16730857 | 2006 | KLKLKLKQ{cyc:N-C} | BPC8S1 | Free | Free | Cyclic | L | None | 8 | Hemolytic | 1±0.1% hemolysis at 360µM | Human | Synthetic peptide | NA | NA | ||
| 16730857 | 2006 | LKLKLKLQ{cyc:N-C} | BPC8S3 | Free | Free | Cyclic | L | None | 8 | Hemolytic | 5±0.1% hemolysis at 360µM | Human | Synthetic peptide | NA | NA | ||
| 16848415 | 2006 | GIGAVLKVLTTGLPALISWIKRKRQQ | M0 | Free | Free | Linear | L | None | 26 | Hemolytic | HL50 = 1.5 μM at pH 7.4 | Mouse | Analog of Melittin | NA | NA | ||
| 16848415 | 2006 | GIGAVLKVLTTGLPALISWIKRKRQQ | M0 | Free | Free | Linear | L | None | 26 | Hemolytic | HL50 = 6 μM at pH 4.5 | Mouse | Analog of Melittin | NA | NA | ||
| 16848415 | 2006 | CIGAVLKVLTTGLPALISWIKRKRQQC | M1 | Free | Free | Linear | L | None | 27 | Hemolytic | HL50 = 3.0 at pH 7.4 | Mouse | Analog of Melittin | NA | NA | ||
| 16848415 | 2006 | CIGAVLKVLTTGLPALISWIKRKRQQC | M1 | Free | Free | Linear | L | None | 27 | Hemolytic | HL50 = 1 μM at pH 4.5 | Mouse | Analog of Melittin | NA | NA | ||
| 16848415 | 2006 | CKKIGAVLKVLTTGLPALISWIKRKRQQKKC | M6 | Free | Free | Linear | L | None | 30 | Hemolytic | HL50 = 2.5 μM at pH 7.4 | Mouse | Analog of Melittin | NA | NA | ||
| 17142988 | 2006 | INWLKLGKKILGAI{ct:Amid} | Pm-R1 | Amidation | Free | Linear | L | None | 14 | Hemolytic | 24 % of hemolysis at 50mM | Sheep | Kinins derivative (Polistes rothneyi iwatai) | NA | NA | ||
| 17142988 | 2006 | LNFKALAALAKKIL{ct:Amid} | Pm-R2 | Amidation | Free | Linear | L | None | 14 | Hemolytic | 23 % of hemolysis at 50mM | Sheep | Kinins derivative (Polistes rothneyi iwatai) | NA | NA | ||
| 17142988 | 2006 | IAWLKLGKGILGAL{ct:Amid} | Pm-R3 | Amidation | Free | Linear | L | None | 14 | Hemolytic | 36 % of hemolysis at 50mM | Sheep | Kinins derivative (Polistes rothneyi iwatai) | NA | NA | ||
| 17142988 | 2006 | ILGTILGLLKGL{ct:Amid} | Polistes-protonectin | Amidation | Free | Linear | L | None | 12 | Hemolytic | 97 % of hemolysis at 50mM | Sheep | Kinins derivative (Polistes rothneyi iwatai) | NA | NA | ||
| 17142988 | 2006 | IALKALAALAKKIL{ct:Amid} | Mastparan | Amidation | Free | Linear | L | None | 14 | Hemolytic | 18 % of hemolysis at 50mM | Sheep | Mastoparans family | NA | NA | ||
| 17547385 | 2007 | GKGL{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GKR{ct:Amid} | Peptide-2 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 29 | Antibiotic | 100% hemolysis at100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GKGL{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GKR{ct:Amid} | Peptide-2 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 29 | Antibiotic | 100% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GKGL{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GLR{ct:Amid} | Peptide-3 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 29 | Antibiotic | 100% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GKGL{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GLR{ct:Amid} | Peptide-3 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 29 | Antibiotic | 100% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GKGL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GKR{ct:Amid} | Peptide-4 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 29 | Antibiotic | 100% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GKGL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GKR{ct:Amid} | Peptide-4 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 29 | Antibiotic | 100% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GKGL{nnr:Tic}{nnr:Oic}FK{nnr:Tic}{nnr:Oic}KF{nnr:Tic}{nnr:Oic}FK{nnr:Tic}{nnr:Oic}KF{nnr:Tic}{nnr:Oic}FK{nnr:Tic}{nnr:Oic}FKR{ct:Amid} | Peptide-5 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 29 | Antibiotic | 100% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GKGL{nnr:Tic}{nnr:Oic}FK{nnr:Tic}{nnr:Oic}KF{nnr:Tic}{nnr:Oic}FK{nnr:Tic}{nnr:Oic}KF{nnr:Tic}{nnr:Oic}FK{nnr:Tic}{nnr:Oic}FKR{ct:Amid} | Peptide-5 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 29 | Antibiotic | 100% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GKGL{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}ELMNS{ct:Amid} | Peptide-6 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 27 | Antibiotic | 70% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GKGL{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}ELMNS{ct:Amid} | Peptide-6 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 27 | Antibiotic | 70% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | ELMNS{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}ELMNS{ct:Amid} | Peptide-7 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 28 | Antibiotic | 3% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | ELMNS{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}ELMNS{ct:Amid} | Peptide-7 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 28 | Antibiotic | 3% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | ELMNS{nnr:Tic}{nnr:Oic}GKLGK{nnr:Tic}{nnr:Oic}ELMS{ct:Amid} | Peptide-8 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 18 | Antibiotic | 23% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | ELMNS{nnr:Tic}{nnr:Oic}GKLGK{nnr:Tic}{nnr:Oic}ELMS{ct:Amid} | Peptide-8 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 18 | Antibiotic | 23% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | ELS{nnr:Tic}{nnr:Oic}GKG{nnr:Tic}{nnr:Oic}LKES{ct:Amid} | Peptide-9 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 14 | Antibiotic | 23% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | ELS{nnr:Tic}{nnr:Oic}GKG{nnr:Tic}{nnr:Oic}LKES{ct:Amid} | Peptide-9 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 14 | Antibiotic | 23% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GKGL{nnr:Tic}{nnr:Oic}{nnr:βAla}K{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}{nnr:βAla}K{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}ELMNS{ct:Amid} | Peptide-20 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, βAla = β-alanine{nnr:Bala} – β-Alanine | 27 | Antibiotic | 55% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GKGL{nnr:Tic}{nnr:Oic}{nnr:βAla}K{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}{nnr:βAla}K{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}ELMNS{ct:Amid} | Peptide-20 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, βAla = β-alanine{nnr:Bala} – β-Alanine | 27 | Antibiotic | 55% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | EGKGLG{nnr:βAla}{nnr:βAla}K{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}{nnr:βAla}E{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}ELMNS{ct:Amid} | Peptide-21 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, βAla = β-alanine{nnr:Bala} – β-Alanine | 28 | Antibiotic | 27% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | EGKGLG{nnr:βAla}{nnr:βAla}K{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}{nnr:βAla}E{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}ELMNS{ct:Amid} | Peptide-21 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, βAla = β-alanine{nnr:Bala} – β-Alanine | 28 | Antibiotic | 27% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | KL{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}F{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}F{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}KR{ct:Amid} | Peptide-22 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 21 | Antibiotic | 63% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | KL{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}F{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}F{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}KR{ct:Amid} | Peptide-22 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 21 | Antibiotic | 63% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-23 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 19 | Antibiotic | 14% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-23 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 19 | Antibiotic | 14% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}KKKK{ct:Amid} | Peptide-26 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 19 | Antibiotic | 33.4% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}KKKK{ct:Amid} | Peptide-26 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 19 | Antibiotic | 14.3% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | KL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}KKKK{ct:Amid} | Peptide-27 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 19 | Antibiotic | 43.6% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | KL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}KKKK{ct:Amid} | Peptide-27 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 19 | Antibiotic | 24.9% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | F{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}F{nnr:Tic}{nnr:Oic}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-28 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 15 | Antibiotic | 86.8% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | F{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}F{nnr:Tic}{nnr:Oic}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-28 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 15 | Antibiotic | 50% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | {nnr:GABA}F{nnr:Tic}{nnr:Oic}{nnr:GABA}K{nnr:Tic}{nnr:Oic}{nnr:GABA}F{nnr:Tic}{nnr:Oic}{nnr:GABA}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-29 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, GABA= γ-aminobutyric acid | 19 | Antibiotic | 10.8% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | {nnr:GABA}F{nnr:Tic}{nnr:Oic}{nnr:GABA}K{nnr:Tic}{nnr:Oic}{nnr:GABA}F{nnr:Tic}{nnr:Oic}{nnr:GABA}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-29 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, GABA= γ-aminobutyric acid | 19 | Antibiotic | 1% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | G{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}G{nnr:Tic}{nnr:Oic}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-30 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 15 | Antibiotic | 26.7% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | G{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}G{nnr:Tic}{nnr:Oic}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-30 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 15 | Antibiotic | 9.2% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GF{nnr:Oic}GK{nnr:Oic}GF{nnr:Oic}GKKKKK{nt:Acet}{ct:Amid} | Peptide-31 | Amidation | Acetylation | Linear | L | Oic = octahydroindolecarboxylic acid | 15 | Antibiotic | 5.9% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GF{nnr:Oic}GK{nnr:Oic}GF{nnr:Oic}GKKKKK{nt:Acet}{ct:Amid} | Peptide-31 | Amidation | Acetylation | Linear | L | Oic = octahydroindolecarboxylic acid | 15 | Antibiotic | 3.2% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GF{nnr:Tic}GK{nnr:Tic}GF{nnr:Tic}GK{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-32 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid | 16 | Antibiotic | 6% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GF{nnr:Tic}GK{nnr:Tic}GF{nnr:Tic}GK{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-32 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid | 16 | Antibiotic | 4.9% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GF{nnr:Tic}GGK{nnr:Tic}GGF{nnr:Tic}GGK{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-33 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid | 19 | Antibiotic | 5.70% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GF{nnr:Tic}GGK{nnr:Tic}GGF{nnr:Tic}GGK{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-33 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid | 19 | Antibiotic | 3.80% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GFG-{nnr:Oic}-GKG-{nnr:Oic}-GFG-{nnr:Oic}-GKGKKKK{nt:Acet}{ct:Amid} | Peptide-34 | Amidation | Acetylation | Linear | L | Oic = octahydroindolecarboxylic acid | 19 | Antibiotic | 3.30% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GFG{nnr:Oic}GKG{nnr:Oic}GFG{nnr:Oic}GKGKKKK{nt:Acet}{ct:Amid} | Peptide-34 | Amidation | Acetylation | Linear | L | Oic = octahydroindolecarboxylic acid | 19 | Antibiotic | 3.3% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GFF{nnr:Oic}GKF{nnr:Oic}GFF{nnr:Oic}GKFKKKK{nt:Acet}{ct:Amid} | Peptide-35 | Amidation | Acetylation | Linear | L | Oic = octahydroindolecarboxylic acid | 19 | Antibiotic | 27.30% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GFF{nnr:Oic}GKF{nnr:Oic}GFF{nnr:Oic}GKFKKKK{nt:Acet}{ct:Amid} | Peptide-35 | Amidation | Acetylation | Linear | L | Oic = octahydroindolecarboxylic acid | 19 | Antibiotic | 8.9% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | {nnr:βAla}F{nnr:Tic}{nnr:Oic}{nnr:βAla}K{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}{nnr:βAla}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-36 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, βAla = β-alanine{nnr:Bala} – β-Alanine | 19 | Antibiotic | 24.4% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | {nnr:βAla}F{nnr:Tic}{nnr:Oic}{nnr:βAla}K{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}{nnr:βAla}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-36 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, βAla = β-alanine{nnr:Bala} – β-Alanine | 19 | Antibiotic | 7.4% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | {nnr:Ahx}F{nnr:Tic}{nnr:Oic}{nnr:Ahx}K{nnr:Tic}{nnr:Oic}{nnr:Ahx}F{nnr:Tic}{nnr:Oic}{nnr:Ahx}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-37 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, Ahx = 6-aminohexanoic acid | 19 | Antibiotic | 44.7% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | {nnr:Ahx}F{nnr:Tic}{nnr:Oic}{nnr:Ahx}K{nnr:Tic}{nnr:Oic}{nnr:Ahx}F{nnr:Tic}{nnr:Oic}{nnr:Ahx}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid} | Peptide-37 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, Ahx = 6-aminohexanoic acid | 19 | Antibiotic | 26.6% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | F{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}F{nnr:Tic}{nnr:Oic}K{nnr:Tic}KKKKKK{nt:Acet}{ct:Amid} | Peptide-38 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 17 | Antibiotic | 41.3% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | F{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}F{nnr:Tic}{nnr:Oic}K{nnr:Tic}KKKKKK{nt:Acet}{ct:Amid} | Peptide-38 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 17 | Antibiotic | 33.5% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}KKKKK{nt:Acet}{ct:Amid} | Peptide-39 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 20 | Antibiotic | 24.9% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}KKKKK{nt:Acet}{ct:Amid} | Peptide-39 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 20 | Antibiotic | 18.9% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | {nnr:GABA}F{nnr:Tic}{nnr:Oic}{nnr:GABA}K{nnr:Tic}{nnr:Oic}{nnr:GABA}F{nnr:Tic}{nnr:Oic}{nnr:GABA}K{nnr:Tic}KKKKK{nt:Acet}{ct:Amid} | Peptide-40 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, GABA= γ-aminobutyric acid | 18 | Antibiotic | 29.7% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | {nnr:GABA}F{nnr:Tic}{nnr:Oic}{nnr:GABA}K{nnr:Tic}{nnr:Oic}{nnr:GABA}F{nnr:Tic}{nnr:Oic}{nnr:GABA}K{nnr:Tic}KKKKK{nt:Acet}{ct:Amid} | Peptide-40 | Amidation | Acetylation | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, GABA= γ-aminobutyric acid | 18 | Antibiotic | 10.5% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17826814 | 2007 | SELAGTIIDGASLTFEVLDKVLGELGKVSRK | St I 1–31 | Free | Free | Linear | L | None | 31 | Hemolytic | Hemolytic activity expresssed as the initial rate (∆A/∆t, min- 1) i.e. at above 100 µM activity is above 0.002 min-1 | Human | Sticholysin (Stichodactyla helianthus) | NA | NA | ||
| 17826814 | 2007 | ELAGTIIDGASLTFEVLDKVLGELGKVSRK | St I 2–31 | Free | Free | Linear | L | None | 30 | Hemolytic | Hemolytic activity expresssed as the initial rate (∆A/∆t, min- 1) i.e. at above 100 µM activity is less than 0.002 min-1 | Human | Sticholysin (Stichodactyla helianthus) | NA | NA | ||
| 17826814 | 2007 | SLTFEVLDKVLGELGKVSRK | St I 12–31 | Free | Free | Linear | L | None | 20 | Hemolytic | Hemolytic activity expresssed as the initial rate (∆A/∆t, min- 1) i.e. at above 100 µM activity is ~0.004 min-1 | Human | Sticholysin (Stichodactyla helianthus) | NA | NA | ||
| 17826814 | 2007 | ALAGTIIAGASLTFQVLDKVLEELGKVSRK | St II 1–30 | Free | Free | Linear | L | None | 30 | Hemolytic | Hemolytic activity expresssed as the initial rate (∆A/∆t, min- 1) i.e. at above 100 µM activity is above 0.010 min-1 | Human | Sticholysin (Stichodactyla helianthus) | NA | NA | ||
| 17826814 | 2007 | SLTFQVLDKVLEELGKVSRK | St II 11–30 | Free | Free | Linear | L | None | 20 | Hemolytic | Hemolytic activity expresssed as the initial rate (∆A/∆t, min- 1) i.e. at above 100 µM activity is ~0.002 min-1 | Human | Sticholysin (Stichodactyla helianthus) | NA | NA | ||
| 17927208 | 2007 | FHPSLWVLIPQYIQLIRKILKSG | Conolysin-Mt | Free | Free | Linear | L | None | 23 | Hemolytic | 40% hemolysis at 1 µM | Human | Conolysin-Mt (Conus mustelinus) | NA | NA | ||
| 17927208 | 2007 | FHPSLWVLIPQYIQLIRKILKSG | Conolysin-Mt | Free | Free | Linear | L | None | 23 | Hemolytic | 90% hemolysis at 10 µM | Human | Conolysin-Mt (Conus mustelinus) | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKFL{ct:Amid} | BP76 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 3±1% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKVL{nt:Benzoylation}{ct:Amid} | BP31 | Amidation | Benzoylation | Linear | L | None | 11 | Hemolytic | 34±9.2% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKWL{ct:Amid} | BP52 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 51±4.8% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | FKLFKKILKFL{ct:Amid} | BP66 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 9±2.2% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKFL{nt:Acet}{ct:Amid} | BP77 | Amidation | Acetylation | Linear | L | None | 11 | Hemolytic | 6±0.6% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKFL{nt:Tosylation}{ct:Amid} | BP78 | Amidation | Tosylation | Linear | L | None | 11 | Hemolytic | 40±4.0% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | LKLFKKILKFL{ct:Amid} | BP81 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 10±1.3% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 3±0.1% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKYL{nt:Tosylation}{ct:Amid} | BP102 | Amidation | Tosylation | Linear | L | None | 11 | Hemolytic | 40±3.5% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKYL{nt:Benzoylation}{ct:Amid} | BP103 | Amidation | Benzoylation | Linear | L | None | 11 | Hemolytic | 42±4.7% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | LKLFKKILKYL{ct:Amid} | BP105 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 14±1.6% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | YKLFKKILKKL{nt:Tosylation}{ct:Amid} | BP121 | Amidation | Tosylation | Linear | L | None | 11 | Hemolytic | 22±1.3% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKKL{nt:Tosylation}{ct:Amid} | BP125 | Amidation | Tosylation | Linear | L | None | 11 | Hemolytic | 2±0.7% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKKL{nt:Benzoylation}{ct:Amid} | BP126 | Amidation | Benzoylation | Linear | L | None | 11 | Hemolytic | 2±0.4% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKFL{ct:Amid} | BP76 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 34±2.1% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKVL{nt:Benzoylation}{ct:Amid} | BP31 | Amidation | Benzoylation | Linear | L | None | 11 | Hemolytic | 71±2.3% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKWL{ct:Amid} | BP52 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 84±6.5% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | FKLFKKILKFL{ct:Amid} | BP66 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 63±5.9% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKFL{nt:Acet}{ct:Amid} | BP77 | Amidation | Acetylation | Linear | L | None | 11 | Hemolytic | 40±3.8% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKFL{nt:Tosylation}{ct:Amid} | BP78 | Amidation | Tosylation | Linear | L | None | 11 | Hemolytic | 85±7.4% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | LKLFKKILKFL{ct:Amid} | BP81 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 65±1.5% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 22±2.8% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKYL{nt:Tosylation}{ct:Amid} | BP102 | Amidation | Tosylation | Linear | L | None | 11 | Hemolytic | 79±6.5% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKYL{nt:Benzoylation}{ct:Amid} | BP103 | Amidation | Benzoylation | Linear | L | None | 11 | Hemolytic | 83±13.5% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | LKLFKKILKYL{ct:Amid} | BP105 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 91±6.2% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | YKLFKKILKKL{nt:Tosylation}{ct:Amid} | BP121 | Amidation | Tosylation | Linear | L | None | 11 | Hemolytic | 81±3.7% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKKL{ct:Amid} | BP125 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 8±1.6% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17980935 | 2007 | KKLFKKILKKL{ct:Amid} | BP126 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 14±2.9% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 17981364 | 2007 | SLLSLINKLIT | Decoralin | Free | Free | Linear | L | None | 11 | Hemolytic | 50-60% hemolysis at 10-3 M | Mouse | Decoralin (Oreumenes decoratus) | NA | NA | ||
| 17981364 | 2007 | SLLSLINKLIT{ct:Amid} | Decoralin-NH2 | Amidation | Free | Linear | L | None | 11 | Hemolytic | 100% hemolysis at 10-3 M | Mouse | Decoralin analog (Oreumenes decoratus) | NA | NA | ||
| 17981364 | 2007 | SLLSLINKLIT{ct:Amid} | Decoralin-NH2 | Amidation | Free | Linear | L | None | 11 | Hemolytic | EC50 = 80 µM | Human | Decoralin analog (Oreumenes decoratus) | NA | NA | ||
| 15052574 | 2004 | I/LLGTILGLLKGI/L{ct:Amid} | Agelaia-CP | Amidation | Free | Linear | L | None | 15 | Inflammatory | 0% hemolysis at 1x10-5 M (non-hemolytic) | Rat | Mastoparan (Agelaia pallipes pallipes) | NA | Non-hemolytic | ||
| 15196144 | 2004 | DSHEKRHHGYKRKFHEKHHSHRGY | Histatin-5 | Free | Free | Linear | L | None | 24 | Fungicidal | 0% hemolysis at 100µM (non-hemolytic) | Human | Histatin | NA | Non-hemolytic | ||
| 15196144 | 2004 | FKCRRWQWRMKKLG | LFB(17–30) | Free | Free | Linear | L | None | 14 | Fungicidal | 0% hemolysis at 100µM (non-hemolytic) | Human | Human lactoferrin | NA | Non-hemolytic | ||
| 15196144 | 2004 | KRLFKKLLFSLRKY | Dhvar 4 | Free | Free | Linear | L | None | 14 | Fungicidal | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 15196144 | 2004 | KRLFRRWQWRMKKY | JH8194 | Free | Free | Linear | L | None | 14 | Fungicidal | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 15196144 | 2004 | KRLFRRLLFSMKKY | JH8195 | Free | Free | Linear | L | None | 14 | Fungicidal | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 15196144 | 2004 | FKCKKVVISLRRY | JH8944 | Free | Free | Linear | L | None | 13 | Fungicidal | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 15304333 | 2004 | ACGILHDNCVYVPAQNPCCRGLQCRYGKCLVQV | Psalmopeotoxin I (PcFK1) | Free | Free | Linear | L | None | 33 | Antimalarial | 0%hemolysis at 100µM (non-hemolytic) | Human | Venom of the tarantula Psalmopoeus cambridgei | NA | Non-hemolytic | ||
| 15304333 | 2004 | ACGILHDNCVYVPAQNPCCRGLQCRYGKCLVQV | Psalmopeotoxin I (PcFK1) | Free | Free | Linear | L | None | 28 | Antimalarial | No hemolysis at 10µM (non-hemolytic) | Human | Venom of the tarantula Psalmopoeus cambridgei | NA | Non-hemolytic | ||
| 15581688 | 2005 | INWKAIIEAAKQAL{ct:Amid} | MP II | Amidation | Free | Linear | L | None | 14 | Hemolytic | No hemolysis at 10µM (non-hemolytic) | Rat | Mastoparan (Parapolybia indica) | NA | Non-hemolytic | ||
| 15581688 | 2005 | INWLKLGKAVIDAL{ct:Amid} | MP III | Amidation | Free | Linear | L | None | 14 | Hemolytic | No hemolysis at 10µM (non-hemolytic) | Rat | Mastoparan (Parapolybia indica) | NA | Non-hemolytic | ||
| 15822124 | 2005 | NRLARHFRDIAGRVNQRL{nt:Acet}{ct:Amid} | P1c9k | Amidation | Acetylation | Linear | L | None | 18 | Hemolytic | Non-hemolytic | Rat | Protein Data Bank (PDB) | NA | Non-hemolytic | ||
| 15822124 | 2005 | LKDVEEAQQKIINIIRRL{nt:Acet}{ct:Amid} | P1qc7 | Amidation | Acetylation | Linear | L | None | 18 | Hemolytic | Non-hemolytic | Rat | Protein Data Bank (PDB) | NA | Non-hemolytic | ||
| 11242518 | 2001 | AVGIGALFLGFLGAAGSTMGARS{ct:Amid} | FP-1 | Amidation | Free | Linear | L | None | 23 | Hemolytic | 50% hemolysis at 40 µM | Human | Synthetic peptides derived from the gp41 domain | NA | NA | ||
| 11242518 | 2001 | AVGIGALFLGFLGAAGSTMGARS{ct:Amid} | FP-1 | Amidation | Free | Linear | L | None | 23 | Hemolytic | 90% hemolysis at 100 µM | Human | Synthetic peptides derived from the gp41 domain | NA | NA | ||
| 11242518 | 2001 | AAGLAMLFLGILSAAGSTMGARA{ct:Amid} | FP-IVAU | Amidation | Free | Linear | L | None | 23 | Hemolytic | 50-55% hemolysis at 40 µM | Human | Synthetic peptides derived from the gp41 domain | NA | NA | ||
| 11242518 | 2001 | AAGLAMLFLGILSAAGSTMGARA{ct:Amid} | FP-IVAU | Amidation | Free | Linear | L | None | 23 | Hemolytic | 55-60% hemolysis at 80 µM | Human | Synthetic peptides derived from the gp41 domain | NA | NA | ||
| 11242518 | 2001 | NNLLRAIEAQQHLLQLTVWGIKQLQARILAVERYLKDQ{ct:Amid} | DP-107 | Amidation | Free | Linear | L | None | 38 | Hemolytic | 20-30% hemolysis at40 µM | Human | Synthetic peptides derived from the gp41 domain | NA | NA | ||
| 11242518 | 2001 | NNLLRAIEAQQHLLQLTVWGIKQLQARILAVERYLKDQ{ct:Amid} | DP-107 | Amidation | Free | Linear | L | None | 38 | Hemolytic | 20-30% hemolysis at 40 µM | Human | Synthetic peptides derived from the gp41 domain | NA | NA | ||
| 11478963 | 2001 | LKLKSIVSWAKKVL{ct:Amid} | MP-B | Amidation | Free | Linear | L | None | 14 | Hypotensive | 80-85% hemolysis at 15 µM | Guinea-pig | MP-B (Vespa basalis) | NA | NA | ||
| 11478963 | 2001 | LKLKSIVSWAKKVL{ct:Amid} | MP-B | Amidation | Free | Linear | L | None | 14 | Hypotensive | 81-85% hemolysis at 15 µM | Guinea-pig | MP-B (Vespa basalis) | NA | NA | ||
| 11478963 | 2001 | L{d}K{d}L{d}K{d}S{d}I{d}V{d}S{d}W{d}A{d}K{d}K{d}V{d}L{d}{ct:Amid} | D-MP-B | Amidation | Free | Linear | D | None | 14 | Hypotensive | 82-85% hemolysis at 15 µM | Guinea-pig | Synthetic peptide | NA | NA | ||
| 11478963 | 2001 | L{d}K{d}L{d}K{d}S{d}I{d}V{d}S{d}W{d}A{d}K{d}K{d}V{d}L{d}{ct:Amid} | D-MP-B | Amidation | Free | Linear | D | None | 14 | Hypotensive | 83-85% hemolysis at 15 µM | Guinea-pig | Synthetic peptide | NA | NA | ||
| 11478963 | 2001 | LK{d}LKSIVSWAKKVL{ct:Amid} | [D-Lys2]-MP-B | Amidation | Free | Linear | Mix | None | 14 | Hypotensive | 84-85% hemolysis at 15 µM | Guinea-pig | Synthetic peptide | NA | NA | ||
| 11478963 | 2001 | LK{d}LKSIVSWAKKVL{ct:Amid} | [D-Lys2]-MP-B | Amidation | Free | Linear | Mix | None | 14 | Hypotensive | 85-85% hemolysis at 15 µM | Guinea-pig | Synthetic peptide | NA | NA | ||
| 11478963 | 2001 | LKLK{d}SIVSWAKKVL{ct:Amid} | [D-Lys4]-MP-B | Amidation | Free | Linear | Mix | None | 14 | Hypotensive | 86-85% hemolysis at 15 µM | Guinea-pig | Synthetic peptide | NA | NA | ||
| 11478963 | 2001 | LKLK{d}SIVSWAKKVL{ct:Amid} | [D-Lys4]-MP-B | Amidation | Free | Linear | Mix | None | 14 | Hypotensive | 87-85% hemolysis at 15 µM | Guinea-pig | Synthetic peptide | NA | NA | ||
| 11478963 | 2001 | LKLKSIVSWAK{d}K{d}VL{ct:Amid} | [D-Lys11,12]-MP-B | Amidation | Free | Linear | Mix | None | 14 | Hypotensive | 88-85% hemolysis at 15 µM | Guinea-pig | Synthetic peptide | NA | NA | ||
| 11478963 | 2001 | LKLKSIVSWAK{d}K{d}VL{ct:Amid} | [D-Lys11,12]-MP-B | Amidation | Free | Linear | Mix | None | 14 | Hypotensive | 89-85% hemolysis at 15 µM | Guinea-pig | Synthetic peptide | NA | NA | ||
| 11532323 | 2001 | WEAKLAKALAKALAKHLAKALAKALKACEA | PEG-KALA | Free | Free | Linear | L | None | 30 | Hemolytic | 50-60% hemolysis at 10 µg/ml | Human | Synthetic peptide | NA | NA | ||
| 11532323 | 2001 | WEAKLAKALAKALAKHLAKALAKALKACEA | PEG-KALA | Free | Free | Linear | L | None | 30 | Hemolytic | 90-95% hemolysis at 100 µg/ml | Human | Synthetic peptide | NA | NA | ||
| 21924309 | 2011 | LKLKSIVSWAKKVL{ct:Amid} | MP-B | Amidation | Free | Linear | L | None | 14 | Antioxidant | Non-hemolytic | Human | MP-B (Vespa basalis) | NA | Non-hemolytic | ||
| 21924309 | 2011 | LKWKSIVSWAKKVL{ct:Amid} | MP-B-1 | Amidation | Free | Linear | L | None | 14 | Antioxidant | Non-hemolytic | Human | MP-B analog (Vespa basalis) | NA | Non-hemolytic | ||
| 21924309 | 2011 | LKLKNIVSWAKKVL{ct:Amid} | MP-B-2 | Amidation | Free | Linear | L | None | 14 | Antioxidant | Non-hemolytic | Human | MP-B analog (Vespa basalis) | NA | Non-hemolytic | ||
| 21924309 | 2011 | LKLKSIVSYAKKVL{ct:Amid} | MP-B-3 | Amidation | Free | Linear | L | None | 14 | Antioxidant | Non-hemolytic | Human | MP-B analog (Vespa basalis) | NA | Non-hemolytic | ||
| 10747913 | 2000 | CGETCVGGTCNTPGCTCSWPVCTRNGLPV{cyc:N-C} | Kalata B1 | Free | Free | Cyclic | L | None | 29 | Anti-HIV | 50% hemolytic at 50μM | Human | Macrocyclic peptides | NA | NA | ||
| 10821683 | 2000 | CKLLLKWLLKLLKC{cyc:N-C} | Cyclic-K4L7W | Free | Free | Cyclic | L | None | 14 | Cytolytic | 50% hemolytic at 50μM | Human | Synthetic peptide | NA | NA | ||
| 10821683 | 2000 | CH3-S-CKLLLKWLLKLLKC-S-CH3 | Linear-K4L7W | Free | Free | Linear | L | None | 14 | Cytolytic | 100% hemolytic at 5μM | Human | Synthetic peptide | NA | NA | ||
| 10821683 | 2000 | C{d}K{d}L{d}L{d}L{d}K{d}W{d}L{d}L{d}K{d}L{d}L{d}K{d}C{d}{cyc:N-C} | cyclic-[D]-L3,4,8,10-K4L7W | Free | Free | Cyclic | D | None | 14 | Cytolytic | 90% hemolytic at 50μM | Human | Synthetic peptide | NA | NA | ||
| 10821683 | 2000 | C{d}K{d}L{d}L{d}L{d}K{d}W{d}L{d}L{d}K{d}L{d}L{d}K{d}C{d}{nt:CH3-S-}{ct:-S-CH3} | linear-[D]-L3,4,8,10-K4L7W | Free | Free | Linear | D | None | 14 | Cytolytic | 5% hemolytic at 50μM | Human | Synthetic peptide | NA | NA | ||
| 18501981 | 2008 | GVIIDTLKGAAKTVAAELLRKAHCKLTNSC{ct:Amid} | Brevinin-2GUb | Amidation | Free | Linear | L | None | 30 | Cytolytic | LC50 = 700μM | Human | Insulin-releasing peptide (Hylarana guntheri) | NA | NA | ||
| 19960443 | 2010 | P{d}S{d}L{d}V{d}S{d}L{d}V{d}VQ{d}LV{d}{nnr:Δ-But}-A{d}L{d}L{d}O{d}T{d}H{d}R{d}-I-{nnr:Hse}-{nnr:dab}-K{nt:β-hydroxyoctanoyl-Δ-But} | Tolaasin | Free | β-hydroxyoctanoyl-Δ-But | Linear | Mix | Δ-But = 2,3-dehydro-2-aminobutyric acid, Hse = L-homoserine, dab = D-2,4-diaminobutyric acid | 18 | Hemolytic | 100% hemolysis at 0.53 μg/mL | Rat | Tolaasin (Pseudomonas tolaasii) | NA | NA | ||
| 21343499 | 2011 | K{d}W{d}K{d}L{d}F{d}K{d}K{d}I{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d}{ct:Amid} | HDP D-P18 | Amidation | Free | Linear | D | None | 18 | Antimcrobial and Hemolytic | ~94% hemolytic at 500μM | Human | Host defense peptides analog (Rana temporaria) | NA | NA | ||
| 21343499 | 2011 | K{d}W{d}K{d}L{d}F{d}K{d}K{d}I{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d}{ct:Amid} | HDP D-P18 | Amidation | Free | Linear | D | None | 18 | Antimcrobial and Hemolytic | ~10% hemolytic at 50μM | Human | Host defense peptides analog (Rana temporaria) | NA | NA | ||
| 21343499 | 2011 | EEEEAAAK{d}W{d}K{d}L{d}F{d}K{d}K{d}I{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d}{nt:Acet}{ct:Amid} | Ac-E4-A3–D-P18 | Amidation | Acetylation | Linear | Mix | None | 24 | Antimcrobial and Hemolytic | ~3.5% hemolytic upto 500μM | Human | Host defense peptides analog (Rana temporaria) | NA | NA | ||
| 21801309 | 2011 | SWLRDIWDWICEVLSDFK | C5A | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC= 3.46μM | Human | C5A derived from the membrane anchor domain of the N-terminal region of NS5A protein | NA | NA | ||
| 21801309 | 2011 | SWLRDLWDWICEVLSDFK | I6L | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC = 13.84μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDIWDWLCEVLSDFK | I10L | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC =6.92μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDIWDWICELLSDFK | V13L | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC = 3.44μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDLWDWLCEVLSDFK | I6L/I10L | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC = 6.92μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDLWDWICELLSDFK | I6L/V13L | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC = 53.75μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDIWDWLCELLSDFK | I10L/V13L | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC = 3.44μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDLWDWLCELLSDFK | I6L/I10L/V13L | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC = 107.50μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDIWDWLCEVLSDFK | I10L | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC = 6.92μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDIWDWVCEVLSDFK | I10V | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC =13.93μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDIWDWACEVLSDFK | I10A | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC = 14.10μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDIWDWGCEVLSDFK | I10G | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC = 28.38μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDIWDWSCEVLSDFK | I10S | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC =28.00μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDIWDWECEVLSDFK | I10E | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC =217.91μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21801309 | 2011 | SWLRDIWDWKCEVLSDFK | I10K | Free | Free | Linear | L | None | 18 | Anti-HCV/HIV | MHC =214.81μM | Human | C5A derivatives (HCV) | NA | NA | ||
| 21576247 | 2011 | GLPVCGETCVGGTCNTPGCTCSWPVCTRN{cyc:N-C} | kB1 | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 41.2 ±1.5% hemolytic at 25μM | Human | Kalata B1 (Oldenlandia affinis) | NA | NA | ||
| 21576247 | 2011 | GLPKCGETCVGGTCNTPGCTCSWPVCTRN{cyc:N-C} | V4K | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 2.9±0.5% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | NA | ||
| 21576247 | 2011 | GLPVCGDTCVGGTCNTPGCTCSWPVCTRN{cyc:N-C} | E7D | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 3.8±0.4% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | NA | ||
| 21576247 | 2011 | GLPVCGEKCVGGTCNTPGCTCSWPVCTRN{cyc:N-C} | T8K | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 3.4±0.7% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | NA | ||
| 21576247 | 2011 | GLPVCGETCKGGTCNTPGCTCSWPVCTRN{cyc:N-C} | V10K | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 0±1.7% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | Non-hemolytic | ||
| 21576247 | 2011 | GLPVCGETCVGGTCKTPGCTCSWPVCTRN{cyc:N-C} | N15K | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 2.1±0.4% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | NA | ||
| 21576247 | 2011 | GLPVCGETCVGGTCNKPGCTCSWPVCTRN{cyc:N-C} | T16K | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 4.3±0.1% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | NA | ||
| 21576247 | 2011 | GLPVCGETCVGGTCNTPGCKCSWPVCTRN{cyc:N-C} | T20K | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 51.3±1.6% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | NA | ||
| 21576247 | 2011 | GLPVCGETCVGGTCNTPGCTCSWPKCTRN{cyc:N-C} | V25K | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 1.1±1.0% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | NA | ||
| 21576247 | 2011 | GLPVCGETCVGGTCNTPGCTCSWPVCTRK{cyc:N-C} | N29K | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 54.5±0.9% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | NA | ||
| 21576247 | 2011 | GLPVCGETCVGGTCNTPGCTCSKPVCTRN{cyc:N-C} | W23K | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 2.4±0.7% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | NA | ||
| 21576247 | 2011 | GLPVCGETCVGGTCNTPGCNCSWPVCTRK{cyc:N-C} | T20N29K | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 64.4±2.2% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | NA | ||
| 21576247 | 2011 | GLPVCGETCVGGTCNTPGCTCSWPVCTKN{cyc:N-C} | R28K | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 12.0±1.8% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | NA | ||
| 21576247 | 2011 | GLPVCGETCVGGTCNTPGCTCSWPVCTRN | acyclic | Free | Free | Linear | L | None | 29 | Hemolytic and Anti-HIV | 2.8±0.3% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | NA | ||
| 23262358 | 2013 | DLLGTLGNLPLPFI{ct:Amid} | frenatin 2D | Amidation | Free | Linear | L | None | 14 | Immunomodulatory | No hemolysis upto 500μM | Human | Derived from skin secretions of Discoglossus sardus (Alytidae) | NA | Non-hemolytic | ||
| 23415044 | 2013 | FLGFLKNLF | WT | Free | Free | Linear | L | None | 9 | Antiviral | HC50 =137.9μg/ml | Human | Synthetic peptide (Ctry2459) | α-helical | NA | ||
| 23415044 | 2013 | FLGFLHHLF | H2 | Free | Free | Linear | L | None | 9 | Antiviral | HC50 =203.3μg/ml | Human | Synthetic peptide (Ctry2459) | α-helical | NA | ||
| 23415044 | 2013 | FLHFLHHLF | H3 | Free | Free | Linear | L | None | 9 | Antiviral | HC50 =416.4μg/ml | Human | Synthetic peptide (Ctry2459) | α-helical | NA | ||
| 23523532 | 2013 | GFGALFKFLAKKVAKTVAKQAAKQGAKYVVNKQME{ct:Amid} | Cu 1a | Amidation | Free | Linear | L | None | 35 | Cytolytic | EC50 =7.8μM | Human | Derived from venom of Cupiennius salei | α-helical | NA | ||
| 23523532 | 2013 | GAGALAKFLAKKVAKTVAKQAAKQGAKYVVNKQME{ct:Amid} | A-Cu 1a | Amidation | Free | Linear | L | None | 35 | Cytolytic | EC50 >40μM | Human | Cu 1a analog | α-helical | NA | ||
| 23523532 | 2013 | GKGALKKFLAKKVAKTVAKQAAKQGAKYVVNKQME{ct:Amid} | K-Cu 1a | Amidation | Free | Linear | L | None | 35 | Cytolytic | EC50 >40μM | Human | Cu 1a analog | α-helical | NA | ||
| 23523532 | 2013 | GFGTILKALAKIAGKVVKKLATKPGATYMLKENLK{ct:Amid} | Cu 2a | Amidation | Free | Linear | L | None | 35 | Cytolytic | EC50 =2.6μM | Human | Derived from venom of Cupiennius salei | α-helical | NA | ||
| 6325405 | 1984 | KFTIVFPHNQKGNWKNVPSNYHYCP | VSV G | Free | Free | Linear | L | None | 25 | Hemolysin | 400μg of peptide can totally lyse 7x108 erythrocytes in 10 min at pH 5.0 | Sheep | Synthetic peptide (Vesicular Stomatitis Virus) | NA | NA | ||
| 6325405 | 1984 | CKTRTSTNTDHLWIAKSKARLSET | Synthetic peptide-1 | Free | Free | Linear | L | None | 24 | Not mentioned | 0% hemolysis upto 500μg/ml (non hemolytic) | Sheep | Synthetic peptide | NA | Non-hemolytic | ||
| 6325405 | 1984 | PKDLKETLQEKKP | Synthetic peptide-2 | Free | Free | Linear | L | None | 13 | Not mentioned | 0% hemolysis upto 500μg/ml (non hemolytic) | Sheep | Synthetic peptide | NA | Non-hemolytic | ||
| 8027544 | 1994 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Cytolytic | 100% hemolysis at 120μM | Mouse | Melttin (Honey bee venom) | NA | NA | ||
| 8027544 | 1994 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:Acet}{ct:Amid} | Ac-Melittin | Amidation | Acetylation | Linear | L | None | 26 | Cytolytic | 100% hemolysis at 120μM compared with melittin | Mouse | Melttin analog (Honey bee venom) | NA | NA | ||
| 8027544 | 1994 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Lac=p-amidophenyl-β-D-lactopyranoside} | Melittin-Lac | Lac=p-amidophenyl-β-D-lactopyranoside | Free | Linear | L | None | 26 | Cytolytic | 120% hemolysis at 120μM compared with melittin | Mouse | Melttin analog (Honey bee venom) | NA | NA | ||
| 8027544 | 1994 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:Lac=p-amidophenyl-β-D-lactopyranoside and Suc=Succinyl}{ct:Amid} | LacSuc-Melittin | Amidation | Lac=p-amidophenyl-β-D-lactopyranoside and Suc=Succinyl | Linear | L | None | 26 | Cytolytic | 43% hemolysis at 120μM compared with melittin | Mouse | Melttin analog (Honey bee venom) | NA | NA | ||
| 8027544 | 1994 | KRKRQQGIGAVLKVLTTGLPALISWI{ct:Amid} | Melittin-(21-26) (1-20) | Amidation | Free | Linear | L | None | 26 | Cytolytic | 20% hemolysis at 120μM compared with melittin | Mouse | Melttin analog (Honey bee venom) | NA | NA | ||
| 8027544 | 1994 | KRKRQQGIGAVLKVLTTGLPALISWI{nt:Acet}{ct:Amid} | Ac-Melttin-(21-26) (1-20) | Amidation | Acetylation | Linear | L | None | 26 | Cytolytic | 20% hemolysis at 120μM compared with melittin | Mouse | Melttin analog (Honey bee venom) | NA | NA | ||
| 8027544 | 1994 | QQRKRKGIGAVLKVLTTGLPALISWI{ct:Amid} | Melttin-(26-21) (1-20) | Amidation | Free | Linear | L | None | 26 | Cytolytic | 15% hemolysis at 120μM compared with melittin | Mouse | Melttin analog (Honey bee venom) | NA | NA | ||
| 8027544 | 1994 | QQRKRKGIGAVLKVLTTGLPALISWI{nt:Acet} | Ac-Melittin-(26-21) (1-20) | Free | Acetylation | Linear | L | None | 26 | Cytolytic | 15% hemolysis at 120μM compared with melittin | Mouse | Melttin analog (Honey bee venom) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-A | Free | Formylation | Linear | L | None | 26 | Cytolytic | 82% hemolysis at 25μg | Human | δ-toxin (Staphylococcus aurezis) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-A | Free | Formylation | Linear | L | None | 26 | Cytolytic | 100% hemolysis at 75μg | Human | δ-toxin (Staphylococcus aurezis) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-A | Free | Formylation | Linear | L | None | 26 | Cytolytic | 73% hemolysis at 25μg | Horse | δ-toxin (Staphylococcus aurezis) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-A | Free | Formylation | Linear | L | None | 26 | Cytolytic | 85% hemolysis at 75μg | Horse | δ-toxin (Staphylococcus aurezis) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-A | Free | Formylation | Linear | L | None | 26 | Cytolytic | 92% hemolysis at 25μg | Guinea-pig | δ-toxin (Staphylococcus aurezis) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-A | Free | Formylation | Linear | L | None | 26 | Cytolytic | 100% hemolysis at 75μg | Guinea-pig | δ-toxin (Staphylococcus aurezis) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-A | Free | Formylation | Linear | L | None | 26 | Cytolytic | 87% hemolysis at 25μg | Rabbit | δ-toxin (Staphylococcus aurezis) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-A | Free | Formylation | Linear | L | None | 26 | Cytolytic | 100% hemolysis at 75μg | Rabbit | δ-toxin (Staphylococcus aurezis) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-A | Free | Formylation | Linear | L | None | 26 | Cytolytic | 38% hemolysis at 25μg | Sheep | δ-toxin (Staphylococcus aurezis) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-A | Free | Formylation | Linear | L | None | 26 | Cytolytic | 80% hemolysis at 75μg | Sheep | δ-toxin (Staphylococcus aurezis) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-B | Free | Formylation | Linear | L | None | 26 | Cytolytic | 47% hemolysis at 25μg | Human | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-B | Free | Formylation | Linear | L | None | 26 | Cytolytic | 55% hemolysis at 75μg | Human | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-B | Free | Formylation | Linear | L | None | 26 | Cytolytic | 34% hemolysis at 25μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-B | Free | Formylation | Linear | L | None | 26 | Cytolytic | 43% hemolysis at 75μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-B | Free | Formylation | Linear | L | None | 26 | Cytolytic | 32% hemolysis at 25μg | Guinea-pig | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-B | Free | Formylation | Linear | L | None | 26 | Cytolytic | 55% hemolysis at 75μg | Guinea-pig | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-B | Free | Formylation | Linear | L | None | 26 | Cytolytic | 20% hemolysis at 25μg | Rabbit | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-B | Free | Formylation | Linear | L | None | 26 | Cytolytic | 22% hemolysis at 75μg | Rabbit | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-B | Free | Formylation | Linear | L | None | 26 | Cytolytic | 2% hemolysis at 75μg | Sheep | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK | Peptide-C | Free | Free | Linear | L | None | 26 | Cytolytic | 60% hemolysis at 75μg | Human | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK | Peptide-C | Free | Free | Linear | L | None | 26 | Cytolytic | 50% hemolysis at 75μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK | Peptide-C | Free | Free | Linear | L | None | 26 | Cytolytic | 58% hemolysis at 75μg | Guinea-pig | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK | Peptide-C | Free | Free | Linear | L | None | 26 | Cytolytic | 25% hemolysis at 75μg | Rabbit | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK | Peptide-C | Free | Free | Linear | L | None | 26 | Cytolytic | 8% hemolysis at 75μg | Sheep | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 0% hemolysis at 75μg | Human | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 12% hemolysis at 250μg | Human | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 18% hemolysis at 500μg | Human | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 0% hemolysis at 75μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 20% hemolysis at 250μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 19% hemolysis at 500μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 0% hemolysis at 75μg | Guinea-pig | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 23% hemolysis at 250μg | Guinea-pig | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 51% hemolysis at 500μg | Guinea-pig | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 0% hemolysis at 250μg | Rabbit | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 14% hemolysis at 500μg | Rabbit | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 0% hemolysis at 250μg | Sheep | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 17% hemolysis at 500μg | Sheep | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGD{nt:Formylation} | Peptide-E | Free | Formylation | Linear | L | None | 11 | Cytolytic | 0% hemolysis at 1000μg (non hemolytic) | Human | δ-toxin derivative (Synthetic peptide) | NA | Non-hemolytic | ||
| 2474443 | 1989 | MAQDIISTIGD{nt:Formylation} | Peptide-E | Free | Formylation | Linear | L | None | 11 | Cytolytic | 0% hemolysis at 1000μg (non hemolytic) | Horse | δ-toxin derivative (Synthetic peptide) | NA | Non-hemolytic | ||
| 2474443 | 1989 | MAQDIISTIGD{nt:Formylation} | Peptide-E | Free | Formylation | Linear | L | None | 11 | Cytolytic | 0% hemolysis at 1000μg (non hemolytic) | Guinea-pig | δ-toxin derivative (Synthetic peptide) | NA | Non-hemolytic | ||
| 2474443 | 1989 | MAQDIISTIGD{nt:Formylation} | Peptide-E | Free | Formylation | Linear | L | None | 11 | Cytolytic | 0% hemolysis at 1000μg (non hemolytic) | Rabbit | δ-toxin derivative (Synthetic peptide) | NA | Non-hemolytic | ||
| 2474443 | 1989 | MAQDIISTIGD{nt:Formylation} | Peptide-E | Free | Formylation | Linear | L | None | 11 | Cytolytic | 0% hemolysis at 1000μg (non hemolytic) | Sheep | δ-toxin derivative (Synthetic peptide) | NA | Non-hemolytic | ||
| 2474443 | 1989 | MLQDLLSSLGDLLKSWLDTLNKFTKK{nt:Formylation} | Peptide-F | Free | Formylation | Linear | L | None | 26 | Cytolytic | 4% hemolysis at 75μg | Human | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDLLSSLGDLLKSWLDTLNKFTKK{nt:Formylation} | Peptide-F | Free | Formylation | Linear | L | None | 26 | Cytolytic | 12% hemolysis at 75μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDLLSSLGDLLKSWLDTLNKFTKK{nt:Formylation} | Peptide-F | Free | Formylation | Linear | L | None | 26 | Cytolytic | 36% hemolysis at 75μg | Guinea-pig | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDLLSSLGDLLKSWLDTLNKFTKK{nt:Formylation} | Peptide-F | Free | Formylation | Linear | L | None | 26 | Cytolytic | 0% hemolysis at 75μg (non hemolytic) | Rabbit | δ-toxin derivative (Synthetic peptide) | NA | Non-hemolytic | ||
| 2474443 | 1989 | MLQDLLSSLGDLLKSWLDTLNKFTKK{nt:Formylation} | Peptide-F | Free | Formylation | Linear | L | None | 26 | Cytolytic | 0% hemolysis at 75μg (non hemolytic) | Sheep | δ-toxin derivative (Synthetic peptide) | NA | Non-hemolytic | ||
| 2474443 | 1989 | MLQDLLSSLGDLLKSWLDTLNKFTKK | Peptide-G | Free | Free | Linear | L | None | 26 | Cytolytic | 13% hemolysis at 75μg | Human | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDLLSSLGDLLKSWLDTLNKFTKK | Peptide-G | Free | Free | Linear | L | None | 26 | Cytolytic | 31% hemolysis at 75μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDLLSSLGDLLKSWLDTLNKFTKK | Peptide-G | Free | Free | Linear | L | None | 26 | Cytolytic | 34% hemolysis at 75μg | Guinea-pig | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDLLSSLGDLLKSWLDTLNKFTKK | Peptide-G | Free | Free | Linear | L | None | 26 | Cytolytic | 35% hemolysis at 75μg | Rabbit | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDLLSSLGDLLKSWLDTLNKFTKK | Peptide-G | Free | Free | Linear | L | None | 26 | Cytolytic | 13% hemolysis at 75μg | Sheep | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDWLSSLGDLLKSLLDTVNKFTKK{nt:Fmoc} | Peptide-H | Free | Fmoc | Linear | L | None | 26 | Cytolytic | 59% hemolysis at 75μg | Human | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDWLSSLGDLLKSLLDTVNKFTKK{nt:Fmoc} | Peptide-H | Free | Fmoc | Linear | L | None | 26 | Cytolytic | 25% hemolysis at 75μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDWLSSLGDLLKSLLDTVNKFTKK{nt:Fmoc} | Peptide-H | Free | Fmoc | Linear | L | None | 26 | Cytolytic | 91% hemolysis at 75μg | Guinea-pig | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDWLSSLGDLLKSLLDTVNKFTKK{nt:Fmoc} | Peptide-H | Free | Fmoc | Linear | L | None | 26 | Cytolytic | 43% hemolysis at 75μg | Sheep | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDWLSSLGDLLKSLLDTVNKFTKK | Peptide-I | Free | Free | Linear | L | None | 26 | Cytolytic | 40% hemolysis at 75μg | Human | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDWLSSLGDLLKSLLDTVNKFTKK | Peptide-I | Free | Free | Linear | L | None | 26 | Cytolytic | 11% hemolysis at 75μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDWLSSLGDLLKSLLDTVNKFTKK | Peptide-I | Free | Free | Linear | L | None | 26 | Cytolytic | 66% hemolysis at 75μg | Guinea-pig | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDWLSSLGDLLKSLLDTVNKFTKK | Peptide-I | Free | Free | Linear | L | None | 26 | Cytolytic | 24% hemolysis at 75μg | Sheep | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 8896194 | 1996 | LKLKSIVSWAKKVL{ct:Amid} | MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | >95% hemolysis at 30μM | Guinea-pig | Mastoparan B (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLKSIVSWAKKVL{ct:Amid} | MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | 80% hemolysis at 20μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LNLKSIVSWAKKVL{ct:Amid} | [Asn2]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | ~5% hemolysis at 30μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LNLKSIVSWAKKVL{ct:Amid} | [Asn2]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | ~4% hemolysis at 20μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLNSIVSWAKKVL{ct:Amid} | [Asn4]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | >95% hemolysis at 30μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLNSIVSWAKKVL{ct:Amid} | [Asn4]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | >75% hemolysis at 20μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLLSIVSWAKKVL{ct:Amid} | [Leu4]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | ~80% hemolysis at 30μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLLSIVSWAKKVL{ct:Amid} | [Leu4]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | >75% hemolysis at 20μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LNLNSIVSWAKKVL{ct:Amid} | [Asn2,4]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | ~5% hemolysis at 30μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LNLNSIVSWAKKVL{ct:Amid} | [Asn2,4]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | ~3% hemolysis at 20μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLKSIVSFAKKVL{ct:Amid} | [Phe9]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | ~5% hemolysis at 30μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLKSIVSFAKKVL{ct:Amid} | [Phe9]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | ~3% hemolysis at 20μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLKSIVSYAKKVL{ct:Amid} | [Tyr9]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | ~4% hemolysis at 30μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLKSIVSYAKKVL{ct:Amid} | [Tyr9]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | ~2% hemolysis at 20μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLKSIVSWALKVL{ct:Amid} | [Leu11]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | >80% hemolysis at 30μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLKSIVSWALKVL{ct:Amid} | [Leu11]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | >70% hemolysis at 20μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLKSIVSWAKLVL{ct:Amid} | [Leu12]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | ~70% hemolysis at 30μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLKSIVSWAKLVL{ct:Amid} | [Leu12]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | >55% hemolysis at 20μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLKSIVSWALLVL{ct:Amid} | [Leu11,12]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | ~80% hemolysis at 30μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 8896194 | 1996 | LKLKSIVSWALLVL{ct:Amid} | [Leu11,12]-MP-B | Amidation | Free | Linear | L | None | 14 | Edema inducer | ~55% hemolysis at 20μM | Guinea-pig | Mastoparan B analog (from the venom of black-bellied hornet Vespa basalis) | NA | NA | ||
| 9026036 | 1997 | CIGAVLKVLTTGLPALISWIKRKRQQ | Dioleoylmelittin | Free | Free | Linear | L | None | 26 | Membrane disturbing | ~20% hemolysis at 1μM | Dog | Synthetic peptide | NA | NA | ||
| 9026036 | 1997 | CIGAVLKVLTTGLPALISWIKRKRQQ | Dioleoylmelittin | Free | Free | Linear | L | None | 26 | Membrane disturbing | 100% hemolysis at 10μM | Dog | Synthetic peptide | NA | NA | ||
| 15304333 | 2004 | ACGILHDNCVYVPAQNPCCRGLQCRYGKCLVQV{ct:Amid} | PcFK1 | Amidation | Free | Linear | L | None | 33 | Antiplasmodial | No hemolysis at 10μM (non hemolytic) | Human | Psalmopeotoxins (venom of the Trinidad chevron tarantula Psalmopoeus cambridgei) | NA | Non-hemolytic | ||
| 15304333 | 2004 | RCLPAGKTCVRGPMRVPCCGSCSQNKCT | PcFK2 | Free | Free | Linear | L | None | 28 | Antiplasmodial | No hemolysis at 10μM (non hemolytic) | Human | Psalmopeotoxins (venom of the Trinidad chevron tarantula Psalmopoeus cambridgei) | NA | Non-hemolytic | ||
| 18332165 | 2008 | KILRGVCKKIMRTFLRRISKDILTGKK{ct:Amid} | NK-2 | Amidation | Free | Linear | L | None | 27 | Antiplasmodial | No hemolysis upto 10μM (non hemolytic) | Human | Synthetic shortened analog of the mammalian defense protein NK-lysin | NA | Non-hemolytic | ||
| 10600529 | 1999 | RHARHD | Hannahpep | Free | Free | Linear | L | None | 6 | Plasma-anticlotting | No hemolysis (non hemolytic) | Human | Indian King Cobra (Ophiophagus hannah) Venom | NA | Non-hemolytic | ||
| 10600529 | 1999 | RHARHD | Hannahpep | Free | Free | Linear | L | None | 6 | Plasma-anticlotting | No hemolysis (non hemolytic) | Goat | Indian King Cobra (Ophiophagus hannah) Venom | NA | Non-hemolytic | ||
| 10600529 | 1999 | RHARHD | Hannahpep | Free | Free | Linear | L | None | 6 | Plasma-anticlotting | No hemolysis (non hemolytic) | Mouse | Indian King Cobra (Ophiophagus hannah) Venom | NA | Non-hemolytic | ||
| 17927208 | 2007 | FHPSLWVLIPQYIQLIRKILKSG | Conolysin-Mt | Free | Free | Linear | L | None | 23 | Cytolytic | 40% hemolysis at 1µM | Human | Derived from venom of Conus mustelinus | NA | NA | ||
| 17927208 | 2007 | FHPSLWVLIPQYIQLIRKILKSG | Conolysin-Mt | Free | Free | Linear | L | None | 23 | Cytolytic | ~90% hemolysis at 10µM | Human | Derived from venom of Conus mustelinus | NA | NA | ||
| 17884127 | 2007 | GLLDFVTGVGKDIFAQLIKQI{ct:Amid} | Ocellatin 4 | Amidation | Free | Linear | L | None | 21 | Cytolytic | HC50 =14.3 mM | Human | Derived from skin secretion of Leptodactylus ocellatus | NA | NA | ||
| 9108731 | 1996 | GFFALIPKIISSPLFKTLLSAVGSALSSSGEQE | PX1–33 | Free | Free | Linear | L | None | 33 | Cytolytic | Conc. Required for hemolysis =1.75nmols | Human | Synthetic Peptide | NA | NA | ||
| 9108731 | 1996 | GFFALIAKIISSPLFKTLLSAVGSALSSSGEQE | PX1–33 (P7A) | Free | Free | Linear | L | None | 33 | Cytolytic | Conc. Required for hemolysis =0.6nmols | Human | Synthetic Peptide | NA | NA | ||
| 9108731 | 1996 | GFFALIPKIISSPLFKTLLSAVGSAL | PX1–26 | Free | Free | Linear | L | None | 26 | Cytolytic | Conc. Required for hemolysis =1.1nmols | Human | Synthetic Peptide | NA | NA | ||
| 9108731 | 1996 | GFFALIPKIISSPLFKTL{ct:Amid} | PX1–18 | Amidation | Free | Linear | L | None | 18 | Cytolytic | No hemolysis (Non hemolysis) | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 9108731 | 1996 | GFFALIAKIISSPLFKTL{ct:Amid} | PX1–18 (P7A) | Amidation | Free | Linear | L | None | 18 | Cytolytic | Conc. Required for hemolysis =7.1nmols | Human | Synthetic Peptide | NA | NA | ||
| 9518597 | 1998 | {nnr:Aib}-P-{nnr:Aib}-A-{nnr:Aib}-AQ-{nnr:Aib}-V-{nnr:Aib}-GL-{nnr:Aib}-PV-{nnr:Aib}-{nnr:Aib}-EQ{nt:Acet}{ct:Phenol} | Alam-P14 | Phenol | Acetylation | Linear | L | Aib = α- methylalanine | 19 | Cytolytic | EC50 =30μM | Human | Alamethicin | NA | NA | ||
| 9889358 | 1998 | KLLLK{nt:Dansylation}{ct:Amid} | DnsLK5NH2 | Amidation | Dansylation | Linear | L | None | 5 | Cytotoxin | LD50 =90μM | Human | Synthetic Peptide | α-Helix | NA | ||
| 9889358 | 1998 | KLLLKLLLK{nt:Dansylation} | DnsLK9 | Free | Dansylation | Linear | L | None | 9 | Cytotoxin | LD50 =4.5 μM | Human | Synthetic Peptide | α-Helix | NA | ||
| 9889358 | 1998 | KLLLKLLLK{nt:Dansylation}{ct:Amid} | DnsLK9 | Amidation | Dansylation | Linear | L | None | 9 | Cytotoxin | LD50 =2.5 μM | Human | Synthetic Peptide | α-Helix | NA | ||
| 9889358 | 1998 | KLLKLLLKLLKLLLKLLLKLLK{nt:Dansylation} | DnsLK22 | Free | Dansylation | Linear | L | None | 22 | Cytotoxin | LD50 =0.3 μM | Human | Synthetic Peptide | α-Helix | NA | ||
| 9889358 | 1998 | KLLKLLLKLLKLLLKLLLKLLK{nt:Dansylation}{ct:Amid} | DnsLK22 | Amidation | Dansylation | Linear | L | None | 22 | Cytotoxin | LD50 =0.1 μM | Human | Synthetic Peptide | α-Helix | NA | ||
| 9889358 | 1998 | KLLKLLLKLLLKLLK | LK15 | Free | Free | Linear | L | None | 15 | Cytotoxin | LD50 =0.8 μM | Human | Synthetic Peptide | α-Helix | NA | ||
| 9889358 | 1998 | KLLKLLLKLLLKLLK{nt:Dansylation} | DnsLK15 | Free | Dansylation | Linear | L | None | 15 | Cytotoxin | LD50 =0.3 μM | Human | Synthetic Peptide | α-Helix | NA | ||
| 9889358 | 1998 | LKLLLLKLLKLKLWK | r-LK15 | Free | Free | Linear | L | None | 15 | Cytotoxin | LD50 =5 μM | Human | Synthetic Peptide | α-Helix | NA | ||
| 11318033 | 2001 | QL{d}LVDL{d}I{cyc:N-C} | Lichenysin | Free | Free | Cyclic | Mix | None | 7 | Chelating agent | 100% hemolysis at 15μM | Human | Bacillus licheniformis | NA | NA | ||
| 10600388 | 1999 | CAESCVYIPCTVTALLGCSCSNRVCYNGIP{cyc:N-C} | Cycloviolacin O1 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CGESCVWIPCISSAIGCSCKSKVCYRNGIP{cyc:N-C} | Cycloviolacin O2 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CGESCVWIPCLTSAIGCSCKSKVCYRNGIP{cyc:N-C} | Cycloviolacin O3 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CGESCVWIPCISSAIGCSCKNKVCYRNGIP{cyc:N-C} | Cycloviolacin O4 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CGESCVWIPCISSAVGCSCKNKVCYKNGTP{cyc:N-C} | Cycloviolacin O5 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CGESCVWIPCISAAVGCSCKSKVCYKNGTLP{cyc:N-C} | Cycloviolacin O6 | Free | Free | Cyclic | L | None | 31 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CGESCVWIPCTITALAGCKCKSKVCYNSIP{cyc:N-C} | Cycloviolacin O7 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CESCVWIPCISSVVGCSCKSKVCYKNGTLP{cyc:N-C} | Cycloviolacin O8 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CGESCVWIPCLTSAVGCSCKSKVCYRNGIP{cyc:N-C} | Cycloviolacin O9 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CGESCVYIPCLTSAVGCSCKSKVCYRNGIP{cyc:N-C} | Cycloviolacin O10 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CGESCVWIPCISAVVGCSCKSKVCYKNGTLP{cyc:N-C} | Cycloviolacin O11 | Free | Free | Cyclic | L | None | 31 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CGESCVYIPCLTSAIGCSCKSKVCYRNGIP{cyc:N-C} | Cycloviolacin H1 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CGESCVYIPCISGVIGCSCTDKVCYLNGTP{cyc:N-C} | Kalata B5 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CGESCVWIPCISAALGCSCKNKVCYRNGIP{cyc:N-C} | Circulin A | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CGESCVFIPCISTLLGCSCKNKVCYRNGVIP{cyc:N-C} | Circulin B | Free | Free | Cyclic | L | None | 31 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CGESCVFIPCVTALLGCSCKSKVCYKNSIP{cyc:N-C} | Cyclopsychotride A | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | VCGETCVGGTCNTPGCSCSRPVCTRNGLP{cyc:N-C} | Violapeptide I | Free | Free | Cyclic | L | None | 29 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | ICGETCVGGTCNTPGCSCSWPVCTRNGLP{cyc:N-C} | Cycloviolacin O12 | Free | Free | Cyclic | L | None | 29 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | VCGETCFGGTCNTPGCSCTWPICTRDGLP{cyc:N-C} | Kalata B2 | Free | Free | Cyclic | L | None | 29 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | TCGETCFGGTCNTPGCTCDPWPICTDRGLP{cyc:N-C} | Kalata B3 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | VCGETCVGGTCNTPGCTCSWPVCTRDGLP{cyc:N-C} | Kalata B4 | Free | Free | Cyclic | L | None | 29 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | VCGETCEGGTCNTPGCSCSWPVCTRNGLP{cyc:N-C} | Kalata S | Free | Free | Cyclic | L | None | 29 | Anti-HIV | 51% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 3125066 | 1988 | GIGKFLHSAKKFGKAFVGEIMNS | Maganin 2 | Free | Free | Linear | L | None | 23 | Antiparasitic | 4% hemolysis at 50μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GIGKFLHSAKKFGKAFVGEIMNS | Maganin 2 | Free | Free | Linear | L | None | 23 | Antiparasitic | 3% hemolysis at 100μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GIGKFLHSAKKFGKAFVGEIMNS | Maganin 2 | Free | Free | Linear | L | None | 23 | Antiparasitic | 3% hemolysis at 200μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GIGKFLHSAKKFGKAFVGEIMNS | Maganin 2 | Free | Free | Linear | L | None | 23 | Antiparasitic | 4% hemolysis at 500μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GIGKFLHSAKKFGKAFVGEIMNS | Maganin 2 | Free | Free | Linear | L | None | 23 | Antiparasitic | 6% hemolysis at 1000μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GWASKIGQTLGKIAKVGLKELIQPK | XPF | Free | Free | Linear | L | None | 24 | Antiparasitic | 1% hemolysis at 50μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GWASKIGQTLGKIAKVGLKELIQPK | XPF | Free | Free | Linear | L | None | 24 | Antiparasitic | 1% hemolysis at 100μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GWASKIGQTLGKIAKVGLKELIQPK | XPF | Free | Free | Linear | L | None | 24 | Antiparasitic | 2% hemolysis at 200μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GWASKIGQTLGKIAKVGLKELIQPK | XPF | Free | Free | Linear | L | None | 24 | Antiparasitic | 5% hemolysis at 500μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GWASKIGQTLGKIAKVGLKELIQPK | XPF | Free | Free | Linear | L | None | 24 | Antiparasitic | 6% hemolysis at 1000μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GMASKAGAIAGKIAKVALKAL{ct:Amid} | PGLa | Amidation | Free | Linear | L | None | 21 | Antiparasitic | 4% hemolysis at 50μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GMASKAGAIAGKIAKVALKAL{ct:Amid} | PGLa | Amidation | Free | Linear | L | None | 21 | Antiparasitic | 3% hemolysis at 100μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GMASKAGAIAGKIAKVALKAL{ct:Amid} | PGLa | Amidation | Free | Linear | L | None | 21 | Antiparasitic | 4% hemolysis at 200μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GMASKAGAIAGKIAKVALKAL{ct:Amid} | PGLa | Amidation | Free | Linear | L | None | 21 | Antiparasitic | 5% hemolysis at 500μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GMASKAGAIAGKIAKVALKAL{ct:Amid} | PGLa | Amidation | Free | Linear | L | None | 21 | Antiparasitic | 7% hemolysis at 1000μg/ml | Human | Xenopus laevis | NA | NA | ||
| 11937508 | 2002 | ALWKTLLKKVLKA{ct:Amid} | K4-S4(1-13)NH2 | Amidation | Free | Linear | L | None | 13 | Antiparasitic | 3% hemolysis at 10μM | Human | Synthetic Peptide | NA | NA | ||
| 11937508 | 2002 | ALWKTLLKKVLKA{nt:H2N-CH2-CO-P}{ct:Amid} | Glycyl-P | Amidation | H2N-CH2-CO-P | Linear | L | None | 13 | Antiparasitic | 2% hemolysis at 10μM | Human | Synthetic Peptide | NA | NA | ||
| 11937508 | 2002 | ALWKTLLKKVLKA{nt:H2N-(CH2)3-CO-P}{ct:Amid} | Aminobutyryl-P | Amidation | H2N-(CH2)3-CO-P | Linear | L | None | 13 | Antiparasitic | 1% hemolysis at 10μM | Human | Synthetic Peptide | NA | NA | ||
| 11937508 | 2002 | ALWKTLLKKVLKA{nt:H2N-(CH2)6-CO-P}{ct:Amid} | Aminoheptanoyl-P | Amidation | H2N-(CH2)6-CO-P | Linear | L | None | 13 | Antiparasitic | 1% hemolysis at 10μM | Human | Synthetic Peptide | NA | NA | ||
| 11937508 | 2002 | ALWKTLLKKVLKA{nt:H2N-(CH2)11-CO-P}{ct:Amid} | Aminolauroyl-P | Amidation | H2N-(CH2)11-CO-P | Linear | L | None | 13 | Antiparasitic | 4% hemolysis at 10μM | Human | Synthetic Peptide | NA | NA | ||
| 11937508 | 2002 | ALWKTLLKKVLKA{nt:H2N-C((CH2)4-NH2)H-CO-P}{ct:Amid} | Lysyl-P | Amidation | H2N-C((CH2)4-NH2)H-CO-P | Linear | L | None | 13 | Antiparasitic | 5% hemolysis at 10μM | Human | Synthetic Peptide | NA | NA | ||
| 12379643 | 2002 | GLWSTIKQKGKEAAIAAAKAAGQAALGAL{ct:Amid} | DS 01 | Amidation | Free | Linear | L | None | 29 | Antiparasitic | 0.41% hemolysis at 4μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 12379643 | 2002 | GLWSTIKQKGKEAAIAAAKAAGQAALGAL{ct:Amid} | DS 01 | Amidation | Free | Linear | L | None | 29 | Antiparasitic | 0.54% hemolysis at 8μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 12379643 | 2002 | GLWSTIKQKGKEAAIAAAKAAGQAALGAL{ct:Amid} | DS 01 | Amidation | Free | Linear | L | None | 29 | Antiparasitic | 0.81% hemolysis at 16μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 12379643 | 2002 | GLWSTIKQKGKEAAIAAAKAAGQAALGAL{ct:Amid} | DS 01 | Amidation | Free | Linear | L | None | 29 | Antiparasitic | 1.08% hemolysis at 32μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 12379643 | 2002 | GLWSTIKQKGKEAAIAAAKAAGQAALGAL{ct:Amid} | DS 01 | Amidation | Free | Linear | L | None | 29 | Antiparasitic | 1.36% hemolysis at 64μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 12379643 | 2002 | GLWSTIKQKGKEAAIAAAKAAGQAALGAL{ct:Amid} | DS 01 | Amidation | Free | Linear | L | None | 29 | Antiparasitic | 2.17% hemolysis at 128μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 15513914 | 2004 | FLPLIGRVLSGIL{ct:Amid} | Temporin A | Amidation | Free | Linear | L | None | 13 | Antiparasitic | LC50 >120μM | Human | Rana temporaria | NA | NA | ||
| 15513914 | 2004 | LLPIVGNLLKSLL{ct:Amid} | Temporin B | Amidation | Free | Linear | L | None | 13 | Antiparasitic | LC50 >120μM | Human | Rana temporaria | NA | NA | ||
| 18984589 | 2009 | KKALL{nnr:O}HALH{nnr:O}LALLA{nnr:O}HLAH{nnr:O}LKKA{ct:Amid} | HALO | Amidation | Free | Linear | L | O = L-Ornithine | 26 | Antiparasitic | HC50 =179.2μM | Human | Synthetic Peptide | NA | NA | ||
| 18984589 | 2009 | ALALL{nnr:O}HALH{nnr:O}LALLA{nnr:O}HLAH{nnr:O}LALA{ct:Amid} | HALO-2 | Amidation | Free | Linear | L | O = L-Ornithine | 26 | Antiparasitic | HC50 <5.6μM | Human | Synthetic Peptide | NA | NA | ||
| 18984589 | 2009 | FFKKL{nnr:O}HALH{nnr:O}LALLA{nnr:O}HLAH{nnr:O}LKKA{ct:Amid} | HALO-F | Amidation | Free | Linear | L | O = L-Ornithine | 26 | Antiparasitic | HC50 <5.6μM | Human | Synthetic Peptide | NA | NA | ||
| 18984589 | 2009 | KKALL{nnr:O}HPLH{nnr:O}LALLA{nnr:O}HLAH{nnr:O}LKKA{ct:Amid} | HALO-P8 | Amidation | Free | Linear | L | O = L-Ornithine | 26 | Antiparasitic | HC50 =89.6μM | Human | Synthetic Peptide | NA | NA | ||
| 18984589 | 2009 | A{d}K{d}K{d}L{d}{nnr:d-o}H{d}A{d}L{d}H{d}{nnr:d-o}A{d}L{d}L{d}A{d}L{d}{nnr:d-o}H{d}L{d}A{d}H{d}{nnr:d-o}L{d}L{d}A{d}K{d}K{d}{ct:Amid} | D-HALO-rev | Amidation | Free | Linear | D | o = D-Ornithine | 26 | Antiparasitic | HC50 =716.8μM | Human | Synthetic Peptide | NA | NA | ||
| 18984589 | 2009 | A{d}K{d}K{d}L{d}{nnr:d-o}H{d}A{d}L{d}H{d}{nnr:d-o}A{d}L{d}L{d}A{d}L{d}{nnr:d-o}H{d}L{d}P{d}H{d}{nnr:d-o}L{d}K{d}K{d}F{d}F{d}{ct:Amid} | D-HALO-P8F-rev | Amidation | Free | Linear | D | o = D-Ornithine | 26 | Antiparasitic | HC50 >65.2μM | Human | Synthetic Peptide | NA | NA | ||
| 10441158 | 1999 | CGETCVGGTCNTPGCTCSWPVCTRNGLPV{cyc:N-C} | Kalata B1 | Free | Free | Cyclic | L | None | 29 | Uterotonic | HD50 =50μM | Human | O. affinis | NA | NA | ||
| 10441158 | 1999 | CGESCVFIPCISTLLGCSCKNKVCYRNGVIP{cyc:N-C} | Circulin B | Free | Free | Cyclic | L | None | 30 | Uterotonic | HD50 =30μM | Human | O. affinis | NA | NA | ||
| 20564013 | 2010 | GLPVCGETCVGGTCNTPGCTCSWPVCTRN{cyc:N-C} | Kalata B1 | Free | Free | Cyclic | L | None | 30 | Pesticidal | HD50 = 20.0±1.1μM | Human | Cyclotides (Oldenlandia affinis) | NA | NA | ||
| 20564013 | 2010 | GLPVCGETCTLGTVYTQGCTCSWPICKRN{cyc:N-C} | Kalata B7 | Free | Free | Cyclic | L | None | 30 | Pesticidal | HD50 = 55.2±1.3μM | Human | Cyclotides (Oldenlandia affinis) | NA | NA | ||
| 16460023 | 2006 | FKIKASKVLDKFGKIVGKVLKQLKKVSAVAKV | P6_1 | Free | Free | Linear | L | None | 32 | Hemolytic | LD50=12.6µM | Human | Peptides derived from Trialysin protein found in the saliva of Triatoma infestans | NA | NA | ||
| 16460023 | 2006 | FSISASKVLDKFGKIVGKVLKQLKKVSAVAKV | P6_2 | Free | Free | Linear | L | None | 32 | Hemolytic | LD50=28.1µM | Human | Peptides derived from Trialysin protein found in the saliva of Triatoma infestans | NA | NA | ||
| 24041697 | 2013 | GIVEQCCTSICSLYQLENYCN | Porcine Insulin | Free | Free | Linear | L | None | 21 | Amyloidogenicity | 57.4 ± 4.6 % Hemolysis at 60 µM | Human | Insulin Derived From Pigs | α-Helix | NA | ||
| 24041697 | 2013 | FVNQHLCGSHLVEALYLVCGERGFFYTPKA | DOI | Free | Free | Linear | L | None | 30 | Amyloidogenicity | 45.9 ± 3.4 % Hemolysis at 60 µM | Human | An Insulin Analog | α-Helix | NA | ||
| 23868208 | 2013 | ALAGTIIAGASLTFQVLDKVLEELGKVSRK{ct:Amid} | StII1–30 | Amidation | Free | Linear | L | None | 30 | Cytolytic | 1.0±0.02 % Hemolysis at 40 µM | Human | Stichodactyla Helianthus | α-Helical | Non-hemolytic | ||
| 23868208 | 2013 | AWAGTIIAGASLTFQVLDKVLEELGKVSRK{ct:Amid} | StII1–30L2W | Amidation | Free | Linear | L | None | 30 | Cytolytic | 1.0±0.02 % Hemolysis at 40 µM | Human | Analogs Of Stii1–30 | α-Helical | Non-hemolytic | ||
| 23868208 | 2013 | ALAGTIIAGASWTFQVLDKVLEELGKVSRK{ct:Amid} | StII1–30L12W | Amidation | Free | Linear | L | None | 30 | Cytolytic | 1.0±0.01 % Hemolysis at 40 µM | Human | Analogs Of Stii1–30 | α-Helical | Non-hemolytic | ||
| 23868208 | 2013 | ALAGTIIAGASLTFQVWDKVLEELGKVSRK{ct:Amid} | StII1–30L17W | Amidation | Free | Linear | L | None | 30 | Cytolytic | 0.9 ±0.8 % Hemolysis at 40 µM | Human | Analogs Of Stii1–30 | α-Helical | Non-hemolytic | ||
| 23868208 | 2013 | ALAGTIIAGASLTFQVLDKVLEEWGKVSRK{ct:Amid} | StII1–30L24W | Amidation | Free | Linear | L | None | 30 | Cytolytic | 1.0±0.02 % Hemolysis at 40 µM | Human | Analogs Of Stii1–30 | α-Helical | Non-hemolytic | ||
| 25054164 | 2014 | LRPAILVRTK{ct:Amid} | sauvatide | Amidation | Free | Linear | L | None | 10 | myotropic agent on rat | <8 % Hemolysis at 512 mg/L | Horse | Phyllomedusa Sauvagei Skin Secretion | NA | Low hemolytic | ||
| 24411680 | 2014 | RKDVY{ct:Amid} | TP-5 | Amidation | Free | Linear | L | None | 5 | Anti-mycobacterial | 50 % Hemolysis at >2000 mg/L | Rat | Synthetic Immunomodulatory Pentapeptide Of Thymopentin | α-Helix | Non-hemolytic | ||
| 24411680 | 2014 | RRRRRR{ct:Amid} | RR-6 | Amidation | Free | Linear | L | None | 6 | Anti-mycobacterial | 50 % Hemolysis at >2000 mg/L | Rat | Synthetic Peptide | α-Helix | Non-hemolytic | ||
| 24411680 | 2014 | RKDVYRRRRRR{ct:Amid} | RR-11 | Amidation | Free | Linear | L | None | 11 | Anti-mycobacterial | 50 % Hemolysis at >2000 mg/L | Rat | Synthetic Modified Peptides Of Thymopentin | α-Helix | Non-hemolytic | ||
| 24411680 | 2014 | RRRRRRRKDVY{ct:Amid} | RY-11 | Amidation | Free | Linear | L | None | 11 | Anti-mycobacterial | 50 % Hemolysis at >2000 mg/L | Rat | Synthetic Modified Peptides Of Thymopentin | α-Helix | Non-hemolytic | ||
| 24965354 | 2014 | WQWRMKKLG | LfcinB9 | Free | Free | Linear | L | None | 9 | Anti-ovarian cancer | ~7 % Hemolysis at 640 μg/ml | Sheep | Bovine Lactoferricin B | NA | Low hemolytic | ||
| 25025626 | 2014 | KGD | vasotab TY | Free | Free | Linear | L | None | 3 | Anti-thrombosis, vasodilator activity | 0 % Hemolysis at 5 μg/ml | Human | Horsefly Of Tabanus Yao | NA | Non-hemolytic | ||
| 25025626 | 2014 | KGD | vasotab TY | Free | Free | Linear | L | None | 3 | Anti-thrombosis, vasodilator activity | 0 % Hemolysis at 320 μg/ml | Human | Horsefly Of Tabanus Yao | NA | Non-hemolytic | ||
| 25056849 | 2015 | FLGLLGSLL{ct:Amid} | Feleucin-BO1 | Amidation | Free | Linear | L | None | 9 | Antibaterial | 100 % Hemolysis at 80 µM | Horse | Synthetic,Skin Secretion Of Bombina Orientalis | Random coil | NA | ||
| 25869678 | 2015 | MQFITDLIKKAVDFFKGLFGNK | WRK | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 2.78 µM | Human | Staphylococcus Warneri | α-Helix | NA | ||
| 25869678 | 2015 | MQFITDLIGKAVDFFKGLFGNK | WRK_K9G | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at >20 µM | Human | Staphylococcus Warneri | α-Helix | NA | ||
| 25869678 | 2015 | MQFITDLIKKAVDFFKGLFDNK | WRK_G20D | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 9.09 µM | Human | Staphylococcus Warneri | α-Helix | NA | ||
| 25869678 | 2015 | MQFITDLIGKAVDFFKGLFDNK | WRK_K9G-G20D | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at >20 µM | Human | Staphylococcus Warneri | α-Helix | NA | ||
| 25869678 | 2015 | MQFITDLIKKAVDVFKGLFGNK | WRK_F14V | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 12.5 µM | Human | Staphylococcus Warneri | α-Helix | NA | ||
| 25869678 | 2015 | MQFITDLIKKAVDFIKGLFGNK | WRK_F15I | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 2.63 µM | Human | Staphylococcus Warneri | α-Helix | NA | ||
| 25869678 | 2015 | MQFITDLIKKAVDVIKGLFGNK | WRK_F14V-F15I | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 8.33 µM | Human | Staphylococcus Warneri | α-Helix | NA | ||
| 25869678 | 2015 | MQFITDLIKKAVDFFKGLVGNK | WRK_F19V | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 11.1 µM | Human | Staphylococcus Warneri | α-Helix | NA | ||
| 25869678 | 2015 | MQTFQDILGKVIEVIKAIVDAK | rPSM | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 20 µM | Human | Staphylococcus Warneri | α-Helix | NA | ||
| 25869678 | 2015 | MADVIAKIVEIVKGLIDQFTQK | PSM | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 7.14 µM | Human | Staphylococcus Epidermidis | α-Helix | NA | ||
| 25869678 | 2015 | MAGVIAKIVEIVKGLIDQFTQK | PSM_D3G | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 3.7 µM | Human | Staphylococcus Epidermidis | α-Helix | NA | ||
| 25869678 | 2015 | MADVIAKIVEIVKKLIDQFTQK | PSM_G14K | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 9.88 µM | Human | Staphylococcus Epidermidis | α-Helix | NA | ||
| 25869678 | 2015 | MAGVIAKIVEIVKKLIDQFTQK | PSM_D3G-G14K | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 3.125 µM | Human | Staphylococcus Epidermidis | α-Helix | NA | ||
| 25869678 | 2015 | MADVIAKFVEIVKGLIDQFTQK | PSM_I8F | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at >20 µM | Human | Staphylococcus Epidermidis | α-Helix | NA | ||
| 25869678 | 2015 | MADVIAKIFEIVKGLIDQFTQK | PSM_V9F | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 4.76 µM | Human | Staphylococcus Epidermidis | α-Helix | NA | ||
| 25869678 | 2015 | MADVIAKFFEIVKGLIDQFTQK | PSM_I8F-V9F | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at >20 µM | Human | Staphylococcus Epidermidis | α-Helix | NA | ||
| 25869678 | 2015 | MADFIAKIVEIVKGLIDQFTQK | PSM_V4F | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 10 µM | Human | Staphylococcus Epidermidis | α-Helix | NA | ||
| 25869678 | 2015 | MNGFILGKFFDVAKKILDTIFQK | rWRK | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 4 µM | Human | Staphylococcus Epidermidis | α-Helix | NA | ||
| 26134716 | 2015 | SELAGTIIDGASLTFEVLDKVLGELGKVSRK{ct:Amid} | StI1-31 | Amidation | Free | Linear | L | None | 31 | Hemolytic | 50 % Hemolysis at 7.25 ± 0.01 nM | Human | Stichodactyla Helianthus | α-Helix | NA | ||
| 26134716 | 2015 | ALAGTIIAGASLTFQVLDKVLEELGKVSRK{ct:Amid} | StII1-30 | Amidation | Free | Linear | L | None | 30 | Hemolytic | 50 % Hemolysis at 0.22 ± 0.002 nM | Human | Stichodactyla Helianthus | α-Helix | NA | ||
| 26134716 | 2015 | SADVAGAVIDGASLSFDILKTVLEALGNVKRK{ct:Amid} | EqtII1-32 | Amidation | Free | Linear | L | None | 32 | Hemolytic | 50 % Hemolysis at 0.91 ± 0.01 nM | Human | Actinia Equina | α-Helix | NA | ||
| 26134716 | 2015 | SADVAGAVIDGAGLGFDVLKTVLEALGNVKRK{ct:Amid} | FraC1-32 | Amidation | Free | Linear | L | None | 32 | Hemolytic | 50 % Hemolysis at 0.96 ± 0.06 nM | Human | Actinia Fragacea | α-Helix | NA | ||
| 26380930 | 2015 | LLKKLLKK{ct:Amid} | LK | Amidation | Free | Linear | L | None | 8 | Anti-mycobacterial | 50 % Hemolysis at >500 μg/ml | Rat | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 26380930 | 2015 | PLLKKLLKKP{ct:Amid} | PP | Amidation | Free | Linear | L | None | 10 | Anti-mycobacterial | 50 % Hemolysis at >500 μg/ml | Rat | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 26380930 | 2015 | CLLKKLLKKC{ct:Amid} | CC | Amidation | Free | Linear | L | None | 10 | Anti-mycobacterial | 50 % Hemolysis at >500 μg/ml | Rat | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 26380930 | 2015 | ILLKKLLKKI{ct:Amid} | II | Amidation | Free | Linear | L | None | 10 | Anti-mycobacterial | 50 % Hemolysis at >500 μg/ml | Rat | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 26380930 | 2015 | MLLKKLLKKM{ct:Amid} | MM | Amidation | Free | Linear | L | None | 10 | Anti-mycobacterial | 50 % Hemolysis at >500 μg/ml | Rat | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 26380930 | 2015 | WLLKKLLKKW{ct:Amid} | WW | Amidation | Free | Linear | L | None | 10 | Anti-mycobacterial | 50 % Hemolysis at 363 μg/ml | Rat | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 26196285 | 2015 | IALILEPICCQERAA | PA | Free | Free | Linear | L | None | 15 | Hemolytic | 50 % Hemolysis at 0.77 mM | Human | Peptide Inhibitors Of Complement C1 (Pic1) | NA | NA | ||
| 26196285 | 2015 | RALILEPICCQERAA | PA-I1R | Free | Free | Linear | L | None | 15 | Hemolytic | 91.93 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IRLILEPICCQERAA | PA-A2R | Free | Free | Linear | L | None | 15 | Hemolytic | 87.28 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IARILEPICCQERAA | PA-L3R | Free | Free | Linear | L | None | 15 | Hemolytic | 80.45 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALRLEPICCQERAA | PA-I4R | Free | Free | Linear | L | None | 15 | Hemolytic | 43.71 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALIREPICCQERAA | PA-L5R | Free | Free | Linear | L | None | 15 | Hemolytic | 93.4 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILRPICCQERAA | PA-E6R | Free | Free | Linear | L | None | 15 | Hemolytic | 87.59 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILERICCQERAA | PA-P7R | Free | Free | Linear | L | None | 15 | Hemolytic | 89.85 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPRCCQERAA | PA-I8R | Free | Free | Linear | L | None | 15 | Hemolytic | 62.32 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPIRCQERAA | PA-C9R | Free | Free | Linear | L | None | 15 | Hemolytic | 89.54 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPICRQERAA | PA-C10R | Free | Free | Linear | L | None | 15 | Hemolytic | 89.8 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPICCRERAA | PA-Q11R | Free | Free | Linear | L | None | 15 | Hemolytic | 90.87 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQRRAA | PA-E12R | Free | Free | Linear | L | None | 15 | Hemolytic | 95.83 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQERRA | PA-A14R | Free | Free | Linear | L | None | 15 | Hemolytic | 88.65 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQERAR | PA-A15R | Free | Free | Linear | L | None | 15 | Hemolytic | 44.24 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | EALILEPICCQERAA | PA-I1E | Free | Free | Linear | L | None | 15 | Hemolytic | 89.27 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IELILEPICCQERAA | PA-A2E | Free | Free | Linear | L | None | 15 | Hemolytic | 92.24 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IAEILEPICCQERAA | PA-L3E | Free | Free | Linear | L | None | 15 | Hemolytic | 100.27 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALELEPICCQERAA | PA-I4E | Free | Free | Linear | L | None | 15 | Hemolytic | 92.07 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALIEEPICCQERAA | PA-L5E | Free | Free | Linear | L | None | 15 | Hemolytic | 94.33 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEEICCQERAA | PA-P7E | Free | Free | Linear | L | None | 15 | Hemolytic | 96.1 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPECCQERAA | PA-I8E | Free | Free | Linear | L | None | 15 | Hemolytic | 95.74 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPIECQERAA | PA-C9E | Free | Free | Linear | L | None | 15 | Hemolytic | 91.62 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPICEQERAA | PA-C10E | Free | Free | Linear | L | None | 15 | Hemolytic | 95.21 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPICCEERAA | PA-Q11E | Free | Free | Linear | L | None | 15 | Hemolytic | 65.6 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQEEAA | PA-R13E | Free | Free | Linear | L | None | 15 | Hemolytic | 101.99 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQEREA | PA-A14E | Free | Free | Linear | L | None | 15 | Hemolytic | 98.09 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQERAE | PA-A15E | Free | Free | Linear | L | None | 15 | Hemolytic | 93.13 % Hemolysis at 0.77 mM | Human | Pa Derivatives | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQERAA{ct:dPEG24} | PA-dPEG24 | dPEG24 | Free | Linear | L | None | 15 | Inhibits complement activation in vivo | 2.99 % Hemolysis at 0.77 mM | Human | Pegylated Pa Peptides | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQERAA{ct:dPEG20} | PA-dPEG20 | dPEG20 | Free | Linear | L | None | 15 | Hemolytic | 11.41 % Hemolysis at 0.77 mM | Human | Pegylated Pa Peptides | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQERAA{ct:dPEG16} | PA-dPEG16 | dPEG16 | Free | Linear | L | None | 15 | Hemolytic | 12.04 % Hemolysis at 0.77 mM | Human | Pegylated Pa Peptides | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQERAA{ct:dPEG12} | PA-dPEG12 | dPEG12 | Free | Linear | L | None | 15 | Hemolytic | 11.41 % Hemolysis at 0.77 mM | Human | Pegylated Pa Peptides | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQERAA{ct:dPEG08} | PA-dPEG08 | dPEG08 | Free | Linear | L | None | 15 | Hemolytic | 34.66 % Hemolysis at 0.77 mM | Human | Pegylated Pa Peptides | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQERAA{ct:dPEG06} | PA-dPEG06 | dPEG06 | Free | Linear | L | None | 15 | Hemolytic | 44.82 % Hemolysis at 0.77 mM | Human | Pegylated Pa Peptides | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQERAA{ct:dPEG04} | PA-dPEG04 | dPEG04 | Free | Linear | L | None | 15 | Hemolytic | 12.36 % Hemolysis at 0.77 mM | Human | Pegylated Pa Peptides | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQERAA{ct:dPEG03} | PA-dPEG03 | dPEG03 | Free | Linear | L | None | 15 | Hemolytic | 12.57 % Hemolysis at 0.77 mM | Human | Pegylated Pa Peptides | NA | NA | ||
| 26196285 | 2015 | IALILEPICCQERAA{ct:dPEG02} | PA-dPEG02 | dPEG02 | Free | Linear | L | None | 15 | Hemolytic | 11.62 % Hemolysis at 0.77 mM | Human | Pegylated Pa Peptides | NA | NA | ||
| 26905802 | 2016 | WILEYLWKVPFDFWRGVI | E1P47 | Free | Free | Linear | L | None | 18 | Antiviral, Anti-HIV | 100 % Hemolysis at 0 µM | Rabbit | Gb Virus C | α-Helix | NA | ||
| 26905802 | 2016 | WILEYLWKVPFDFWRGVI | E1P47 | Free | Free | Linear | L | None | 18 | Antiviral, Anti-HIV | 50 % Hemolysis at 1 µM | Rabbit | Gb Virus C | α-Helix | NA | ||
| 26905802 | 2016 | WILEYLWKVPFDFWRGVI | E1P47 | Free | Free | Linear | L | None | 18 | Antiviral, Anti-HIV | 25 % Hemolysis at 2 µM | Rabbit | Gb Virus C | α-Helix | NA | ||
| 26905802 | 2016 | WILEYLWKVPFDFWRGVI | E1P47 | Free | Free | Linear | L | None | 18 | Antiviral, Anti-HIV | <25 % Hemolysis at 3 µM | Rabbit | Gb Virus C | α-Helix | NA | ||
| 26905802 | 2016 | WILEYLWKVPFDFWRGVI | E1P47 | Free | Free | Linear | L | None | 18 | Antiviral, Anti-HIV | <25 % Hemolysis at 4 µM | Rabbit | Gb Virus C | α-Helix | NA | ||
| 26905802 | 2016 | WILEYLWKVPFDFWRGVI | E1P47 | Free | Free | Linear | L | None | 18 | Antiviral, Anti-HIV | <25 % Hemolysis at 5 µM | Rabbit | Gb Virus C | α-Helix | NA | ||
| 27598770 | 2016 | MQFITDLIKKAVDFFKGLFGNK | WRK | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 2.78 µM | Human | Staphylococci | α-Helix | NA | ||
| 27598770 | 2016 | MQFITDLIKKAVDFFKGLFDNK | WarnG20D | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 12.36 µM | Human | Warnericin Rk Derivative | α-Helix | NA | ||
| 27598770 | 2016 | MQFITDLIKKAVDVFKGLFGNK | WarnF14V | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 12.5 µM | Human | Warnericin Rk Derivative | α-Helix | NA | ||
| 27008420 | 2016 | KKLKKFKKLQ{cyc:N-C} | BPC194 | Free | Free | Cyclic | L | None | 10 | Anti-plant-pathogenic bacteria and fungi | 4 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C7H15})FKKLQ{cyc:N-C} | BPC498 | Free | Free | Cyclic | L | CO-C7H15 = octanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 78 ± 4 % Hemolysis at 150 µM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C3H7})FKKLQ{cyc:N-C} | BPC500 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 28 ± 5 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C4H9})FKKLQ{cyc:N-C} | BPC526 | Free | Free | Cyclic | L | CO-C4H9 = pentanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 62 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-isoC5H11})FKKLQ{cyc:N-C} | BPC504 | Free | Free | Cyclic | L | CO-isoC5H11 = 4-methylpentanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 89 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-nC5H11})FKKLQ{cyc:N-C} | BPC528 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 98 ± 7 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK(LK-{nnr:CO-nC5H11})FKKLQ{cyc:N-C} | BPC596 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 12 | Anti-plant-pathogenic bacteria and fungi | 93 ± 5 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C6H13})FKKLQ{cyc:N-C} | BPC592 | Free | Free | Cyclic | L | CO-C6H13 = 2-methylhexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 100 ± 4 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C8H17})FKKLQ{cyc:N-C} | BPC594 | Free | Free | Cyclic | L | CO-C8H17 = 4-methyloctanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 93 ± 11 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C11H23})FKKLQ{cyc:N-C} | BPC530 | Free | Free | Cyclic | L | CO-C11H23 = lauroyl | 10 | Anti-plant-pathogenic bacteria and fungi | 89 ± 7 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C11H22OH})FKKLQ{cyc:N-C} | BPC524 | Free | Free | Cyclic | L | CO-C11H22OH = 12-hydroxylauroyl | 10 | Anti-plant-pathogenic bacteria and fungi | 100 ± 8 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C15H31})FKKLQ{cyc:N-C} | BPC502 | Free | Free | Cyclic | L | CO-C15H31 = palmitoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 78 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C17H33})FKKLQ{cyc:N-C} | BPC622 | Free | Free | Cyclic | L | CO-C17H33 = oleoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 91 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKFKK({nnr:CO-nC5H11})LQ{cyc:N-C} | BPC582 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 92 ± 3 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKFK({nnr:CO-nC5H11})KLQ{cyc:N-C} | BPC584 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 72 ± 5 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLK({nnr:CO-nC5H11})KFKKLQ{cyc:N-C} | BPC586 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 92 ± 9 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK({nnr:CO-nC5H11})LKKFKKLQ{cyc:N-C} | BPC588 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 95 ± 4 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK({nnr:CO-C3H7})LKKFKKLQ{cyc:N-C} | BPC708 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 2 ± 0.5 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K({nnr:CO-nC5H11})KLKKFKKLQ{cyc:N-C} | BPC590 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 100 ± 9 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K({nnr:CO-C3H7})KLKKFKKLQ{cyc:N-C} | BPC710 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 7 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{nnr:CO-C3H7}F{d}KKLQ{cyc:N-C} | BPC712 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 30 ± 4 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKLK-{nnr:CO-C3H7}F{d}KKLQ{cyc:N-C} | BPC726 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, f = D-phenylalanine | 12 | Anti-plant-pathogenic bacteria and fungi | 0 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{nnr:CO-nC5H11}F{d}KKLQ{cyc:N-C} | BPC624 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 53 ± 5 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{nnr:CO-isoC5H11}F{d}KKLQ{cyc:N-C} | BPC626 | Free | Free | Cyclic | Mix | CO-isoC5H11 = 4-methylpentanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 51 ± 7 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKLK-{nnr:CO-nC5H11}F{d}KKLQ{cyc:N-C} | BPC674 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine | 12 | Anti-plant-pathogenic bacteria and fungi | 51 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{nnr:CO-C7H15}F{d}KKLQ{cyc:N-C} | BPC668 | Free | Free | Cyclic | Mix | CO-C7H15 = octanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 79 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK{nnr:CO-C3H7}LKKF{d}KKLQ{cyc:N-C} | BPC714 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 3 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK{nnr:CO-nC5H11}LKKF{d}KKLQ{cyc:N-C} | BPC680 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 77 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K{nnr:CO-C3H7}KLKKF{d}KKLQ{cyc:N-C} | BPC716 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 2 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K{nnr:CO-nC5H11}KLKKF{d}KKLQ{cyc:N-C} | BPC686 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 10 ± 0.2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-C3H7}FKKLQ{cyc:N-C} | BPC702 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 1 ± 0.1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}LK-{nnr:CO-C3H7}FKKLQ{cyc:N-C} | BPC724 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, k = D-Lys | 12 | Anti-plant-pathogenic bacteria and fungi | 3 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-nC5H11}FKKLQ{cyc:N-C} | BPC628 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 19 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-isoC5H11}FKKLQ{cyc:N-C} | BPC630 | Free | Free | Cyclic | Mix | CO-isoC5H11 = 4-methylpentanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 22 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}LK-{nnr:CO-nC5H11}FKKLQ{cyc:N-C} | BPC672 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, k = D-Lys | 12 | Anti-plant-pathogenic bacteria and fungi | 33 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-C7H15}FKKLQ{cyc:N-C} | BPC666 | Free | Free | Cyclic | Mix | CO-C7H15 = octanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 61 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK{d}{nnr:CO-nC5H11}LKKFKKLQ{cyc:N-C} | BPC678 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 68 ± 3 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK{d}{nnr:CO-C3H7}LKKFKKLQ{cyc:N-C} | BPC704 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 9 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K{d}{nnr:CO-nC5H11}KLKKFKKLQ{cyc:N-C} | BPC684 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 8 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K{d}{nnr:CO-C3H7}KLKKFKKLQ{cyc:N-C} | BPC706 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 35 ± 3 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-nC5H11}F{d}KKLQ{cyc:N-C} | BPC632 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 21 ± 13 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-isoC5H11}F{d}KKLQ{cyc:N-C} | BPC634 | Free | Free | Cyclic | Mix | CO-isoC5H11 = 4-methylpentanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 7 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C3H7})HKKLQ{cyc:N-C} | BPC718 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 3 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK(LK-{nnr:CO-C3H7})HKKLQ{cyc:N-C} | BPC728 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 12 | Anti-plant-pathogenic bacteria and fungi | 0 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Non-hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-nC5H11})HKKLQ{cyc:N-C} | BPC636 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 5 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-isoC5H11})HKKLQ{cyc:N-C} | BPC638 | Free | Free | Cyclic | L | CO-isoC5H11 = 4-methylpentanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 6 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK(LK-{nnr:CO-nC5H11})HKKLQ{cyc:N-C} | BPC676 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 12 | Anti-plant-pathogenic bacteria and fungi | 3 ± 0.3 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C7H15})HKKLQ{cyc:N-C} | BPC670 | Free | Free | Cyclic | L | CO-C7H15 = octanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 34 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK({nnr:CO-nC5H11})LKKHKKLQ{cyc:N-C} | BPC682 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 20 ± 3 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK({nnr:CO-C3H7})LKKHKKLQ{cyc:N-C} | BPC720 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 3 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K({nnr:CO-nC5H11})KLKKHKKLQ{cyc:N-C} | BPC688 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 1 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K({nnr:CO-C3H7})KLKKHKKLQ{cyc:N-C} | BPC722 | Free | Free | Cyclic | L | CO-C3H7= butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 3 ± 0.2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKFKKLQ{cyc:N-C} | BPC194 | Free | Free | Cyclic | L | None | 10 | Anti-plant-pathogenic bacteria and fungi | 6 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C7H15})FKKLQ{cyc:N-C} | BPC498 | Free | Free | Cyclic | L | CO-C7H15 = octanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 100 ± 12 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C3H7})FKKLQ{cyc:N-C} | BPC500 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 38 ± 4 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C4H9})FKKLQ{cyc:N-C} | BPC526 | Free | Free | Cyclic | L | CO-C4H9 = pentanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 78 ± 3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-isoC5H11})FKKLQ{cyc:N-C} | BPC504 | Free | Free | Cyclic | L | CO-isoC5H11 = 4-methylpentanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 93 ± 3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-nC5H11})FKKLQ{cyc:N-C} | BPC528 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 100 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK(LK-{nnr:CO-nC5H11})FKKLQ{cyc:N-C} | BPC596 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 12 | Anti-plant-pathogenic bacteria and fungi | 100 ± 11 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C6H13})FKKLQ{cyc:N-C} | BPC592 | Free | Free | Cyclic | L | CO-C6H13 = 2-methylhexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 98 ± 6 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C8H17})FKKLQ{cyc:N-C} | BPC594 | Free | Free | Cyclic | L | CO-C8H17 = 4-methyloctanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 96 ± 3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C11H23})FKKLQ{cyc:N-C} | BPC530 | Free | Free | Cyclic | L | CO-C11H23 = lauroyl | 10 | Anti-plant-pathogenic bacteria and fungi | 91 ± 9 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C11H22OH})FKKLQ{cyc:N-C} | BPC524 | Free | Free | Cyclic | L | CO-C11H22OH = 12-hydroxylauroyl | 10 | Anti-plant-pathogenic bacteria and fungi | 100 ± 6 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C15H31})FKKLQ{cyc:N-C} | BPC502 | Free | Free | Cyclic | L | CO-C15H31 = palmitoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 99 ± 2 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C17H33})FKKLQ{cyc:N-C} | BPC622 | Free | Free | Cyclic | L | CO-C17H33 = oleoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 97 ± 3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKFKK({nnr:CO-nC5H11})LQ{cyc:N-C} | BPC582 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 96 ± 10 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKFK({nnr:CO-nC5H11})KLQ{cyc:N-C} | BPC584 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 97 ± 12 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLK({nnr:CO-nC5H11})KFKKLQ{cyc:N-C} | BPC586 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 95 ± 20 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK({nnr:CO-nC5H11})LKKFKKLQ{cyc:N-C} | BPC588 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 92 ± 12 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK({nnr:CO-C3H7})LKKFKKLQ{cyc:N-C} | BPC708 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 3 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K({nnr:CO-nC5H11})KLKKFKKLQ{cyc:N-C} | BPC590 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 100 ± 9 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K({nnr:CO-C3H7})KLKKFKKLQ{cyc:N-C} | BPC710 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 13 ± 2 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{nnr:CO-C3H7}F{d}KKLQ{cyc:N-C} | BPC712 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 38 ± 7 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKLK-{nnr:CO-C3H7}F{d}KKLQ{cyc:N-C} | BPC726 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, f = D-phenylalanine | 12 | Anti-plant-pathogenic bacteria and fungi | 4 ± 2 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{nnr:CO-nC5H11}F{d}KKLQ{cyc:N-C} | BPC624 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 64 ± 9 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{nnr:CO-isoC5H11}F{d}KKLQ{cyc:N-C} | BPC626 | Free | Free | Cyclic | Mix | CO-isoC5H11 = 4-methylpentanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 54 ± 4 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKLK-{nnr:CO-nC5H11}F{d}KKLQ{cyc:N-C} | BPC674 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine | 12 | Anti-plant-pathogenic bacteria and fungi | 56 ± 2 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{nnr:CO-C7H15}F{d}KKLQ{cyc:N-C} | BPC668 | Free | Free | Cyclic | Mix | CO-C7H15 = octanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 79 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK{nnr:CO-C3H7}LKKF{d}KKLQ{cyc:N-C} | BPC714 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 3 ± 0.5 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK{nnr:CO-nC5H11}LKKF{d}KKLQ{cyc:N-C} | BPC680 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 81 ± 4 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K{nnr:CO-C3H7}KLKKF{d}KKLQ{cyc:N-C} | BPC716 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 4 ± 0.5 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K{nnr:CO-nC5H11}KLKKF{d}KKLQ{cyc:N-C} | BPC686 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 14 ± 0.4 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-C3H7}FKKLQ{cyc:N-C} | BPC702 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 2 ± 0.3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}LK-{nnr:CO-C3H7}FKKLQ{cyc:N-C} | BPC724 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, k = D-Lys | 12 | Anti-plant-pathogenic bacteria and fungi | 3 ± 0.5 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-nC5H11}FKKLQ{cyc:N-C} | BPC628 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 34 ± 3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-isoC5H11}FKKLQ{cyc:N-C} | BPC630 | Free | Free | Cyclic | Mix | CO-isoC5H11 = 4-methylpentanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 28 ± 3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}LK-{nnr:CO-nC5H11}FKKLQ{cyc:N-C} | BPC672 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, k = D-Lys | 12 | Anti-plant-pathogenic bacteria and fungi | 33 ± 2 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-C7H15}FKKLQ{cyc:N-C} | BPC666 | Free | Free | Cyclic | Mix | CO-C7H15 = octanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 73 ± 3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK{d}{nnr:CO-nC5H11}LKKFKKLQ{cyc:N-C} | BPC678 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 73 ± 4 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK{d}{nnr:CO-C3H7}LKKFKKLQ{cyc:N-C} | BPC704 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 16 ± 2 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K{d}{nnr:CO-nC5H11}KLKKFKKLQ{cyc:N-C} | BPC684 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 13 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K{d}{nnr:CO-C3H7}KLKKFKKLQ{cyc:N-C} | BPC706 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 46 ± 3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-nC5H11}F{d}KKLQ{cyc:N-C} | BPC632 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 22 ± 10 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}({nnr:CO-isoC5H11})F{d}KKLQ{cyc:N-C} | BPC634 | Free | Free | Cyclic | L | CO-isoC5H11 = 4-methylpentanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 17 ± 8 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C3H7})HKKLQ{cyc:N-C} | BPC718 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 4 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK(LK-{nnr:CO-C3H7})HKKLQ{cyc:N-C} | BPC728 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 12 | Anti-plant-pathogenic bacteria and fungi | 7 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-nC5H11})HKKLQ{cyc:N-C} | BPC636 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 16 ± 5 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-isoC5H11})HKKLQ{cyc:N-C} | BPC638 | Free | Free | Cyclic | L | CO-isoC5H11 = 4-methylpentanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 8 ± 5 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK(LK-{nnr:CO-nC5H11})HKKLQ{cyc:N-C} | BPC676 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 12 | Anti-plant-pathogenic bacteria and fungi | 3 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C7H15})HKKLQ{cyc:N-C} | BPC670 | Free | Free | Cyclic | L | CO-C7H15 = octanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 40 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK({nnr:CO-nC5H11})LKKHKKLQ{cyc:N-C} | BPC682 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 27 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK({nnr:CO-C3H7})LKKHKKLQ{cyc:N-C} | BPC720 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 4 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K({nnr:CO-nC5H11})KLKKHKKLQ{cyc:N-C} | BPC688 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 1 ± 0.2 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Non-hemolytic | ||
| 27008420 | 2016 | K({nnr:CO-C3H7})KLKKHKKLQ{cyc:N-C} | BPC722 | Free | Free | Cyclic | L | CO-C3H7= butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 3 ± 0.1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 26450121 | 2016 | GIHDILKYGKPS | Myxinidin | Free | Free | Linear | L | None | 12 | Anti‑biofilm | 0 % Hemolysis at 50-400 µM | Human | Epidermal Mucus Of The Hagfish | α-Helical | Non-hemolytic | ||
| 26450121 | 2016 | GIHHILKYGKPS | Myxinidin 1 | Free | Free | Linear | L | None | 12 | Anti‑biofilm | 0 % Hemolysis at 50-400 µM | Human | Epidermal Mucus Of The Hagfish | α-Helical | Non-hemolytic | ||
| 26450121 | 2016 | KIKWILKYWKWS | Myxinidin 2 | Free | Free | Linear | L | None | 12 | Anti‑biofilm | 10 % Hemolysis at 50 µM | Human | Myxinidin Analogs | α-Helical | NA | ||
| 26450121 | 2016 | KIKWILKYWKWS | Myxinidin 2 | Free | Free | Linear | L | None | 12 | Anti‑biofilm | <20 % Hemolysis at 100 µM | Human | Myxinidin Analogs | α-Helical | NA | ||
| 26450121 | 2016 | KIKWILKYWKWS | Myxinidin 2 | Free | Free | Linear | L | None | 12 | Anti‑biofilm | 30 % Hemolysis at 200 µM | Human | Myxinidin Analogs | α-Helical | NA | ||
| 26450121 | 2016 | KIKWILKYWKWS | Myxinidin 2 | Free | Free | Linear | L | None | 12 | Anti‑biofilm | 50 % Hemolysis at 400 µM | Human | Myxinidin Analogs | α-Helical | NA | ||
| 26450121 | 2016 | RIRWILRYWRWS | Myxinidin 3 | Free | Free | Linear | L | None | 12 | Anti‑biofilm | 12 % Hemolysis at 25 µM | Human | Myxinidin Analogs | α-Helical | NA | ||
| 26450121 | 2016 | RIRWILRYWRWS | Myxinidin 4 | Free | Free | Linear | L | None | 12 | Anti‑biofilm | 30 % Hemolysis at 50 µM | Human | Myxinidin Analogs | α-Helical | NA | ||
| 26450121 | 2016 | RIRWILRYWRWS | Myxinidin 5 | Free | Free | Linear | L | None | 12 | Anti‑biofilm | <50 % Hemolysis at 100 µM | Human | Myxinidin Analogs | α-Helical | NA | ||
| 26450121 | 2016 | RIRWILRYWRWS | Myxinidin 6 | Free | Free | Linear | L | None | 12 | Anti‑biofilm | 60 % Hemolysis at 200 µM | Human | Myxinidin Analogs | α-Helical | NA | ||
| 26450121 | 2016 | RIRWILRYWRWS | Myxinidin 7 | Free | Free | Linear | L | None | 12 | Anti‑biofilm | ~60 % Hemolysis at 400 µM | Human | Myxinidin Analogs | α-Helical | NA | ||
| 25546564 | 2016 | VRPPPASKSL | 1 | Free | Free | Linear | L | None | 10 | Antioxidant | <25 % Hemolysis at 1 mg/mL | Rat | Synthetic | NA | NA | ||
| 25546564 | 2016 | LPGGGHGDL | 2 | Free | Free | Linear | L | None | 10 | Antioxidant | <35 % Hemolysis at 1 mg/mL | Rat | Synthetic | NA | NA | ||
| 25546564 | 2016 | FLKMN | 3 | Free | Free | Linear | L | None | 5 | Antioxidant | 35 % Hemolysis at 1 mg/mL | Rat | Synthetic | NA | NA | ||
| 25546564 | 2016 | GKFNV | 4 | Free | Free | Linear | L | None | 5 | Antioxidant | <35 % Hemolysis at 1 mg/mL | Rat | Synthetic | NA | NA | ||
| 25546564 | 2016 | LPGGGT | 5 | Free | Free | Linear | L | None | 6 | Antioxidant | <45 % Hemolysis at 1 mg/mL | Rat | Synthetic | NA | NA | ||
| 25546564 | 2016 | HA | 6 | Free | Free | Linear | L | None | 2 | Antioxidant | 45 % Hemolysis at 1 mg/mL | Rat | Synthetic | NA | NA | ||
| 25546564 | 2016 | KEER | 7 | Free | Free | Linear | L | None | 4 | Antioxidant | <40 % Hemolysis at 1 mg/mL | Rat | Synthetic | NA | NA | ||
| 28126555 | 2017 | RCGNQQFKVFVNGQ | G4 | Free | Free | Linear | L | None | 14 | Batericidal | 0 % Hemolysis at 100 µM | Fish | Channa Striatus | α-Helix | Non-hemolytic | ||
| 28126555 | 2017 | RCGNQQFKVFVNGQWWWWW | G4W | Free | Free | Linear | L | None | 19 | Batericidal | 0 % Hemolysis at 100 µM | Fish | Fish Galectin 4 Derived Membrane | α-Helix | Non-hemolytic | ||
| 28004513 | 2017 | GVSRCLSRRGVSRCLSRR | 2Ser_L | Free | Free | Linear | L | None | 12 | Antitumour | 0.0 ± 0.4 % Hemolysis at 5 μg/ml | Human | Synthesized Θ-Defensin Analogues | NA | Non-hemolytic | ||
| 28004513 | 2017 | GVSRCLSRRGVSRCLSRR | 2Ser_L | Free | Free | Linear | L | None | 12 | Antitumour | 0.0 ± 0.5 % Hemolysis at 10 μg/ml | Human | Synthesized Θ-Defensin Analogues | NA | Non-hemolytic | ||
| 28004513 | 2017 | GVSRCLSRRGVSRCLSRR | 2Ser_L | Free | Free | Linear | L | None | 12 | Antitumour | 0.0 ± 0.1 % Hemolysis at 25 μg/ml | Human | Synthesized Θ-Defensin Analogues | NA | Non-hemolytic | ||
| 28608418 | 2017 | LVGKLLKGAVGDVCGLLPIC | OA-A1 | Free | Free | Linear | L | None | 20 | Anti-diabetic | 1.82% ± 0.14 % Hemolysis at 1 nM | Human | Skin Secretions Of Odorrana Andersonii | NA | NA | ||
| 28608418 | 2017 | LVGKLLKGAVGDVCGLLPIC | OA-A1 | Free | Free | Linear | L | None | 20 | Anti-diabetic | 2.82% ± 0.17 % Hemolysis at 10 nM | Human | Skin Secretions Of Odorrana Andersonii | NA | NA | ||
| 28608418 | 2017 | LVGKLLKGAVGDVCGLLPIC | OA-A1 | Free | Free | Linear | L | None | 20 | Anti-diabetic | 1.03% ± 0.86 % Hemolysis at 100 nM | Human | Skin Secretions Of Odorrana Andersonii | NA | NA | ||
| 28608418 | 2017 | LVGKLLKGAVGDVCGLLPIC | OA-A1 | Free | Free | Linear | L | None | 20 | Anti-diabetic | 2.72% ± 0.54 % Hemolysis at 1 µM | Human | Skin Secretions Of Odorrana Andersonii | NA | NA | ||
| 28608418 | 2017 | LVGKLLKGAVGDVCGLLPIC | OA-A1 | Free | Free | Linear | L | None | 20 | Anti-diabetic | 2.58% ± 0.11 % Hemolysis at 10 µM | Human | Skin Secretions Of Odorrana Andersonii | NA | NA | ||
| 28608418 | 2017 | LVGKLLKGAVGDVCGLLPIC | OA-A1 | Free | Free | Linear | L | None | 20 | Anti-diabetic | 1.26% ± 0.39 % Hemolysis at 100 µM | Human | Skin Secretions Of Odorrana Andersonii | NA | NA | ||
| 28883642 | 2017 | LCLRNWDQGHRP | L12P | Free | Free | Linear | L | None | 12 | Fungicidal | 0.32 % Hemolysis at 50 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LCLRNWDQGHRP | L12P | Free | Free | Linear | L | None | 12 | Fungicidal | 0 % Hemolysis at 50 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LCLRNWDQGHRP | L12P | Free | Free | Linear | L | None | 12 | Fungicidal | 0.16 % Hemolysis at 100 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LCLRNWDQGHRP | L12P | Free | Free | Linear | L | None | 12 | Fungicidal | 0 % Hemolysis at 100 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LCLRNWDQGHRP | L12P | Free | Free | Linear | L | None | 12 | Fungicidal | 0 % Hemolysis at 250 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LCLRNWDQGHRP | L12P | Free | Free | Linear | L | None | 12 | Fungicidal | 0 % Hemolysis at 250 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LCLRNWDQGHRP | L12P | Free | Free | Linear | L | None | 12 | Fungicidal | 0 % Hemolysis at 500 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LCLRNWDQGHRP | L12P | Free | Free | Linear | L | None | 12 | Fungicidal | 0 % Hemolysis at 500 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | WTFGQGTKVEIK | W12K | Free | Free | Linear | L | None | 12 | Fungicidal | 0 % Hemolysis at 50 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | WTFGQGTKVEIK | W12K | Free | Free | Linear | L | None | 12 | Fungicidal | 0 % Hemolysis at 50 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | WTFGQGTKVEIK | W12K | Free | Free | Linear | L | None | 12 | Fungicidal | 0 % Hemolysis at 100 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | WTFGQGTKVEIK | W12K | Free | Free | Linear | L | None | 12 | Fungicidal | 0 % Hemolysis at 100 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | WTFGQGTKVEIK | W12K | Free | Free | Linear | L | None | 12 | Fungicidal | 0.21 % Hemolysis at 250 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | WTFGQGTKVEIK | W12K | Free | Free | Linear | L | None | 12 | Fungicidal | 0 % Hemolysis at 250 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | WTFGQGTKVEIK | W12K | Free | Free | Linear | L | None | 12 | Fungicidal | 0.16 % Hemolysis at 500 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | WTFGQGTKVEIK | W12K | Free | Free | Linear | L | None | 12 | Fungicidal | 0 % Hemolysis at 500 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | GYCSGGSCYS | G10S | Free | Free | Linear | L | None | 10 | Fungicidal | 0 % Hemolysis at 50 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | GYCSGGSCYS | G10S | Free | Free | Linear | L | None | 10 | Fungicidal | 0.59 % Hemolysis at 50 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | GYCSGGSCYS | G10S | Free | Free | Linear | L | None | 10 | Fungicidal | 0 % Hemolysis at 100 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | GYCSGGSCYS | G10S | Free | Free | Linear | L | None | 10 | Fungicidal | 0 % Hemolysis at 100 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | GYCSGGSCYS | G10S | Free | Free | Linear | L | None | 10 | Fungicidal | 0.11 % Hemolysis at 250 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | GYCSGGSCYS | G10S | Free | Free | Linear | L | None | 10 | Fungicidal | 0.51 % Hemolysis at 250 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | GYCSGGSCYS | G10S | Free | Free | Linear | L | None | 10 | Fungicidal | 0.53 % Hemolysis at 500 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | GYCSGGSCYS | G10S | Free | Free | Linear | L | None | 10 | Fungicidal | 0.98 % Hemolysis at 500 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LLVLRSLGPWHPGHCLLR | L18R | Free | Free | Linear | L | None | 18 | Fungicidal | 0 % Hemolysis at 50 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LLVLRSLGPWHPGHCLLR | L18R | Free | Free | Linear | L | None | 18 | Fungicidal | 4.4 % Hemolysis at 50 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LLVLRSLGPWHPGHCLLR | L18R | Free | Free | Linear | L | None | 18 | Fungicidal | 0 % Hemolysis at 100 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LLVLRSLGPWHPGHCLLR | L18R | Free | Free | Linear | L | None | 18 | Fungicidal | 5.8 % Hemolysis at 100 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LLVLRSLGPWHPGHCLLR | L18R | Free | Free | Linear | L | None | 18 | Fungicidal | 0 % Hemolysis at 250 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LLVLRSLGPWHPGHCLLR | L18R | Free | Free | Linear | L | None | 18 | Fungicidal | 7.54 % Hemolysis at 250 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LLVLRSLGPWHPGHCLLR | L18R | Free | Free | Linear | L | None | 18 | Fungicidal | 0.2 % Hemolysis at 500 µM in 30min | Human | Synthetic | NA | Non-hemolytic | ||
| 28883642 | 2017 | LLVLRSLGPWHPGHCLLR | L18R | Free | Free | Linear | L | None | 18 | Fungicidal | 9.66 % Hemolysis at 500 µM in 120min | Human | Synthetic | NA | Non-hemolytic | ||
| 28834399 | 2017 | YA{d}F{nnr:Cyn} | 1 | Free | Free | Linear | Mix | Cyn = trans-1-cinnamilpiperazine, a = D-Ala | 3 | Antitumour | 0.8±0.1 % Hemolysis at 0 µM | Human | Synthetic Peptidomimetics | NA | NA | ||
| 28834399 | 2017 | YA{d}F{nnr:Cyn} | 1 | Free | Free | Linear | Mix | Cyn = trans-1-cinnamilpiperazine, a = D-Ala | 3 | Antitumour | 2.2±0.0 % Hemolysis at 100 µM | Human | Synthetic Peptidomimetics | NA | NA | ||
| 28834399 | 2017 | YA{d}F{nnr:Cyn} | 1 | Free | Free | Linear | Mix | Cyn = trans-1-cinnamilpiperazine, a = D-Ala | 3 | Antitumour | 2.4±0.1 % Hemolysis at 250 µM | Human | Synthetic Peptidomimetics | NA | NA | ||
| 28834399 | 2017 | YA{d}W{cyn} | 2 | Free | Free | Linear | Mix | Cyn = trans-1-cinnamilpiperazine, a = D-Ala | 3 | Antitumour | 1.1±0.0 % Hemolysis at 0 µM | Human | Synthetic Peptidomimetics | NA | NA | ||
| 28834399 | 2017 | YA{d}W{cyn} | 2 | Free | Free | Linear | Mix | Cyn = trans-1-cinnamilpiperazine, a = D-Ala | 3 | Antitumour | 1.7±0.0 % Hemolysis at 100 µM | Human | Synthetic Peptidomimetics | NA | NA | ||
| 28834399 | 2017 | YA{d}W{cyn} | 2 | Free | Free | Linear | Mix | Cyn = trans-1-cinnamilpiperazine, a = D-Ala | 3 | Antitumour | 2.4±0.0 % Hemolysis at 250 µM | Human | Synthetic Peptidomimetics | NA | NA | ||
| 28834399 | 2017 | YT{d}F{nnr:Cyn} | 3 | Free | Free | Linear | Mix | Cyn = trans-1-cinnamilpiperazine, t = D-Thr | 3 | Antitumour | 1.2±0.1 % Hemolysis at 0 µM | Human | Synthetic Peptidomimetics | NA | NA | ||
| 28834399 | 2017 | YT{d}F{nnr:Cyn} | 3 | Free | Free | Linear | Mix | Cyn = trans-1-cinnamilpiperazine, t = D-Thr | 3 | Antitumour | 1.8±0.1 % Hemolysis at 100 µM | Human | Synthetic Peptidomimetics | NA | NA | ||
| 28834399 | 2017 | YT{d}F{nnr:Cyn} | 3 | Free | Free | Linear | Mix | Cyn = trans-1-cinnamilpiperazine, t = D-Thr | 3 | Antitumour | 1.8±0.1 % Hemolysis at 250 µM | Human | Synthetic Peptidomimetics | NA | NA | ||
| 28834399 | 2017 | YT{d}W{nnr:Cyn} | 4 | Free | Free | Linear | Mix | Cyn = trans-1-cinnamilpiperazine, t = D-Thr | 3 | Antitumour | 0.8±0.1 % Hemolysis at 0 µM | Human | Synthetic Peptidomimetics | NA | NA | ||
| 28834399 | 2017 | YT{d}W{nnr:Cyn} | 4 | Free | Free | Linear | Mix | Cyn = trans-1-cinnamilpiperazine, t = D-Thr | 3 | Antitumour | 1.0±0.1 % Hemolysis at 100 µM | Human | Synthetic Peptidomimetics | NA | NA | ||
| 28834399 | 2017 | YT{d}W{nnr:Cyn} | 4 | Free | Free | Linear | Mix | Cyn = trans-1-cinnamilpiperazine, t = D-Thr | 3 | Antitumour | 0.9±0.0 % Hemolysis at 250 µM | Human | Synthetic Peptidomimetics | NA | NA | ||
| 28987278 | 2017 | RSVSKSR | REPRSV | Free | Free | Linear | L | None | 7 | LPS-neutralizing, angiogenic activities | 4.6 % Hemolysis at 500 µM | Sheep | Peptic Hydrolysates Of Rice Endosperm Protein | NA | Non-hemolytic | ||
| 28987278 | 2017 | RRVIEPR | REP-RRV | Free | Free | Linear | L | None | 7 | LPS-neutralizing, angiogenic activities | 2.5 % Hemolysis at 500 µM | Sheep | Peptic Hydrolysates Of Rice Endosperm Protein | NA | Non-hemolytic | ||
| 28987278 | 2017 | ERFQPMFRRPG | REP-ERF | Free | Free | Linear | L | None | 12 | LPS-neutralizing, angiogenic activities | 3.2 % Hemolysis at 500 µM | Sheep | Peptic Hydrolysates Of Rice Endosperm Protein | NA | Non-hemolytic | ||
| 28987278 | 2017 | RVRQNIDNPNRADTYNPRAG | REP-RVR | Free | Free | Linear | L | None | 20 | LPS-neutralizing, angiogenic activities | 9.5 % Hemolysis at 500 µM | Sheep | Peptic Hydrolysates Of Rice Endosperm Protein | NA | Non-hemolytic | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P2 | Free | Free | Linear | L | None | 12 | Antibiofilm | 0.84 ± 1.42 % Hemolysis at 1 μg/mL | Human | Brevibacillus Strain | α-Helix | Non-hemolytic | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P3 | Free | Free | Linear | L | None | 12 | Antibiofilm | 0 % Hemolysis at 2 μg/mL | Human | Brevibacillus Strain | α-Helix | Non-hemolytic | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P4 | Free | Free | Linear | L | None | 12 | Antibiofilm | 0 % Hemolysis at 4 μg/mL | Human | Brevibacillus Strain | α-Helix | Non-hemolytic | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P5 | Free | Free | Linear | L | None | 12 | Antibiofilm | 0 % Hemolysis at 8 μg/mL | Human | Brevibacillus Strain | α-Helix | Non-hemolytic | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P6 | Free | Free | Linear | L | None | 12 | Antibiofilm | <10 % Hemolysis at 16 μg/mL | Human | Brevibacillus Strain | α-Helix | Non-hemolytic | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P7 | Free | Free | Linear | L | None | 12 | Antibiofilm | 10 % Hemolysis at 32 μg/mL | Human | Brevibacillus Strain | α-Helix | NA | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P8 | Free | Free | Linear | L | None | 12 | Antibiofilm | 9.92 ± 1.04 % Hemolysis at 64 μg/mL | Human | Brevibacillus Strain | α-Helix | NA | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P9 | Free | Free | Linear | L | None | 12 | Antibiofilm | 16.62 ± 0.85 % Hemolysis at 128 μg/mL | Human | Brevibacillus Strain | α-Helix | NA | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P10 | Free | Free | Linear | L | None | 12 | Antibiofilm | <40 % Hemolysis at 256 μg/mL | Human | Brevibacillus Strain | α-Helix | NA | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P11 | Free | Free | Linear | L | None | 12 | Antibiofilm | 72.03 ± 5.61 % Hemolysis at 512 μg/mL | Human | Brevibacillus Strain | α-Helix | NA | ||
| 38097636 | 2023 | KWKLFKKIGAVLKVL{ct:Amid} | C(1–7)M(2–9) | Amidation | Free | Linear | L | None | 15 | Antibioflm | 50 % Hemolysis at 88.89±4.62 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 38097636 | 2023 | KWKLFKKIGKVLKVL{ct:Amid} | CM-10K | Amidation | Free | Linear | L | None | 15 | Antibioflm | 50 % Hemolysis at 85.78±9.01 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 38097636 | 2023 | KWKLFKKIGKVLKKL{ct:Amid} | CM-10K14K | Amidation | Free | Linear | L | None | 15 | Antibioflm | 50 % Hemolysis at 561.90±88.19 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 38097636 | 2023 | VWKLFKKIGKVLKKL{ct:Amid} | CM-1V10K14K | Amidation | Free | Linear | L | None | 15 | Antibioflm | 50 % Hemolysis at 118.90±8.19 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 38097636 | 2023 | VWKLFKKIGAVLKKL{ct:Amid} | CM-1V14K | Amidation | Free | Linear | L | None | 15 | Antibioflm | 50 % Hemolysis at 131.70±9.23 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 38097636 | 2023 | KWKLFKKIGAVLKVLA{ct:Amid} | CM-A | Amidation | Free | Linear | L | None | 16 | Antibioflm | 50 % Hemolysis at 42.58±1.98 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 38247578 | 2023 | KGGDLGLFEPTL | EYHp6 | Free | Free | Linear | L | None | 12 | Anti-Salmonella | 0 % Hemolysis at 4 mM | Human | Egg Yolk Hydrolysate | NA | Non-hemolytic | ||
| 38247578 | 2023 | KGGDLGLFEPTL | EYHp6 | Free | Free | Linear | L | None | 12 | Anti-Salmonella | <20 % Hemolysis at 8 mM | Human | Egg Yolk Hydrolysate | NA | NA | ||
| 38467553 | 2024 | {nnr:GA}-YYLK{ct:Amid} | AB-10 | Amidation | Free | Linear | L | GA = gallic acid | 6 | Antioxidant (Antiradical) | 0 % Hemolysis at 1000 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38467553 | 2024 | {nnr:GA}-YYLK{ct:Amid} | AB-10 | Amidation | Free | Linear | L | GA = gallic acid | 6 | Antioxidant (Antiradical) | 0 % Hemolysis at 500 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38467553 | 2024 | {nnr:GA}-YYLK{ct:Amid} | AB-10 | Amidation | Free | Linear | L | GA = gallic acid | 6 | Antioxidant (Antiradical) | 0 % Hemolysis at 100 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38467553 | 2024 | ({nnr:GA}-KKIRRLK){ct:Amid} | AB-11 | Amidation | Free | Linear | L | GA = gallic acid | 9 | Antioxidant (Antiradical) | <10 % Hemolysis at 1000 μg/mL | Human | Synthetic | NA | NA | ||
| 38467553 | 2024 | ({nnr:GA}-KKIRRLK){ct:Amid} | AB-11 | Amidation | Free | Linear | L | GA = gallic acid | 9 | Antioxidant (Antiradical) | <10 % Hemolysis at 500 μg/mL | Human | Synthetic | NA | NA | ||
| 38467553 | 2024 | ({nnr:GA}-KKIRRLK){ct:Amid} | AB-11 | Amidation | Free | Linear | L | GA = gallic acid | 9 | Antioxidant (Antiradical) | 0 % Hemolysis at 100 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38467553 | 2024 | {nnr:GA}-KKIRARLKYAC{ct:Amid} | AB-12 | Amidation | Free | Linear | L | GA = gallic acid | 13 | Antioxidant (Antiradical) | 0 % Hemolysis at 1000 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38467553 | 2024 | {nnr:GA}-KKIRARLKYAC{ct:Amid} | AB-12 | Amidation | Free | Linear | L | GA = gallic acid | 13 | Antioxidant (Antiradical) | 0 % Hemolysis at 500 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38467553 | 2024 | {nnr:GA}-KKIRARLKYAC{ct:Amid} | AB-12 | Amidation | Free | Linear | L | GA = gallic acid | 13 | Antioxidant (Antiradical) | 0 % Hemolysis at 100 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38467553 | 2024 | RRRRRRRRKKKKKKKACAC{ct:Amid} | AB-13 | Amidation | Free | Linear | L | None | 19 | Antioxidant (Antiradical) | 0 % Hemolysis at 1000 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38467553 | 2024 | RRRRRRRRKKKKKKKACAC{ct:Amid} | AB-13 | Amidation | Free | Linear | L | None | 19 | Antioxidant (Antiradical) | 0 % Hemolysis at 500 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38467553 | 2024 | RRRRRRRRKKKKKKKACAC{ct:Amid} | AB-13 | Amidation | Free | Linear | L | None | 19 | Antioxidant (Antiradical) | 0 % Hemolysis at 100 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38467553 | 2024 | (WKKIRVRLSWKKIRVRLS)KAC{ct:Amid} | AB-14 | Amidation | Free | Linear | L | None | 21 | Antioxidant (Antiradical) | <20 % Hemolysis at 1000 μg/mL | Human | Synthetic | NA | NA | ||
| 38467553 | 2024 | (WKKIRVRLSWKKIRVRLS)KAC{ct:Amid} | AB-14 | Amidation | Free | Linear | L | None | 21 | Antioxidant (Antiradical) | 10 % Hemolysis at 500 μg/mL | Human | Synthetic | NA | NA | ||
| 38467553 | 2024 | (WKKIRVRLSWKKIRVRLS)KAC{ct:Amid} | AB-14 | Amidation | Free | Linear | L | None | 21 | Antioxidant (Antiradical) | 0 % Hemolysis at 100 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38467553 | 2024 | ({nnr:GA}KKIRARLK{nnr:GA}KKIRARLK)KYAC{ct:Amid} | AB-15 | Amidation | Free | Linear | L | GA = gallic acid | 24 | Antioxidant (Antiradical) | <20 % Hemolysis at 1000 μg/mL | Human | Synthetic | NA | NA | ||
| 38467553 | 2024 | ({nnr:GA}KKIRARLK{nnr:GA}KKIRARLK)KYAC{ct:Amid} | AB-15 | Amidation | Free | Linear | L | GA = gallic acid | 24 | Antioxidant (Antiradical) | <10 % Hemolysis at 500 μg/mL | Human | Synthetic | NA | NA | ||
| 38467553 | 2024 | ({nnr:GA}KKIRARLK{nnr:GA}KKIRARLK)KYAC{ct:Amid} | AB-15 | Amidation | Free | Linear | L | GA = gallic acid | 24 | Antioxidant (Antiradical) | <10 % Hemolysis at 100 μg/mL | Human | Synthetic | NA | NA | ||
| 38467553 | 2024 | (KKLRLKTAFKKKLRLKTAFK)KAC{ct:Amid} | ST-10 | Amidation | Free | Linear | L | None | 23 | Antioxidant (Antiradical) | 0 % Hemolysis at 1000 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38467553 | 2024 | (KKLRLKTAFKKKLRLKTAFK)KAC{ct:Amid} | ST-10 | Amidation | Free | Linear | L | None | 23 | Antioxidant (Antiradical) | 0 % Hemolysis at 500 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38467553 | 2024 | (KKLRLKTAFKKKLRLKTAFK)KAC{ct:Amid} | ST-10 | Amidation | Free | Linear | L | None | 23 | Antioxidant (Antiradical) | 0 % Hemolysis at 100 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38467553 | 2024 | {nnr:GA}-KK{ct:Amid} | AST-1 | Amidation | Free | Linear | L | GA = gallic acid | 4 | Antioxidant (Antiradical) | 0 % Hemolysis at 1000 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38467553 | 2024 | {nnr:GA}-KK{ct:Amid} | AST-1 | Amidation | Free | Linear | L | GA = gallic acid | 4 | Antioxidant (Antiradical) | 0 % Hemolysis at 500 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38467553 | 2024 | {nnr:GA}-KK{ct:Amid} | AST-1 | Amidation | Free | Linear | L | GA = gallic acid | 4 | Antioxidant (Antiradical) | 0 % Hemolysis at 100 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38657271 | 2024 | P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid} | SR16 | Amidation | Acetylation | Linear | Mix | p = D-Proline, Aic = α-aminoisobutyric acid | 18 | Antiviral | <5 % Hemolysis at 0.19 µM | Human | Synthetic | α-Helical | NA | ||
| 38657271 | 2024 | P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid} | SR16 | Amidation | Acetylation | Linear | Mix | p = D-Proline, Aic = α-aminoisobutyric acid | 18 | Antiviral | <5 % Hemolysis at 0.39 µM | Human | Synthetic | α-Helical | NA | ||
| 38657271 | 2024 | P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid} | SR16 | Amidation | Acetylation | Linear | Mix | p = D-Proline, Aic = α-aminoisobutyric acid | 18 | Antiviral | <5 % Hemolysis at 0.78 µM | Human | Synthetic | α-Helical | NA | ||
| 38657271 | 2024 | P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid} | SR16 | Amidation | Acetylation | Linear | Mix | p = D-Proline, Aic = α-aminoisobutyric acid | 18 | Antiviral | <5 % Hemolysis at 1.56 µM | Human | Synthetic | α-Helical | NA | ||
| 38657271 | 2024 | P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid} | SR16 | Amidation | Acetylation | Linear | Mix | p = D-Proline, Aic = α-aminoisobutyric acid | 18 | Antiviral | <5 % Hemolysis at 3.12 µM | Human | Synthetic | α-Helical | NA | ||
| 38657271 | 2024 | P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid} | SR16 | Amidation | Acetylation | Linear | Mix | p = D-Proline, Aic = α-aminoisobutyric acid | 18 | Antiviral | <5 % Hemolysis at 6.25 µM | Human | Synthetic | α-Helical | NA | ||
| 38657271 | 2024 | P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid} | SR16 | Amidation | Acetylation | Linear | Mix | p = D-Proline, Aic = α-aminoisobutyric acid | 18 | Antiviral | <5 % Hemolysis at 12.5 µM | Human | Synthetic | α-Helical | NA | ||
| 38657271 | 2024 | P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid} | SR16 | Amidation | Acetylation | Linear | Mix | p = D-Proline, Aic = α-aminoisobutyric acid | 18 | Antiviral | <5 % Hemolysis at 25 µM | Human | Synthetic | α-Helical | NA | ||
| 38657271 | 2024 | P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid} | SR16 | Amidation | Acetylation | Linear | Mix | p = D-Proline, Aic = α-aminoisobutyric acid | 18 | Antiviral | <5 % Hemolysis at 50 µM | Human | Synthetic | α-Helical | NA | ||
| 38657271 | 2024 | P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid} | SR16 | Amidation | Acetylation | Linear | Mix | p = D-Proline, Aic = α-aminoisobutyric acid | 18 | Antiviral | <5 % Hemolysis at 100 µM | Human | Synthetic | α-Helical | NA | ||
| 38399250 | 2024 | FVVWGCADYRGSCRTACFAYEYSLGAKGCADGYICCVPNTFRLM | CFBD-1 | Free | Free | Linear | L | None | 44 | Antiviral | >100 % Hemolysis at 100 µM | Human | Salamandra Salamandra | NA | NA | ||
| 29136469 | 2017 | {nnr:Dab}V{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2}{ct:Amid} | C7Val2-Pat | Amidation | R2 = heptanoyl | Linear | Mix | R2 = heptanoyl, Dab = 2,4-diaminobutyric acid | 9 | ND = not detected | 0.95 ± 0.45 % Hemolysis at 128 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | NA | ||
| 29136469 | 2017 | {nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2}{ct:Amid} | C7Phe2-Pat | Amidation | R2 = heptanoyl | Linear | Mix | R2 = heptanoyl, Dab = 2,4-diaminobutyric acid | 9 | ND = not detected | 1.28 ± 1.65 % Hemolysis at 128 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | NA | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}L{nnr:Dab}{nt:R3}{ct:Amid} | Dab9-Pat | Amidation | R3 = octanoyl | Linear | Mix | R3 = octanoyl, Dab = 2,4-diaminobutyric acid | 9 | ND = not detected | 2.25 ± 2.18 % Hemolysis at 128 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | NA | ||
| 29136469 | 2017 | {nnr:Dab}{nnr:Dab}{nnr:Dab}F{d}L{nnr:Dab}V{d}L{nnr:Dab}{nt:R3}{ct:Amid} | Dab2,9-Pat | Amidation | R3 = octanoyl | Linear | Mix | R3 = octanoyl, Dab = 2,4-diaminobutyric acid | 9 | ND = not detected | 0.80 ± 0.40 % Hemolysis at 128 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:O}I{nnr:O}F{d}L{nnr:O}V{d}LS{nt:R3}{ct:Amid} | Orn-Pat | Amidation | R3 = octanoyl | Linear | Mix | R3 = octanoyl, Orn = Ornithine | 9 | ND = not detected | 1.12 ± 0.47 % Hemolysis at 128 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}ITL{d}L{nnr:Dab}V{d}LS{nt:R4}{ct:Amid} | C10Thr3Leu4-Pat | Amidation | R4 = decanoyl | Linear | Mix | R4 = decanoyl, Dab = 2,4-diaminobutyric acid | 9 | ND = not detected | 24.9 ± 2.71 % Hemolysis at 128 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | NA | ||
| 29136469 | 2017 | {nnr:Dab}V{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid} | C7Val2-Pat | Amidation | R2 = heptanoyl | Linear | Mix | R2 = heptanoyl, Dab = 2,4-diaminobutyric acid | 9 | ND = not detected | 0.79 ± 0.63 % Hemolysis at 64 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid} | C7Phe2-Pat | Amidation | R2 = heptanoyl | Linear | Mix | R2 = heptanoyl, Dab = 2,4-diaminobutyric acid | 9 | ND = not detected | 0.60 ± 1.35 % Hemolysis at 64 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}L{nnr:Dab}{nt:R3 = octanoyl}{ct:Amid} | Dab9-Pat | Amidation | R3 = octanoyl | Linear | Mix | R3 = octanoyl, Dab = 2,4-diaminobutyric acid | 9 | ND = not detected | 0.73 ± 0.50 % Hemolysis at 64 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}{nnr:Dab}{nnr:Dab}F{d}L{nnr:Dab}V{d}L{nnr:Dab}{nt:R3 = octanoyl}{ct:Amid} | Dab2,9-Pat | Amidation | R3 = octanoyl | Linear | Mix | R3 = octanoyl, Dab = 2,4-diaminobutyric acid | 9 | ND = not detected | 0.41 ± 0.53 % Hemolysis at 64 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:O}I{nnr:O}F{d}L{nnr:O}V{d}LS{nt:R3}{ct:Amid}{nt:R3 = octanoyl}{ct:Amid} | Orn-Pat | Amidation | R3 = octanoyl | Linear | Mix | R3 = octanoyl, Orn = Ornithine | 9 | ND = not detected | 0.69 ± 0.64 % Hemolysis at 64 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}ITL{d}L{nnr:Dab}V{d}LS{nt:R4 = decanoyl}{ct:Amid} | C10Thr3Leu4-Pat | Amidation | R4 = decanoyl | Linear | Mix | R4 = decanoyl, Dab = 2,4-diaminobutyric acid | 9 | ND = not detected | 10.0 ± 1.03 % Hemolysis at 64 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | NA | ||
| 29136469 | 2017 | {nnr:Dab}V{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid} | C7Val2-Pat | Amidation | R2 = heptanoyl | Linear | Mix | R2 = heptanoyl, Dab = 2,4-diaminobutyric acid | 9 | ND = not detected | 0.32 ± 0.74 % Hemolysis at 32 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid} | C7Phe2-Pat | Amidation | R2 = heptanoyl | Linear | Mix | R2 = heptanoyl, Dab = 2,4-diaminobutyric acid | 9 | ND = not detected | 0.49 ± 1.22 % Hemolysis at 32 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}L{nnr:Dab}{nt:R3 = octanoyl}{ct:Amid} | Dab9-Pat | Amidation | R3 = octanoyl | Linear | Mix | R3 = octanoyl, Dab = 2,4-diaminobutyric acid | 9 | ND = not detected | 0.80 ± 0.68 % Hemolysis at 32 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}{nnr:Dab}{nnr:Dab}F{d}L{nnr:Dab}V{d}L{nnr:Dab}{nt:R3 = octanoyl}{ct:Amid} | Dab2,9-Pat | Amidation | R3 = octanoyl | Linear | Mix | R3 = octanoyl, Dab = 2,4-diaminobutyric acid | 9 | ND = not detected | 0.38 ± 0.62 % Hemolysis at 32 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:O}I{nnr:O}F{d}L{nnr:O}V{d}LS{nt:R3}{ct:Amid}{nt:R3 = octanoyl}{ct:Amid} | Orn-Pat | Amidation | R3 = octanoyl | Linear | Mix | R3 = octanoyl, Orn = Ornithine | 9 | ND = not detected | 0.44 ± 0.30 % Hemolysis at 32 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}ITL{d}L{nnr:Dab}V{d}LS{nt:R4 = decanoyl}{ct:Amid} | C10Thr3Leu4-Pat | Amidation | R4 = decanoyl | Linear | Mix | R4 = decanoyl, Dab = 2,4-diaminobutyric acid | 9 | ND = not detected | 5.06 ± 1.14 % Hemolysis at 32 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | NA | ||
| 29136469 | 2017 | {nnr:Dab}V{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid} | C7Val2-Pat | Amidation | R2 = heptanoyl | Linear | Mix | R2 = heptanoyl, Dab = 2,4-diaminobutyric acid | 9 | ND = not detected | −0.17 ± 0.19 % Hemolysis at 16 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid} | C7Phe2-Pat | Amidation | R2 = heptanoyl | Linear | Mix | R2 = heptanoyl, Dab = 2,4-diaminobutyric acid | 9 | ND = not detected | 0.28 ± 1.11 % Hemolysis at 16 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}L{nnr:Dab}{nt:R3 = octanoyl}{ct:Amid} | Dab9-Pat | Amidation | R3 = octanoyl | Linear | Mix | R3 = octanoyl, Dab = 2,4-diaminobutyric acid | 9 | ND = not detected | 0.52 ± 0.58 % Hemolysis at 16 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}{nnr:Dab}{nnr:Dab}F{d}L{nnr:Dab}V{d}L{nnr:Dab}{nt:R3 = octanoyl}{ct:Amid} | Dab2,9-Pat | Amidation | R3 = octanoyl | Linear | Mix | R3 = octanoyl, Dab = 2,4-diaminobutyric acid | 9 | ND = not detected | 0.37 ± 0.62 % Hemolysis at 16 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:O}I{nnr:O}F{d}L{nnr:O}V{d}LS{nt:R3}{ct:Amid}{nt:R3 = octanoyl}{ct:Amid} | Orn-Pat | Amidation | R3 = octanoyl | Linear | Mix | R3 = octanoyl, Orn = Ornithine | 9 | ND = not detected | 0.86 ± 0.72 % Hemolysis at 16 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}ITL{d}L{nnr:Dab}V{d}LS{nt:R4 = decanoyl}{ct:Amid} | C10Thr3Leu4-Pat | Amidation | R4 = decanoyl | Linear | Mix | R4 = decanoyl, Dab = 2,4-diaminobutyric acid | 9 | ND = not detected | 1.25 ± 0.71 % Hemolysis at 16 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | NA | ||
| 29188836 | 2017 | F{d}PVRLF{d}PVRL{cyc:N-C} | GS-2 | Free | Free | Cyclic | Mix | None | 10 | Antibiotic | 50 % Hemolysis at 10.03±0.49 (mean±SD, μM) | Human | Bacillus Brevis (Gramicidin S (Gs)) | NA | Low hemolytic | ||
| 29188836 | 2017 | A{d}PVRLF{d}PVRL{cyc:N-C} | MGR-1 | Free | Free | Cyclic | Mix | None | 10 | Antibiotic | 50 % Hemolysis at 67.18±2.94 (mean±SD, μM) | Human | Bacillus Brevis (Gramicidin S (Gs)) | NA | Low hemolytic | ||
| 29188836 | 2017 | F{d}AVRLF{d}PVRL{cyc:N-C} | MGR-2 | Free | Free | Cyclic | Mix | None | 10 | Antibiotic | 50 % Hemolysis at 55.03±1.77 (mean±SD, μM) | Human | Bacillus Brevis (Gramicidin S (Gs)) | NA | Low hemolytic | ||
| 29188836 | 2017 | F{d}PARLF{d}PVRL{cyc:N-C} | MGR-3 | Free | Free | Cyclic | Mix | None | 10 | Antibiotic | 50 % Hemolysis at 30.56±1.80 (mean±SD, μM) | Human | Bacillus Brevis (Gramicidin S (Gs)) | NA | Low hemolytic | ||
| 29188836 | 2017 | F{d}PVALF{d}PVRL{cyc:N-C} | MGR-4 | Free | Free | Cyclic | Mix | None | 10 | Antibiotic | 50 % Hemolysis at 14.41±0.51 (mean±SD, μM) | Human | Bacillus Brevis (Gramicidin S (Gs)) | NA | Low hemolytic | ||
| 29188836 | 2017 | F{d}PVRAF{d}PVRL{cyc:N-C} | MGR-5 | Free | Free | Cyclic | Mix | None | 10 | Antibiotic | 50 % Hemolysis at 36.33±1.98 (mean±SD, μM) | Human | Bacillus Brevis (Gramicidin S (Gs)) | NA | Low hemolytic | ||
| 29188836 | 2017 | A{d}PVRLA{d}PVRL{cyc:N-C} | DGR-1 | Free | Free | Cyclic | Mix | None | 10 | Antibiotic | 50 % Hemolysis at 137.40±6.20 (mean±SD, μM) | Human | Bacillus Brevis (Gramicidin S (Gs)) | NA | Low hemolytic | ||
| 29188836 | 2017 | F{d}AVRLF{d}AVRL{cyc:N-C} | DGR-2 | Free | Free | Cyclic | Mix | None | 10 | Antibiotic | 50 % Hemolysis at 199.90±9.80 (mean±SD, μM) | Human | Bacillus Brevis (Gramicidin S (Gs)) | NA | Low hemolytic | ||
| 29188836 | 2017 | F{d}PARLF{d}PARL{cyc:N-C} | DGR-3 | Free | Free | Cyclic | Mix | None | 10 | Antibiotic | 50 % Hemolysis at 88.95±7.51 (mean±SD, μM) | Human | Bacillus Brevis (Gramicidin S (Gs)) | NA | Low hemolytic | ||
| 29188836 | 2017 | F{d}PVALF{d}PVAL{cyc:N-C} | DGR-4 | Free | Free | Cyclic | Mix | None | 10 | Antibiotic | 50 % Hemolysis at >200 (mean±SD, μM) | Human | Bacillus Brevis (Gramicidin S (Gs)) | NA | Low hemolytic | ||
| 29188836 | 2017 | F{d}PVRAF{d}PVRA{cyc:N-C} | DGR-5 | Free | Free | Cyclic | Mix | None | 10 | Antibiotic | 50 % Hemolysis at >200 (mean±SD, μM) | Human | Bacillus Brevis (Gramicidin S (Gs)) | NA | Low hemolytic | ||
| 28650592 | 2018 | LVGKLLKGAVGDVCGLLPIC{ct:disulfide bridge} | OM-LV20 | disulfide bridge | Free | Linear | L | None | 20 | Wound healing activity | 0 % Hemolysis at 1 mM | Human | Frog(Odorrana Margaretae) | NA | Non-hemolytic | ||
| 29205108 | 2018 | WAGGFGVAGGAMALGGGIAAAVG | α2 peptide | Free | Free | Linear | L | None | 23 | ND | ~50 % Hemolysis at 100 μM | Sheep | Bordetella Pertussis (Bacteria)- Adenylate Cyclase Toxin (Cyaa) | NA | NA | ||
| 29205108 | 2018 | GAEIALQLTGGTVELASSIALALAAAR | α3 peptide | Free | Free | Linear | L | None | 27 | ND | ~5 % Hemolysis at 100 μM | Sheep | Bordetella Pertussis (Bacteria)- Adenylate Cyclase Toxin (Cyaa) | NA | NA | ||
| 29205108 | 2018 | WAGGFGVAGGAMALGGGIAAAVGAGMSLTDDAPAGQKAAAGAEIALQLTGGTVELASSIALALAAAR | α2-loop-α3 peptide | Free | Free | Linear | L | None | 67 | ND | ~10 % Hemolysis at 100 μM | Sheep | Bordetella Pertussis (Bacteria)- Adenylate Cyclase Toxin (Cyaa) | NA | NA | ||
| 28918200 | 2018 | KIKEKLIEA{ct:Carboxyl (COO-)} | Pep-5 | Carboxyl (COO-) | Free | Linear | L | None | 9 | ND | 0 % Hemolysis at 125 μM | Rat | Scorpion Tityus Obscurus | NA | Non-hemolytic | ||
| 28918200 | 2018 | KPVEPVG{ct:Carboxyl (COO-)} | Pep-9 | Carboxyl (COO-) | Free | Linear | L | None | 7 | ND | ~25 % Hemolysis at 125 μM | Rat | Scorpion Tityus Obscurus | NA | NA | ||
| 28918200 | 2018 | VYWLPAVLGSLLGFTP{ct:Carboxyl (COO-)} | Pep-14 | Carboxyl (COO-) | Free | Linear | L | None | 16 | ND | 0 % Hemolysis at 125 μM | Rat | Scorpion Tityus Obscurus | NA | Non-hemolytic | ||
| 28918200 | 2018 | PHWLFFGVSVLC{ct:Carboxyl (COO-)} | Pep-16 | Carboxyl (COO-) | Free | Linear | L | None | 12 | ND | 0 % Hemolysis at 125 μM | Rat | Scorpion Tityus Obscurus | NA | Non-hemolytic | ||
| 28918200 | 2018 | VTLTLPPAES{ct:Amid} | Pep-17 | Amidation | Free | Linear | L | None | 10 | ND | 0 % Hemolysis at 125 μM | Rat | Scorpion Tityus Obscurus | NA | Non-hemolytic | ||
| 28918200 | 2018 | KETNAKPP{ct:Carboxyl (COO-)} | Pep-18 | Carboxyl (COO-) | Free | Linear | L | None | 8 | ND | 0 % Hemolysis at 125 μM | Rat | Scorpion Tityus Obscurus | NA | Non-hemolytic | ||
| 29343843 | 2018 | IGRDPTWSHLAASCLKCIFDDLPKTHN | Cathelicidin-OA1 | Free | Free | Linear | L | None | 27 | Antioxidant activity | 5.4 ± 0.14 % Hemolysis at 1 nM | Human | Frog (Odorrana Andersonii) | NA | NA | ||
| 29343843 | 2018 | IGRDPTWSHLAASCLKCIFDDLPKTHN | Cathelicidin-OA1 | Free | Free | Linear | L | None | 27 | Antioxidant activity | 4.5 ± 0.61 % Hemolysis at 10 nM | Human | Frog (Odorrana Andersonii) | NA | NA | ||
| 29343843 | 2018 | IGRDPTWSHLAASCLKCIFDDLPKTHN | Cathelicidin-OA1 | Free | Free | Linear | L | None | 27 | Antioxidant activity | 5.4 ± 0.81 % Hemolysis at 100 nM | Human | Frog (Odorrana Andersonii) | NA | NA | ||
| 29343843 | 2018 | IGRDPTWSHLAASCLKCIFDDLPKTHN | Cathelicidin-OA1 | Free | Free | Linear | L | None | 27 | Antioxidant activity | 6.9 ± 0.57 % Hemolysis at 1 μM | Human | Frog (Odorrana Andersonii) | NA | NA | ||
| 29343843 | 2018 | IGRDPTWSHLAASCLKCIFDDLPKTHN | Cathelicidin-OA1 | Free | Free | Linear | L | None | 27 | Antioxidant activity | 5.0 ± 0.86 % Hemolysis at 10 μM | Human | Frog (Odorrana Andersonii) | NA | NA | ||
| 29343843 | 2018 | IGRDPTWSHLAASCLKCIFDDLPKTHN | Cathelicidin-OA1 | Free | Free | Linear | L | None | 27 | Antioxidant activity | 7.7 ± 0.11 % Hemolysis at 100 μM | Human | Frog (Odorrana Andersonii) | NA | NA | ||
| 29359791 | 2018 | ALAGTIIAGASLTFQVLDKVLEELGKVSRK{ct:Amid} | StII1-30 | Amidation | Free | Linear | L | None | 30 | Candidacidal | 50 % Hemolysis at 42.5 μM | Human | Derived From Sticholysin Ii (Sea Anemone Stichodactyla Helianthus) | amphiphilic α-Helix | NA | ||
| 29359791 | 2018 | VLDKVLEELGKVSRKIAVGI{ct:Amid} | StII16-35 | Amidation | Free | Linear | L | None | 20 | Candidacidal | 50 % Hemolysis at 128 μM | Human | Derived From Sticholysin Ii (Sea Anemone Stichodactyla Helianthus) | amphiphilic α-Helix | NA | ||
| 29249197 | 2018 | RADARADARADARADA{nt:Acet}{ct:NHCOCH3} | RADA 16-I hydrogels | NHCOCH3 | Acetylation | Linear | L | Ac = N-acetyl (NHCOCH3) | 16 | Hemostatic agent | 0.78 ± 0.1 % Hemolysis at 0.1 w/v | Rabbit | Synthesised Monomer Peptide | β-Sheet at higher conc | Low hemolytic | ||
| 29249197 | 2018 | RADARADARADARADA{nt:Acet}{ct:NHCOCH3} | RADA 16-I hydrogels | NHCOCH3 | Acetylation | Linear | L | Ac = N-acetyl (NHCOCH3) | 16 | Hemostatic agent | 1±0.1 % Hemolysis at 0.2 w/v | Rabbit | Synthesised Monomer Peptide | Betα-Sheet at higher conc | Low hemolytic | ||
| 29249197 | 2018 | RADARADARADARADA{nt:Acet}{ct:NHCOCH3} | RADA 16-I hydrogels | NHCOCH3 | Acetylation | Linear | L | Ac = N-acetyl (NHCOCH3) | 16 | Hemostatic agent | 1.07±0.1 % Hemolysis at 0.3 w/v | Rabbit | Synthesised Monomer Peptide | Betα-Sheet at higher conc | Low hemolytic | ||
| 29249197 | 2018 | RADARADARADARADA{nt:Acet}{ct:NHCOCH3} | RADA 16-I hydrogels | NHCOCH3 | Acetylation | Linear | L | Ac = N-acetyl (NHCOCH3) | 16 | Hemostatic agent | 1.1±0.1 % Hemolysis at 0.5 w/v | Rabbit | Synthesised Monomer Peptide | Betα-Sheet at higher conc | Low hemolytic | ||
| 29643444 | 2018 | TVLRGCWTKSFPPKPCI{ct:Amid} | K9-HECI | Amidation | Free | Linear | L | None | 17 | Anti-proliferation of cancer cells | ~5 % Hemolysis at 128 µM | Horse | Analogue Of Heci | NA | Low hemolytic | ||
| 29670183 | 2018 | IITHPNFNGNTLDNDIMLIK | Lunathrombase | Free | Free | Linear | L | None | 20 | Anticoagulant, in-vitro thrombolytic activity, Antiplatelet | 7.65 ± 0.53(m/mm3) % Hemolysis at 10 mg/kg | Goat | Serine Protease From Leaves Of Leucas Indica Plant | e CD spectrum of lunathrombase demonstrated that it consists of 23.4% α-Helix, 17% Beta Sheets, with a Turn of 28.2% and 31% Random coils | Non-hemolytic | ||
| 29307075 | 2018 | KWKLFKKIGAVLKVL ({nnr:Cl−}){ct:Amid} | CAMEL chloride | Amidation | Free | Linear | L | Cl− = Counter-ion chloride | 15 | Antistaphylococcal | 65 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | NA | ||
| 29752337 | 2018 | GLLSGHYGRVVSTQSGHYGRG | OA-GL21 | Free | Free | Linear | L | None | 21 | Wound-healing | 0 % Hemolysis at 50 μM | Human | Frog Skin Secretions Of Odorrana Andersonii | aqueous = Helical conformation, membrane-mimetic environments = Helical conformation | Non-hemolytic | ||
| 29799150 | 2018 | EEEEAAAGK{d}W{d}K{d}L{d}F{d}K{d}K{d}L{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d}{nt:Acet}{ct:Amid} | Pro‐P18 | Amidation | Acetylation | Linear | Mix | None | 26 | ND | 0 % Hemolysis at 10 μM | Human | Cecropin/Magainin Hybrid | NA | Non-hemolytic | ||
| 29799150 | 2018 | EEEEAAAGW{d}G{d}L{d}R{d}R{d}L{d}L{d}K{d}Y{d}G{d}K{d}R{d}S{d}{nt:Acet}{ct:Amid} | Pro‐WMR | Amidation | Acetylation | Linear | Mix | None | 21 | ND | 0 % Hemolysis at 10 μM | Human | Myxinidin Analogue From Hagfish | NA | Non-hemolytic | ||
| 30011202 | 2018 | VVKCSFRPGSPAPRCK | odorranain-A-OT | Free | Free | Linear | L | None | 16 | Antioxidant | 5 % Hemolysis at 150 μM | Human | Frog Odorranain | NA | NA | ||
| 30011202 | 2018 | FVPAILCSILKTC | odorranain-G-OT | Free | Free | Linear | L | None | 13 | Antioxidant | 4 % Hemolysis at 150 μM | Human | Frog Odorranain | NA | NA | ||
| 30011202 | 2018 | FFRTSCRSVC | MFL | Free | Free | Linear | L | None | 10 | Antioxidant | 7 % Hemolysis at 150 μM | Human | Derived From Margaratain-B1, Andersnin-C1, And Pleurain-R1 | NA | NA | ||
| 30011202 | 2018 | TSRCIFYRRCVCS | AFL | Free | Free | Linear | L | None | 10 | Antioxidant | 21 % Hemolysis at 150 μM | Human | Derived From Margaratain-B1, Andersnin-C1, And Pleurain-R1 | NA | NA | ||
| 30011202 | 2018 | CVRFRTNTARTVCIAP | PFL | Free | Free | Linear | L | None | 16 | Antioxidant | 5 % Hemolysis at 150 μM | Human | Derived From Margaratain-B1, Andersnin-C1, And Pleurain-R1 | NA | NA | ||
| 30045878 | 2018 | ARGKKECKDDRCRLLMKRGSFSYV | Cathelicidin-NV | Free | Free | Linear | L | None | 24 | Wound healing-promoting activity | 0 % Hemolysis at 200 μg/ml | Rabbit | Frog Nanorana Ventripunctata | NA | Non-hemolytic | ||
| 30216370 | 2018 | ILKPGGGTSGGLLGGLLGKVTSVIPGLNNI | α4 | Free | Free | Linear | L | None | 30 | Antibiofilm | 0 % Hemolysis at 100 μM | Human | Human Splunc1 (Short Palate Lung And Nasal Epithelial Clone 1) | Helical amphipathic structure | Non-hemolytic | ||
| 30216370 | 2018 | ILKKWWGTSGGLLGGLLGKVTSVIKGLNNI | α4M1 | Free | Free | Linear | L | None | 30 | Antibiofilm | 0 % Hemolysis at 100 μM | Human | Human Splunc1 (Short Palate Lung And Nasal Epithelial Clone 1) | Helical amphipathic structure | Non-hemolytic | ||
| 30521892 | 2019 | RYAKMKRRRRRVARRHRRR | PEP-NKSM | Free | Free | Linear | L | None | 19 | biofilm Anti-adherent activity, Antibiofilm | 12 % Hemolysis at 256 µM | Human | Derived From Human Virus Proteomes | α-Helix | Low hemolytic | ||
| 30842341 | 2019 | GLLSGINAEWPC | OA-GL12 | Free | Free | Linear | L | None | 12 | Wound-healing peptide, Antioxidant | 8.9 ± 0.43 % Hemolysis at 0.1 nM | Human | Frog Odorrana Andersonii | NA | NA | ||
| 30842341 | 2019 | GLLSGINAEWPC | OA-GL12 | Free | Free | Linear | L | None | 12 | Wound-healing peptide, Antioxidant | 9.8 ± 0.45 % Hemolysis at 1 nM | Human | Frog Odorrana Andersonii | NA | NA | ||
| 30842341 | 2019 | GLLSGINAEWPC | OA-GL12 | Free | Free | Linear | L | None | 12 | Wound-healing peptide, Antioxidant | 9.9 ± 0.75 % Hemolysis at 10 nM | Human | Frog Odorrana Andersonii | NA | NA | ||
| 30337232 | 2019 | KFNKYGR | FSB-KFN | Free | Free | Linear | L | None | 7 | LPS-neutralizing and angiogenic activities | <0.10 % Hemolysis at 500 µM | Sheep | Putative Uncharacterized Protein | NA | Non-hemolytic | ||
| 30337232 | 2019 | FPFPRPPHQK | FSB-FPF | Free | Free | Linear | L | None | 10 | LPS-neutralizing and angiogenic activities | <0.10 % Hemolysis at 500 µM | Sheep | Beta-Conglycinin Alpha Subunit | NA | Non-hemolytic | ||
| 30337232 | 2019 | GQSSRPQDRHQK | FSB-GQS | Free | Free | Linear | L | None | 12 | LPS-neutralizing and angiogenic activities | <0.10 % Hemolysis at 500 µM | Sheep | Glycinin G1 | NA | Non-hemolytic | ||
| 30337232 | 2019 | QRFDQRSPQ | FSB-QRF | Free | Free | Linear | L | None | 9 | LPS-neutralizing and angiogenic activities | <0.10 % Hemolysis at 500 µM | Sheep | Uncharacterized Protein | NA | Non-hemolytic | ||
| 30337232 | 2019 | ERQFPFPRPPHQK | FSB-ERQ | Free | Free | Linear | L | None | 13 | LPS-neutralizing and angiogenic activities | <0.10 % Hemolysis at 500 µM | Sheep | Beta-Conglycinin Alpha Subunit | NA | Non-hemolytic | ||
| 30337232 | 2019 | GEIPRPRPRPQHPE | FSB-GEI | Free | Free | Linear | L | None | 14 | LPS-neutralizing and angiogenic activities | <0.10 % Hemolysis at 500 µM | Sheep | Beta-Conglycinin Alpha Subunit | NA | Non-hemolytic | ||
| 30337232 | 2019 | EQPRPIPFPRPQPR | FSB-EQP | Free | Free | Linear | L | None | 14 | LPS-neutralizing and angiogenic activities | 0.24 % Hemolysis at 500 µM | Sheep | Beta-Conglycinin Alpha Subunit | NA | Non-hemolytic | ||
| 30973929 | 2019 | EVL{d}ADL{d}V{cyc:N-C}{nt:Palmityl}{ct:Amid} | SLP1 | Amidation | Palmityl | Cyclic | Mix | None | 7 | Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus) | 40 % Hemolysis at 10 μg/mL | Porcine | Synthetic Surfactin Lipopeptide Analogues | NA | NA | ||
| 30973929 | 2019 | EVL{d}DL{d}V{cyc:N-C}{nt:Palmityl}{ct:Amid} | SLP2 | Amidation | Palmityl | Cyclic | Mix | None | 6 | Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus) | 100 % Hemolysis at 10 μg/mL | Porcine | Synthetic Surfactin Lipopeptide Analogues | NA | NA | ||
| 30973929 | 2019 | EVL{d}DL{d}{cyc:N-C}{nt:Palmityl}{ct:Amid} | SLP3 | Amidation | Palmityl | Cyclic | Mix | None | 5 | Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus) | 80 % Hemolysis at 10 μg/mL | Porcine | Synthetic Surfactin Lipopeptide Analogues | NA | NA | ||
| 30973929 | 2019 | EVL{d}L{d}{cyc:N-C}{nt:Palmityl}{ct:Amid} | SLP4 | Amidation | Palmityl | Cyclic | Mix | None | 4 | Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus) | 5 % Hemolysis at 10 μg/mL | Porcine | Synthetic Surfactin Lipopeptide Analogues | NA | Low hemolytic | ||
| 30973929 | 2019 | EVL{d}DL{d}{nt:Palmityl}{ct:Amid} | SLP5 | Amidation | Palmityl | Linear | Mix | None | 5 | Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus) | 25 % Hemolysis at 10 μg/mL | Porcine | Synthetic Surfactin Lipopeptide Analogues | NA | NA | ||
| 30973929 | 2019 | KVL{d}KL{d}{cyc:N-C}{nt:Palmityl}{ct:Amid} | SLP6 | Amidation | Palmityl | Cyclic | Mix | None | 5 | Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus) | 90 % Hemolysis at 10 μg/mL | Porcine | Synthetic Surfactin Lipopeptide Analogues | NA | NA | ||
| 30973929 | 2019 | EVLDL{cyc:N-C}{nt:Palmityl}{ct:Amid} | SLP7 | Amidation | Palmityl | Cyclic | L | None | 5 | Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus) | 30 % Hemolysis at 10 μg/mL | Porcine | Synthetic Surfactin Lipopeptide Analogues | NA | NA | ||
| 30973929 | 2019 | EVL{d}L{d}D{cyc:N-C}{nt:Palmityl}{ct:Amid} | SLP8 | Amidation | Palmityl | Cyclic | Mix | None | 5 | Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus) | 100 % Hemolysis at 10 μg/mL | Porcine | Synthetic Surfactin Lipopeptide Analogues | NA | NA | ||
| 30973929 | 2019 | EDVL{d}L{d}{cyc:N-C}{nt:Palmityl}{ct:Amid} | SLP9 | Amidation | Palmityl | Cyclic | Mix | None | 5 | Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus) | 50 % Hemolysis at 10 μg/mL | Porcine | Synthetic Surfactin Lipopeptide Analogues | NA | NA | ||
| 30973929 | 2019 | EVlDl{cyc:N-C}{nt:Heptaalkyl-biphenyl-acid}{ct:Amid} | SLP10 | Amidation | Heptaalkyl-biphenyl-acid | Cyclic | Mix | Heptaalkyl-biphenyl-acid | 5 | Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus) | 55 % Hemolysis at 10 μg/mL | Porcine | Synthetic Surfactin Lipopeptide Analogues | NA | NA | ||
| 31001677 | 2019 | GKPRPYSPRPTSHPRPIRV | Drosocin | Free | Free | Linear | L | None | 19 | Antiparasitic | <20 % Hemolysis at 100 μM | Mouse | Drosophila Melanogaster | NA | NA | ||
| 31001677 | 2019 | HRHQGPIFDTRPSPFNPNQPRPGPIY | Mtk-1 | Free | Free | Linear | L | None | 26 | Antiparasitic | <20 % Hemolysis at 100 μM | Mouse | Drosophila Melanogaster | NA | Low hemolytic | ||
| 31001677 | 2019 | HRRQGPIFDTRPSPFNPNQPRPGPIY | Mtk-2 | Free | Free | Linear | L | None | 26 | Antiparasitic | <20 % Hemolysis at 100 μM | Mouse | Drosophila Melanogaster | NA | NA | ||
| 31001677 | 2019 | EWRPHGSIGGSGLRPGRPQTLPPQRPRRPDFNGPRHRF | LSer-PRP2 | Free | Free | Linear | L | None | 38 | Antiparasitic | <20 % Hemolysis at 100 μM | Mouse | Lucilia Sericata | NA | NA | ||
| 31001677 | 2019 | SPFVDRPRRPIQHNGPKPRIITNPPFNPNARPAW | LSer-PRP3 | Free | Free | Linear | L | None | 34 | Antiparasitic | <20 % Hemolysis at 100 μM | Mouse | Lucilia Sericata | NA | NA | ||
| 31001677 | 2019 | GFRKRFNKLVKKVKHTIKETANVSKDVAIVAGSGVAVGAAMG | Stomoxyn | Free | Free | Linear | L | None | 42 | Antiparasitic | <20 % Hemolysis at 100 μM | Mouse | Lucilia Sericata | NA | NA | ||
| 31001677 | 2019 | KWKIFKKIEKAGRNIRDGIIKAGPAVSVVGEAATIYKTG | CecA | Free | Free | Linear | L | None | 39 | Antiparasitic | <20 % Hemolysis at 100 μM | Mouse | Galleria Mellonella | NA | NA | ||
| 31001677 | 2019 | KWKFFKKIERVGQNIRDGIIKAGPAVQVVGQAATIYKGK | CecB | Free | Free | Linear | L | None | 39 | Antiparasitic | <20 % Hemolysis at 100 μM | Mouse | Galleria Mellonella | NA | Low hemolytic | ||
| 31001677 | 2019 | RWKVFKKIERMGQHIRDGIIKAGPAVAVVGQASTIISG | CecC | Free | Free | Linear | L | None | 38 | Antiparasitic | <20 % Hemolysis at 100 μM | Mouse | Galleria Mellonella | NA | NA | ||
| 31001677 | 2019 | ENFFKEIERAGQRIRDAIISAAPAVETLAQAQKIIKGGD | CecD | Free | Free | Linear | L | None | 39 | Antiparasitic | <20 % Hemolysis at 100 μM | Mouse | Galleria Mellonella | NA | NA | ||
| 31001677 | 2019 | GKPRPYSPRPTSHPRPIRV | Drosocin | Free | Free | Linear | L | None | 19 | Antiparasitic | <20 % Hemolysis at 100 μM | Pig | Drosophila Melanogaster | low hemolytic | NA | ||
| 31001677 | 2019 | HRHQGPIFDTRPSPFNPNQPRPGPIY | Mtk-1 | Free | Free | Linear | L | None | 26 | Antiparasitic | <20 % Hemolysis at 100 μM | Pig | Drosophila Melanogaster | NA | NA | ||
| 31001677 | 2019 | HRRQGPIFDTRPSPFNPNQPRPGPIY | Mtk-2 | Free | Free | Linear | L | None | 26 | Antiparasitic | <20 % Hemolysis at 100 μM | Pig | Drosophila Melanogaster | NA | NA | ||
| 31001677 | 2019 | EWRPHGSIGGSGLRPGRPQTLPPQRPRRPDFNGPRHRF | LSer-PRP2 | Free | Free | Linear | L | None | 38 | Antiparasitic | <20 % Hemolysis at 100 μM | Pig | Lucilia Sericata | low hemolytic | NA | ||
| 31001677 | 2019 | SPFVDRPRRPIQHNGPKPRIITNPPFNPNARPAW | LSer-PRP3 | Free | Free | Linear | L | None | 34 | Antiparasitic | <20 % Hemolysis at 100 μM | Pig | Lucilia Sericata | low hemolytic | NA | ||
| 31001677 | 2019 | GFRKRFNKLVKKVKHTIKETANVSKDVAIVAGSGVAVGAAMG | Stomoxyn | Free | Free | Linear | L | None | 42 | Antiparasitic | <20 % Hemolysis at 100 μM | Pig | Lucilia Sericata | low hemolytic | NA | ||
| 31001677 | 2019 | KWKIFKKIEKAGRNIRDGIIKAGPAVSVVGEAATIYKTG | CecA | Free | Free | Linear | L | None | 39 | Antiparasitic | <20 % Hemolysis at 100 μM | Pig | Galleria Mellonella | low hemolytic | NA | ||
| 31001677 | 2019 | KWKFFKKIERVGQNIRDGIIKAGPAVQVVGQAATIYKGK | CecB | Free | Free | Linear | L | None | 39 | Antiparasitic | <20 % Hemolysis at 100 μM | Pig | Galleria Mellonella | NA | Low hemolytic | ||
| 31001677 | 2019 | RWKVFKKIERMGQHIRDGIIKAGPAVAVVGQASTIISG | CecC | Free | Free | Linear | L | None | 38 | Antiparasitic | <20 % Hemolysis at 100 μM | Pig | Galleria Mellonella | NA | NA | ||
| 31001677 | 2019 | ENFFKEIERAGQRIRDAIISAAPAVETLAQAQKIIKGGD | CecD | Free | Free | Linear | L | None | 39 | Antiparasitic | <20 % Hemolysis at 100 μM | Pig | Galleria Mellonella | NA | NA | ||
| 30927490 | 2019 | ACYCRIPACIAGERR | HNP‐F | Free | Free | Linear | L | None | 15 | Hemostatic drug | 8.2 % Hemolysis at 5 μM | Mouse | Anterior‐Half Fragment Of Hnp | NA | NA | ||
| 30927490 | 2019 | ACYCRIPACIAGERR | HNP‐F | Free | Free | Linear | L | None | 15 | Hemostatic drug | 8.8 % Hemolysis at 500 μM | Mouse | Anterior‐Half Fragment Of Hnp | NA | Low hemolytic | ||
| 30927490 | 2019 | ACYCRIPACIAGERR | HNP‐F | Free | Free | Linear | L | None | 15 | Hemostatic drug | 9.5 % Hemolysis at 5000 μM | Mouse | Anterior‐Half Fragment Of Hnp | NA | Low hemolytic | ||
| 31324383 | 2019 | IPHVYNSPSPIK{d}PNRL | SBH-IPH | Free | Free | Linear | L | None | 16 | ND = not detected | 1.3 % Hemolysis at 1000 µM | Sheep | Soybean Uncharacterized Protein | NA | Non-hemolytic | ||
| 31324383 | 2019 | AK{d}GITVIGAR | SBH-AKG | Free | Free | Linear | L | None | 10 | ND = not detected | 0 % Hemolysis at 1000 µM | Sheep | Soybean Uncharacterized Protein | NA | Non-hemolytic | ||
| 31324383 | 2019 | VRK{d}RPLVAL | SBH-VRK | Free | Free | Linear | L | None | 9 | ND = not detected | 1.61 % Hemolysis at 1000 µM | Sheep | Soybean Uncharacterized Protein | NA | Non-hemolytic | ||
| 31324383 | 2019 | PSVIK{d}K{d}GISK{d} | SBH-PSV | Free | Free | Linear | L | None | 10 | ND = not detected | 2.46 % Hemolysis at 1000 µM | Sheep | Soybean Uncharacterized Protein | NA | Non-hemolytic | ||
| 31324383 | 2019 | NRVF{d}GALK{d}GAL | SBH-NRV | Free | Free | Linear | L | None | 11 | ND = not detected | 0.055 % Hemolysis at 1000 µM | Sheep | Soybean Uncharacterized Protein | NA | Non-hemolytic | ||
| 31324383 | 2019 | F{d}K{d}NQYGHVR | SBH-FKN | Free | Free | Linear | L | None | 9 | ND = not detected | 0.84 % Hemolysis at 1000 µM | Sheep | Soybean Beta-Conglycinin Alpha’ Chain | NA | Non-hemolytic | ||
| 31324383 | 2019 | RTRGGF{d}MVSR | SBH-RTR | Free | Free | Linear | L | None | 10 | ND = not detected | 0.85 % Hemolysis at 1000 µM | Sheep | Soybean Alpha-Galactosidase | NA | Non-hemolytic | ||
| 31324383 | 2019 | DRRPPPRRDVV | SBH-DRR | Free | Free | Linear | L | None | 11 | ND = not detected | 2.1 % Hemolysis at 1000 µM | Sheep | Soybean Uncharacterized Protein | NA | Non-hemolytic | ||
| 31324383 | 2019 | K{d}K{d}IQVIGK{d}ARVPI | SBH-KKI | Free | Free | Linear | L | None | 13 | ND = not detected | 1.9 % Hemolysis at 1000 µM | Sheep | Soybean Uncharacterized Protein | NA | Non-hemolytic | ||
| 30678611 | 2019 | FFTTSCRSGC | OA-FF10 | Free | Free | Linear | L | None | 10 | Promoted Wound healing and proliferation of human keratinocytes (HaCaT) | 0 % Hemolysis at 100 µM | Human | Frog Species, Odorrana Andersonii | NA | Non-hemolytic | ||
| 32435168 | 2020 | GWINEKKMQQKIDEKIGKNIIGGMAKAVIHKMAKNEFQCVANVDTLGNCKKHCAKTTGEKGYCHGTKCKCGIELSY | Smp76 | Free | Free | Linear | L | None | 76 | Antiviral | 50 % Hemolysis at >10 μg/ml | Human | Scorpion Scorpio Maurus Palmatus | NA | NA | ||
| 33479615 | 2020 | GHR{d}KPAQP | P1 | Free | Free | Linear | Mix | None | 8 | Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral | 50 % Hemolysis at >50 µM | Rabbit | Synthetic Peptide | NA | Low hemolytic | ||
| 33479615 | 2020 | E{d}R{d}R{d}KPAQP | P2 | Free | Free | Linear | Mix | None | 8 | Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral | 0 % Hemolysis at 100 µM | Rabbit | Synthetic Peptide | NA | Low hemolytic | ||
| 33479615 | 2020 | E{d}E{d}EKPAQP | P4 | Free | Free | Linear | Mix | None | 8 | Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral | 50 % Hemolysis at >50 µM | Rabbit | Synthetic Peptide | NA | Low hemolytic | ||
| 33479615 | 2020 | E{d}F{d}R{d}TMVHPK | P5 | Free | Free | Linear | Mix | None | 9 | Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral | 0 % Hemolysis at 100 µM | Rabbit | Synthetic Peptide | NA | Low hemolytic | ||
| 33479615 | 2020 | E{d}D{d}RKHAQA | P8 | Free | Free | Linear | Mix | None | 8 | Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral | 50 % Hemolysis at >40 µM | Rabbit | Synthetic Peptide | NA | Low hemolytic | ||
| 33479615 | 2020 | K{d}EFHKTAQP | P9 | Free | Free | Linear | Mix | None | 9 | Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral | 50 % Hemolysis at >60 µM | Rabbit | Synthetic Peptide | NA | Low hemolytic | ||
| 33479615 | 2020 | F{d}R{d}R{d}RPLRA | P13 | Free | Free | Linear | Mix | None | 8 | Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral | 0 % Hemolysis at 100 µM | Rabbit | Synthetic Peptide | NA | Low hemolytic | ||
| 33479615 | 2020 | DD{d}H{d}KTAHQ | P14 | Free | Free | Linear | Mix | None | 8 | Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral | 50 % Hemolysis at >40 µM | Rabbit | Synthetic Peptide | NA | Low hemolytic | ||
| 33479615 | 2020 | GW{d}RKPAQP | P16 | Free | Free | Linear | Mix | None | 8 | Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral | 0 % Hemolysis at 100 µM | Rabbit | Synthetic Peptide | NA | Low hemolytic | ||
| 33479615 | 2020 | W{d}KR{d}LHHKPA | P18 | Free | Free | Linear | Mix | None | 9 | Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral | 0 % Hemolysis at 100 µM | Rabbit | Synthetic Peptide | NA | Low hemolytic | ||
| 31862270 | 2020 | {conj:Lauric acid}PFKISIHL | Lauric acid – Jellein (L-Jellein) | Free | Lauric acid | Linear | L | None | 8 | Anti-leishmanial | 0 % Hemolysis at 500 μg/ml | Human | Lauric Acid Conjugated Jellein | NA | Non-hemolytic | ||
| 31862270 | 2020 | LPKPPKPVSKMRMATPLLMQALPM | CLIP | Free | Free | Linear | L | None | 24 | Anti-leishmanial | 0 % Hemolysis at 500 μg/ml | Human | Mhc Class Ii Associated Invariant Chain Peptide | NA | Non-hemolytic | ||
| 32342079 | 2020 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicobial | 5 % Hemolysis at 0.25 μM | Human | Honey Bee | α-Helical | NA | ||
| 32612531 | 2020 | AKACTPRLHDCSHDRHSCCRGELFKDVCYCFYPEGEDKTEVCSCQQPKSHKYIEKVVDKTKTLVG | LCTX-F2 | Free | Free | Linear | L | None | 65 | Procoagulant | 0.74 % Hemolysis at 100 µg/ml | Rabbit | Chinese Wolf Spider Lycosa Singoriensis | NA | Non-hemolytic | ||
| 32543191 | 2020 | AAAAMAGPK{ct:Amid} | Rice-derived-peptide-3 (RDP3) | Amidation | Free | Linear | L | None | 9 | Anti-gout, Anti-inflammation | 4.5±0.13 % Hemolysis at 100 µg/mL | Human | Shelled Oryza Sativa Fruits | NA | Non-hemolytic | ||
| 32543191 | 2020 | AAAAMAGPK{ct:Amid} | Rice-derived-peptide-3 (RDP3) | Amidation | Free | Linear | L | None | 9 | Anti-gout, Anti-inflammation | 5.0±0.07 % Hemolysis at 500 µg/mL | Human | Shelled Oryza Sativa Fruits | NA | Non-hemolytic | ||
| 32543191 | 2020 | AAAAMAGPK{ct:Amid} | Rice-derived-peptide-3 (RDP3) | Amidation | Free | Linear | L | None | 9 | Anti-gout, Anti-inflammation | 4.5±0.15 % Hemolysis at 1 mg/mL | Human | Shelled Oryza Sativa Fruits | NA | Non-hemolytic | ||
| 32673701 | 2020 | R{d}RR{d}RR{d}RRR | rR8 | Free | Free | Linear | Mix | None | 8 | Antimalarial | 0 % Hemolysis at 5 μM | Human | Derived From A Cell-Penetrating Peptide | Random coil | Non-hemolytic | ||
| 32673701 | 2020 | R{d}RR{d}RR{d}RRR | rR8 | Free | Free | Linear | Mix | None | 8 | Antimalarial | 0 % Hemolysis at 10 μM | Human | Derived From A Cell-Penetrating Peptide | Random coil | Non-hemolytic | ||
| 32673701 | 2020 | R{d}RR{d}RR{d}RRR | rR8 | Free | Free | Linear | Mix | None | 8 | Antimalarial | 0.8 % Hemolysis at 20 μM | Human | Derived From A Cell-Penetrating Peptide | Random coil | Non-hemolytic | ||
| 32673701 | 2020 | R{d}RR{d}RR{d}RRR | rR8 | Free | Free | Linear | Mix | None | 8 | Antimalarial | 1.3 % Hemolysis at 40 μM | Human | Derived From A Cell-Penetrating Peptide | Random coil | Non-hemolytic | ||
| 32673701 | 2020 | KKKKKKKKKYYKYKKKEKEKK | JR21 | Free | Free | Linear | L | None | 21 | Antimalarial | 0 % Hemolysis at 5 μM | Human | Designed Based On The Junctional Region Of Pfdhfr-Ts | Helical | Non-hemolytic | ||
| 32673701 | 2020 | KKKKKKKKKYYKYKKKEKEKK | JR21 | Free | Free | Linear | L | None | 21 | Antimalarial | 0 % Hemolysis at 10 μM | Human | Designed Based On The Junctional Region Of Pfdhfr-Ts | Helical | Non-hemolytic | ||
| 32673701 | 2020 | KKKKKKKKKYYKYKKKEKEKK | JR21 | Free | Free | Linear | L | None | 21 | Antimalarial | 0.8 % Hemolysis at 20 μM | Human | Designed Based On The Junctional Region Of Pfdhfr-Ts | Helical | Non-hemolytic | ||
| 32673701 | 2020 | KKKKKKKKKYYKYKKKEKEKK | JR21 | Free | Free | Linear | L | None | 21 | Antimalarial | 1 % Hemolysis at 40 μM | Human | Designed Based On The Junctional Region Of Pfdhfr-Ts | Helical | Non-hemolytic | ||
| 32673701 | 2020 | R{d}RR{d}RR{d}RRR-KKKKKKKKKYYKYKKKEKEKK | rR8-JR21 | Free | Free | Linear | Mix | None | 29 | Antimalarial | 0 % Hemolysis at 5 μM | Human | Combination Of Rr8 And Jr21 Sequences | Random coil and Helical | Non-hemolytic | ||
| 32673701 | 2020 | R{d}RR{d}RR{d}RRR-KKKKKKKKKYYKYKKKEKEKK | rR8-JR21 | Free | Free | Linear | Mix | None | 29 | Antimalarial | 0 % Hemolysis at 10 μM | Human | Combination Of Rr8 And Jr21 Sequences | Random coil and Helical | Non-hemolytic | ||
| 32673701 | 2020 | R{d}RR{d}RR{d}RRR-KKKKKKKKKYYKYKKKEKEKK | rR8-JR21 | Free | Free | Linear | Mix | None | 29 | Antimalarial | 0.8 % Hemolysis at 20 μM | Human | Combination Of Rr8 And Jr21 Sequences | Random coil and Helical | Non-hemolytic | ||
| 32673701 | 2020 | R{d}RR{d}RR{d}RRR-KKKKKKKKKYYKYKKKEKEKK | rR8-JR21 | Free | Free | Linear | Mix | None | 29 | Antimalarial | 1.3 % Hemolysis at 40 μM | Human | Combination Of Rr8 And Jr21 Sequences | Random coil and Helical | Non-hemolytic | ||
| 32726461 | 2020 | VLESFKVSFLSALEEYTKKL{nt:H}{ct:OH} | apoA‐I221–240 | OH | H | Linear | L | None | 20 | Anti‐inflammatory | 1.34 ± 0.66 % Hemolysis at 200 μM | mouse | Apolipoprotein A-I (Apoa-I) Mimetic Peptides | aqueous = Disordered, 50% TFE = α‐Helical | Non-hemolytic | ||
| 32726461 | 2020 | FLEKLKELLEHLKELLTKLL{nt:H}{ct:OH} | P12 | OH | H | Linear | L | None | 20 | Anti‐atherosclerotic, Anti‐inflammatory and Antioxidant | 1.71 ± 0.73 % Hemolysis at 200 μM | mouse | Modfied Apoa‐I221–240 Synthetic Peptide | aqueous = Disordered, 50% TFE = α‐Helical | Non-hemolytic | ||
| 32726461 | 2020 | DWFKAFYDKVAEKFKEAF{nt:Acet}{ct:Amid} | L‐4F | Amidation | Acetylation | Linear | L | None | 18 | Anti‐atherosclerotic, Anti‐inflammatory and Antioxidant | 2.10 ± 0.48 % Hemolysis at 200 μM | mouse | Synthetic Peptide | aqueous = α‐Helical, 50% TFE = α‐Helical | Non-hemolytic | ||
| 32891601 | 2020 | GKWMTLLKHILK{ct:Amid} | P5T | Amidation | Free | Linear | L | None | 12 | Anti-leishmanial | 6.5 ± 0.9 % Hemolysis at 64 μM | Human | Analogues Of The Halictine-2 (Honeybee, Halictus Sexcinctus) | 10 mM PB = Disordered, 10 mM SDS or 50% TFE = α-Helix | Non-hemolytic | ||
| 33396521 | 2020 | RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC | D-lp1 | Free | Free | Linear | L | None | 47 | Antiyeast | <10 % Hemolysis at 400 μg/mL | Sheep | Plant Barley (Hordeum Vulgare) Endosperm | Triple Stranded antiparallel Betα-Sheets and Alpha Helix | Non-hemolytic | ||
| 33352972 | 2020 | GLNALKKVFQGIHEAIKLINNHVQ{ct:Amid} | Pseudin-2 | Amidation | Free | Linear | L | None | 24 | Antiyeast | Hemolysis at 64 μM | Mouse | Paradox Frog Pseudis Paradoxa | α-Helical | NA | ||
| 33352972 | 2020 | GLNAAKKVFQGAHEAIKLINNHVQ{ct:Amid} | P2-LZ1 | Amidation | Free | Linear | L | None | 24 | Antiyeast | Hemolysis at 64 μM | Mouse | Synthetic Analogous Peptide | α-Helical | NA | ||
| 33352972 | 2020 | GANALKKVAQGIHEAIKLINNHVQ{ct:Amid} | P2-LZ2 | Amidation | Free | Linear | L | None | 24 | Antiyeast | Hemolysis at 64 μM | Mouse | Synthetic Analogous Peptide | α-Helical | NA | ||
| 33352972 | 2020 | GLNALKKVFQGAHEAIKLANNHVQ{ct:Amid} | P2-LZ3 | Amidation | Free | Linear | L | None | 24 | Antiyeast | Hemolysis at 64 μM | Mouse | Synthetic Analogous Peptide | α-Helical | NA | ||
| 33352972 | 2020 | GLNALKKVAQGIHEAAKLINNHVQ{ct:Amid} | P2-LZ4 | Amidation | Free | Linear | L | None | 24 | Antiyeast | Hemolysis at 64 μM | Mouse | Synthetic Analogous Peptide | α-Helical | NA | ||
| 33352972 | 2020 | GLNALKKVKQGKHEAIKLINNHVQ{ct:Amid} | P2-LZ5 | Amidation | Free | Linear | L | None | 24 | Antiyeast | Hemolysis at 64 μM | Mouse | Synthetic Analogous Peptide | α-Helical | NA | ||
| 33049300 | 2021 | RRGFFKPYGKKPKKVAKKPYYHCGWKYCGWKYCGWKHCGWKY | Gj-CATH3 | Free | Free | Linear | L | None | 42 | Antioxidant | 12.18 ± 1.38 % Hemolysis at 80 μM | Sheep | Lizard Gekko Japonicus Cathelicidins | NA | NA | ||
| 33049300 | 2021 | CGWKYCGWKYCGWKHCGWKY | Gj-CATH3-(23–42)-peptide | Free | Free | Linear | L | None | 20 | Antioxidant | 7.75 ± 0.89 % Hemolysis at 80 μM | Sheep | Gj-Cath3 Analogues | NA | NA | ||
| 33049300 | 2021 | CGWKHCGWKY | Gj-CATH3-(33–42)-peptide | Free | Free | Linear | L | None | 10 | Antioxidant, Wound healing | 1.05 ± 0.23 % Hemolysis at 80 μM | Sheep | Gj-Cath3 Analogues | NA | Non-hemolytic | ||
| 33049300 | 2021 | CGWKY | Gj-CATH3-(38–42)-peptide | Free | Free | Linear | L | None | 5 | Antioxidant, Wound healing | 0.7 ± 0.14 % Hemolysis at 80 μM | Sheep | Gj-Cath3 Analogues | NA | Non-hemolytic | ||
| 33830736 | 2021 | RKVRGPPVSCIKRDSPIQ | LP-2 | Free | Free | Linear | L | None | 18 | Anti-osteoclastogenic | 0 % Hemolysis at 100 µM | Human | Fragment From The N-Terminus Of The N-Lobe Of Human Lactoferrin | aqueous environmen = nano-globular assembly Helical and β-Sheet | Non-hemolytic | ||
| 33689880 | 2021 | LVGKLLKGAVGDVCGLLPIC | Peptide 2 | Free | Free | Linear | L | None | 20 | Anti-inflammatory | 0.22 % Hemolysis at 21.875 µM | Human | Frog Skin Secretions Of Bombina Maxima | NA | Non-hemolytic | ||
| 33689880 | 2021 | LVGKLLKGAVGDVCGLLPIC | Peptide 2 | Free | Free | Linear | L | None | 20 | Anti-inflammatory | 0.26 % Hemolysis at 43.75 µM | Human | Frog Skin Secretions Of Bombina Maxima | NA | Non-hemolytic | ||
| 33689880 | 2021 | LVGKLLKGAVGDVCGLLPIC | Peptide 2 | Free | Free | Linear | L | None | 20 | Anti-inflammatory | 0.31 % Hemolysis at 87.5 µM | Human | Frog Skin Secretions Of Bombina Maxima | NA | Non-hemolytic | ||
| 33689880 | 2021 | LVGKLLKGAVGDVCGLLPIC | Peptide 2 | Free | Free | Linear | L | None | 20 | Anti-inflammatory | 0.32 % Hemolysis at 175 µM | Human | Frog Skin Secretions Of Bombina Maxima | NA | Non-hemolytic | ||
| 33689880 | 2021 | LVGKLLKGAVGDVCGLLPIC | Peptide 2 | Free | Free | Linear | L | None | 20 | Anti-inflammatory | 0.33 % Hemolysis at 350 µM | Human | Frog Skin Secretions Of Bombina Maxima | NA | Non-hemolytic | ||
| 33689880 | 2021 | LVGKLLKGAVGDVCGLLPIC | Peptide 2 | Free | Free | Linear | L | None | 20 | Anti-inflammatory | 0.33 % Hemolysis at 700 µM | Human | Frog Skin Secretions Of Bombina Maxima | NA | Non-hemolytic | ||
| 33689880 | 2021 | LVGKLLKGAVGDVCGLLPIC | Peptide 2 | Free | Free | Linear | L | None | 20 | Anti-inflammatory | 0.4 % Hemolysis at 1.4 mM | Human | Frog Skin Secretions Of Bombina Maxima | NA | Non-hemolytic | ||
| 33689880 | 2021 | LVGKLLKGAVGDVCGLLPIC | Peptide 2 | Free | Free | Linear | L | None | 20 | Anti-inflammatory | 0.56 % Hemolysis at 2.8 mM | Human | Frog Skin Secretions Of Bombina Maxima | NA | Non-hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 50 % Hemolysis at 886.5 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 0 % Hemolysis at 1 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 0 % Hemolysis at 2 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 0.4 % Hemolysis at 4 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 0.7 % Hemolysis at 8 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 1.4 % Hemolysis at 16 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 1.5 % Hemolysis at 32 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 1.8 % Hemolysis at 64 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 2.4 % Hemolysis at 128 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 10.6 % Hemolysis at 256 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 50 % Hemolysis at 16.77 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 0.1 % Hemolysis at 1 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 0.3 % Hemolysis at 2 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 2 % Hemolysis at 4 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 2.5 % Hemolysis at 8 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 5.4 % Hemolysis at 16 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 16.9 % Hemolysis at 32 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 40.3 % Hemolysis at 64 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 99.3 % Hemolysis at 128 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 99.5 % Hemolysis at 256 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 50 % Hemolysis at 33.26 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 0 % Hemolysis at 1 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 0 % Hemolysis at 2 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 0.4 % Hemolysis at 4 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 0.5 % Hemolysis at 8 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 0.9 % Hemolysis at 16 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 2.5 % Hemolysis at 32 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 8.7 % Hemolysis at 64 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 23.6 % Hemolysis at 128 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 65.6 % Hemolysis at 256 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 50 % Hemolysis at 0.99 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 6.1 % Hemolysis at 1 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 15 % Hemolysis at 2 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 33.7 % Hemolysis at 4 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 61.6 % Hemolysis at 8 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 96.2 % Hemolysis at 16 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 97.6 % Hemolysis at 32 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 97.9 % Hemolysis at 64 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 99.8 % Hemolysis at 128 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 100 % Hemolysis at 256 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34021418 | 2021 | RKPRPHQFIGLM | RM12 | Free | Free | Linear | L | None | 12 | Antioxidant | 15-20 % Hemolysis at 320 μM | Fish | Muscle Transcriptome Of A Freshwater Murrel Channa Striatus | Random coil | Low hemolytic | ||
| 34022355 | 2021 | GILGKLWEGVKSIF | Hp1404 | Free | Free | Linear | L | None | 14 | Anti-Acinetobacter baumannii, Anti-Carbapenem-resistant Acinetobacter baumannii (CRAB | 10 % Hemolysis at 32.3 μM | Human | Scorpion Heterometrus Petersii | α-Helical | NA | ||
| 34022355 | 2021 | FLWGLIPGAISAVTSLIKK | ctriporin | Free | Free | Linear | L | None | 19 | Anti-Acinetobacter baumannii | 10 % Hemolysis at 14.9 μM | Human | Scorpion Chaerilus Tricostatus | NA | NA | ||
| 34022355 | 2021 | FLGSLFSIGSKLLPGVIKLFQRKKQ | Im5 | Free | Free | Linear | L | None | 25 | Anti-Acinetobacter baumannii | 10 % Hemolysis at 2.7 μM | Human | Scorpion Isometrus Maculatus | NA | NA | ||
| 34058259 | 2021 | EEVQRDVSIMPYKIIGADNGDAWLDVKGQKMAPPQISAEVLKK | DP1 | Free | Free | Linear | L | None | 43 | Anti-Salmonella | 1 % Hemolysis at 100 µg/ml | Human | Synthetic Multi-Epitope Dnak Peptides | NA | Non-hemolytic | ||
| 34058259 | 2021 | LPYITADATGPKHMNIKVTRAKLESLVE | DP2 | Free | Free | Linear | L | None | 28 | Anti-Salmonella | 1 % Hemolysis at 100 µg/ml | Human | Synthetic Multi-Epitope Dnak Peptides | NA | Non-hemolytic | ||
| 34058259 | 2021 | AEDNQSAVTIHVLQGERKRASDNKSLG | DP3 | Free | Free | Linear | L | None | 27 | Anti-Salmonella | 1 % Hemolysis at 100 µg/ml | Human | Synthetic Multi-Epitope Dnak Peptides | NA | Non-hemolytic | ||
| 34058259 | 2021 | HVSAKDKNSGKEQKITIK | DP4 | Free | Free | Linear | L | None | 18 | Anti-Salmonella | 1 % Hemolysis at 100 µg/ml | Human | Synthetic Multi-Epitope Dnak Peptides | NA | Non-hemolytic | ||
| 34058259 | 2021 | TRNQGDHLLHSTRKQVEEAGDKLPADDKTAIESALSALETALKG | DP5 | Free | Free | Linear | L | None | 44 | Anti-Salmonella | 1 % Hemolysis at 100 µg/ml | Human | Synthetic Multi-Epitope Dnak Peptides | NA | Non-hemolytic | ||
| 34058259 | 2021 | ETALKGEDKAAIEAKMQELAQVSQKLMEIA | DP6 | Free | Free | Linear | L | None | 30 | Anti-Salmonella | 1 % Hemolysis at 100 µg/ml | Human | Synthetic Multi-Epitope Dnak Peptides | NA | Non-hemolytic | ||
| 34058259 | 2021 | HAQQQAGSADASANNAKDDDVVDAEFEEVKDKK | DP7 | Free | Free | Linear | L | None | 33 | Anti-Salmonella | 1 % Hemolysis at 100 µg/ml | Human | Synthetic Multi-Epitope Dnak Peptides | NA | Non-hemolytic | ||
| 34129853 | 2021 | INWKGIAAMGKKLL | Vp1a | Free | Free | Linear | L | None | 14 | Antioxidant | 2.37 % Hemolysis at 120 μM | mouse | Asian Hornet Vespa Velutina | NA | Non-hemolytic | ||
| 34129853 | 2021 | FLPIIDKLLGGLLGKK | Vp2b | Free | Free | Linear | L | None | 16 | Antioxidant | 2.12 % Hemolysis at 120 μM | mouse | Asian Hornet Vespa Velutina | NA | Non-hemolytic | ||
| 34635758 | 2021 | CTKTDVHFC{cyc:N-C} | CP2 | Free | Free | Cyclic | L | None | 9 | Antiviral against WNV (West Nile virus) | 0.2 % Hemolysis at 6 μM | Sheep | Synthetic Cyclic Peptide | NA | Low hemolytic | ||
| 34635758 | 2021 | CIHSSTRAC{cyc:N-C} | CP4 | Free | Free | Cyclic | L | None | 9 | Antiviral against WNV (West Nile virus) | 0.2 % Hemolysis at 6 μM | Sheep | Synthetic Cyclic Peptide | NA | Low hemolytic | ||
| 34635758 | 2021 | CTYENHRTC{cyc:N-C} | CP12 | Free | Free | Cyclic | L | None | 9 | Antiviral against WNV (West Nile virus) | 0.2 % Hemolysis at 6 μM | Sheep | Synthetic Cyclic Peptide | NA | Low hemolytic | ||
| 34635758 | 2021 | CLAQSHPLC{cyc:N-C} | CP16 | Free | Free | Cyclic | L | None | 9 | Antiviral against WNV (West Nile virus) | 0.2 % Hemolysis at 6 μM | Sheep | Synthetic Cyclic Peptide | NA | Low hemolytic | ||
| 35111812 | 2022 | YPASFDDDFDALDDLDDLDLDDLLDLEPADLVLLDMWANMMDSQDFEDFE | TanP | Free | Free | Linear | L | None | 50 | Chelating, Antioxidant, Anti-inflammatory | 3 % Hemolysis at 50 μM | Human | Tityus Stigmurus Scorpion Venom | NA | Low hemolytic | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDFLR{ct:Amid} | LL37-1 | Amidation | Free | Linear | L | None | 23 | Antibiofilm | ≤5 % Hemolysis at 1.5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDFLR{ct:Amid} | LL37-1 | Amidation | Free | Linear | L | None | 23 | Antibiofilm | ≤5 % Hemolysis at 2.5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDFLR{ct:Amid} | LL37-1 | Amidation | Free | Linear | L | None | 23 | Antibiofilm | ≤5 % Hemolysis at 5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDFLR{ct:Amid} | LL37-1 | Amidation | Free | Linear | L | None | 23 | Antibiofilm | ≤20 % Hemolysis at 10 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36551443 | 2022 | RGGRLCYCRRRFCVCVGR | PG-1 | Free | Free | Linear | L | None | 18 | Antimycobacterial | 100 % Hemolysis at 1000 µg/mL | Human | Sus Domesticus | NA | NA | ||
| 36551443 | 2022 | AVKKLLRWWSRWWKK | AK 15-6 | Free | Free | Linear | L | None | 15 | Antimycobacterial | 33.57 % Hemolysis at 1000 µg/mL | Human | Mycobac Teriophage | NA | NA | ||
| 36551443 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | AM-mel | Free | Free | Linear | L | None | 26 | Antimycobacterial | 100 % Hemolysis at 1000 µg/mL | Human | Apis Mellifera | NA | NA | ||
| 36551443 | 2022 | GRRRRSVQWCA | hLF 1-11(L-form) | Free | Free | Linear | L | None | 11 | Antimycobacterial | <1 % Hemolysis at 4000 µg/mL | Human | Homo Sapiens | NA | Non-hemolytic | ||
| 36551443 | 2022 | G{d}R{d}R{d}R{d}R{d}S{d}V{d}Q{d}W{d}C{d}A{d} | hLF 1-11(D-form) | Free | Free | Linear | D | None | 11 | Antimycobacterial | <1 % Hemolysis at 4000 µg/mL | Human | Homo Sapiens | NA | Non-hemolytic | ||
| 36508333 | 2022 | FPWIIS{ct:Amid} | BmT-2 | Amidation | Free | Linear | L | None | 6 | Antioxidant | 0 % Hemolysis at 400 µg/mL | Human | Crude Venom Of Bothrops Moojeni | NA | Non-hemolytic | ||
| 36737967 | 2023 | YPVEPF | YPVEPF | Free | Free | Linear | L | None | 6 | α-glucosidase inhibitory | 0 % Hemolysis at 1 mg/mL | mouse | Chinese Rubing Cheese Whey Protien Hypoglycemic Peptides | antiparallel (50.50 %) and Random coil (35.20 %) structures | Non-hemolytic | ||
| 37336295 | 2023 | FVDLKKIANIINSIFGK{ct:Amid} | Temporin-1CEa | Amidation | Free | Linear | L | None | 17 | Antimycobacterial | 50 % Hemolysis at 95.74 µM | Human | Chinese Brown Frog Rana Chensinensis | NA | NA | ||
| 37336295 | 2023 | FVDLKKIANIINSIFKK{ct:Amid} | LK1 | Amidation | Free | Linear | L | None | 17 | Antimycobacterial | 50 % Hemolysis at 1467 µM | Human | Analog Of Temporin-1Cea | NA | NA | ||
| 37336295 | 2023 | FVKLKKILNIILSIFKK{ct:Amid} | LK2(6)AN(2L) | Amidation | Free | Linear | L | None | 17 | Antimycobacterial | 50 % Hemolysis at 28.34 µM | Human | Analog Of Temporin-1Cea | NA | NA | ||
| 37336295 | 2023 | IKKILSKIKKLLK{ct:Amid} | LK6 | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Temporin-1Ceb | NA | Low hemolytic | ||
| 37336295 | 2023 | IWLSKIKKLLK{ct:Amid} | I4W | Amidation | Free | Linear | L | None | 11 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Lk6 | NA | Low hemolytic | ||
| 37336295 | 2023 | IKKWWSKIKKLLK{ct:Amid} | I4WL5W | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Lk6 | NA | Low hemolytic | ||
| 37336295 | 2023 | IKKIWSKIKKLLK{ct:Amid} | L5W | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Lk6 | NA | Low hemolytic | ||
| 37336295 | 2023 | IKKILSKIKKWLK{ct:Amid} | L11W | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Lk6 | NA | Low hemolytic | ||
| 37336295 | 2023 | IKKILSKIKKLWK{ct:Amid} | L12W | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Lk6 | NA | Low hemolytic | ||
| 37336295 | 2023 | WKKIWSKIKKLLK{ct:Amid} | I1WL5W | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Lk6 | NA | Low hemolytic | ||
| 37336295 | 2023 | WKKILSKIKKLLK{ct:Amid} | I1W | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Lk6 | NA | Low hemolytic | ||
| 37336295 | 2023 | SAVGRHGRRFGLRKHRKH{ct:Amid} | Chensinin-1 | Amidation | Free | Linear | L | None | 18 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Frog Rana Chensinensis | NA | Low hemolytic | ||
| 37336295 | 2023 | SKVWRHWRRFWHRAHRKL{ct:Amid} | Chensinin-1b | Amidation | Free | Linear | L | None | 18 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Chensinin-1 | NA | Low hemolytic | ||
| 37336295 | 2023 | SKVWRHWRRFWHRAHRK({nnr:C8})L | OA-C1b | Free | Free | Linear | L | C8 = C8 | 19 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Lipidated Analog Of Chensinin-1B | NA | Low hemolytic | ||
| 37336295 | 2023 | SKVWRHWRRFWHRAHRK({nnr:C12})L | LA-C1b | Free | Free | Linear | L | C12 = C12 | 19 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Lipidated Analog Of Chensinin-1B | NA | Low hemolytic | ||
| 37336295 | 2023 | SKVWRHWRRFWHRAHRK({nnr:C16})L | PA-C1b | Free | Free | Linear | L | C16 = C16 | 19 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Lipidated Analog Of Chensinin-1B | NA | Low hemolytic | ||
| 37336295 | 2023 | V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{ct:Amid} | D-W3R6 | Amidation | Free | Linear | D | None | 11 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of W3R6 | NA | Low hemolytic | ||
| 37336295 | 2023 | VWRRWRRFWRR{ct:Amid} | W3R6 | Amidation | Free | Linear | L | None | 11 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Chensinin-1 | 40% H2O/TFE-d3 = Random coil, 50%H2O/TFE-d3 = α-Helical | Low hemolytic | ||
| 37336295 | 2023 | V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{ct:Amid} | D-Arg-W3R6 | Amidation | Free | Linear | D | None | 11 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Diastereomer Of W3R6 | NA | Low hemolytic | ||
| 37336295 | 2023 | V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{nt:Acetylation(CH3COOH)}{ct:Amid} | AC-D-W3R6 | Amidation | Acetylation(CH3COOH) | Linear | D | None | 11 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Lipidated Analog Of D-W3R6 (Acetyl) | NA | Low hemolytic | ||
| 37336295 | 2023 | V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{nt:butanoyl = CH3(CH2)2COOH}{ct:Amid} | BA-D-W3R6 | Amidation | butanoyl = CH3(CH2)2COOH | Linear | D | None | 11 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Lipidated Analog Of D-W3R6 (Butanoyl) | NA | Low hemolytic | ||
| 37336295 | 2023 | V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{nt:octanoyl = C8H16O2}{ct:Amid} | OA-D-W3R6 | Amidation | octanoyl = C8H16O2 | Linear | D | None | 11 | Antimycobacterial | 50 % Hemolysis at 100 µM | Human | Lipidated Analog Of D-W3R6 (Octanoyl) | NA | NA | ||
| 37336295 | 2023 | V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{nt:lauric acyl = C12H24O2}{ct:Amid} | LA-D-W3R6 | Amidation | lauric acyl = C12H24O2 | Linear | D | None | 11 | Antimycobacterial | 50 % Hemolysis at 25 µM | Human | Lipidated Analog Of D-W3R6 (Lauric Acid) | NA | NA | ||
| 37336295 | 2023 | V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{nt:palmitic acyl = C16H32O2}{ct:Amid} | PA-D-W3R6 | Amidation | palmitic acyl = C16H32O2 | Linear | D | None | 11 | Antimycobacterial | 50 % Hemolysis at 25 µM | Human | Lipidated Analog Of D-W3R6 (Palmitic Acid) | NA | NA | ||
| 37336295 | 2023 | ILPILSLIGGLL{ct:Amid} | Temporin-1CEb | Amidation | Free | Linear | L | None | 12 | Antimycobacterial | 50 % Hemolysis at 122 µM | Human | Rana Chensinensis | NA | NA | ||
| 37336295 | 2023 | IIPLPLGYFAKKT{ct:Amid} | Temporin-1CEc | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Rana Chensinensis | NA | Low hemolytic | ||
| 37336295 | 2023 | IIPLPLKKFAKKT{ct:Amid} | 2 K | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Temporin-1Cec | NA | Low hemolytic | ||
| 37336295 | 2023 | KIPKPLKKFAKKT{ct:Amid} | 4 K | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Temporin-1Cec | NA | Low hemolytic | ||
| 37336295 | 2023 | IIPLPLKKFLKKL{ct:Amid} | 2 K2L | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Temporin-1Cec | NA | Low hemolytic | ||
| 37336295 | 2023 | KIPKPLKKFLKKL{ct:Amid} | 4 K2L | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Temporin-1Cec | NA | Low hemolytic | ||
| 37336295 | 2023 | IILLLLKKFLKKL{ct:Amid} | 2 K4L | Amidation | Free | Linear | L | None | 14 | Antimycobacterial | 50 % Hemolysis at 62.5 µM | Human | Analog Of Temporin-1Cec | NA | NA | ||
| 37336295 | 2023 | KILKLLKKFLKKL{ct:Amid} | 4 K4L | Amidation | Free | Linear | L | None | 13 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of Temporin-1Cec | NA | Low hemolytic | ||
| 35647551 | 2022 | {nnr:B}FKVARRTVAKYRE{nnr:NIe}L{nt:Acet}{ct:Amid} | WT | Amidation | Acetylation | Stapled | L | B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X | 16 | Antivirulente | 0.12 ± 0.07 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35647551 | 2022 | {nnr:B}FKV{nnr:X}RRT{nnr:X}AKYRE{nnr:NIe}L{nt:Acet}{ct:Amid} | 2 | Amidation | Acetylation | Stapled | L | B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X | 16 | Antivirulente | 6.6 ± 0.3 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35647551 | 2022 | {nnr:B}FKVARR{nnr:X}VAK{nnr:X}RE{nnr:NIe}L{nt:Acet}{ct:Amid} | 10 | Amidation | Acetylation | Stapled | L | B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X | 16 | Antivirulente | 10.7 ± 0.3 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35647551 | 2022 | {nnr:B}FKV{nnr:X}RRT{nnr:X}AKYRE{nnr:NIe}|{nt:Acet}{ct:Amid} | 14 | Amidation | Acetylation | Stapled | L | B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X | 16 | Antivirulente | 35.0 ± 0.5 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35647551 | 2022 | {nnr:B}FKV{nnr:X}KRT{nnr:X}AKYRE{nnr:NIe}L{nt:Acet}{ct:Amid} | 17 | Amidation | Acetylation | Stapled | L | B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X | 16 | Antivirulente | 3.3 ± 0.7 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35647551 | 2022 | {nnr:B}FKV{nnr:X}RKT{nnr:X}AKYRE{nnr:NIe}L{nt:Acet}{ct:Amid} | 18 | Amidation | Acetylation | Stapled | L | B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X | 16 | Antivirulente | 3.3 ± 0.05 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35647551 | 2022 | {nnr:B}FKV{nnr:X}RRT{nnr:X}GKYRE{nnr:NIe}L{nt:Acet}{ct:Amid} | 31 | Amidation | Acetylation | Stapled | L | B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X | 16 | Antivirulente | 0.53 ± 0.05 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35647551 | 2022 | {nnr:B}FRV{nnr:X}RRT{nnr:X}AKYRE{nnr:NIe}L{nt:Acet}{ct:Amid} | 33 | Amidation | Acetylation | Stapled | L | B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X | 16 | Antivirulente | 1.5 ± 0.03 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35246675 | 2022 | KETTTIVR | MoHpP-2 | Free | Free | Linear | L | None | 8 | α-glucosidase inhibitory peptide | 7.18 % Hemolysis at 4 mg/mL | Rabbit | Moringa Oleifera | α-Helix | Low hemolytic | ||
| 35246675 | 2022 | KETTTIVR | MoHpP-2 | Free | Free | Linear | L | None | 8 | α-glucosidase inhibitory peptide | 4.23 % Hemolysis at 2 mg/mL | Rabbit | Moringa Oleifera | α-Helix | Low hemolytic | ||
| 35378215 | 2022 | MDKLQLKGMSYSMCTGKF | PD1 CD44 | Free | Free | Linear | L | None | 18 | Antiviral | 8 % Hemolysis at 196.3 µM | Human | Human | α-Helix | NA | ||
| 35832307 | 2022 | GLFKWHPRCGEEQSMWT{ct:Amid} | OA-GL17d | Amidation | Free | Linear | L | None | 17 | Cell proliferation | 6.26 ± 0.14 % Hemolysis at 100 μg/mL | mouse | Odorrana Andersonii Frog Skin | α-Helix | Non-hemolytic | ||
| 35832307 | 2022 | GLFKWHPRCGEEQSMWT{ct:Amid} | OA-GL17d | Amidation | Free | Linear | L | None | 17 | Cell proliferation | 6.99 ± 0.28 % Hemolysis at 500 μg/mL | mouse | Odorrana Andersonii Frog Skin | α-Helix | Non-hemolytic | ||
| 35832307 | 2022 | GLFKWHPRCGEEQSMWT{ct:Amid} | OA-GL17d | Amidation | Free | Linear | L | None | 17 | Cell proliferation | 8.49 ± 0.46 % Hemolysis at 1 mg/mL | mouse | Odorrana Andersonii Frog Skin | α-Helix | Non-hemolytic | ||
| 35812346 | 2022 | RRRRRRRRRRRRRRRRRR{nt:H}{ct:OH} | R18 (acetate) | OH | H | Linear | L | None | 18 | Mast cell degranulation inducer | low Hemolysis at 16 μM | Human | Synthetic | NA | Low hemolytic | ||
| 35812346 | 2022 | RRRRRRRRRRRRRRRRRR{nt:H}{ct:OH} | R18 (HCl) | OH | H | Linear | L | None | 18 | Mast cell degranulation inducer | No Hemolysis at 16 μM | Human | Synthetic | NA | Non-hemolytic | ||
| 35812346 | 2022 | R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}{nt:H}{ct:OH} | R18D (acetate) | OH | H | Linear | D | Lower case r = d-arginine | 18 | Mast cell degranulation inducer | No Hemolysis at 16 μM | Human | Synthetic | NA | Non-hemolytic | ||
| 35812346 | 2022 | GRKKRRQRRRKLSSIESDV{nt:H}{ct:OH} | Tat-NR2B9c (TFA) | OH | H | Linear | L | TFA = Trifluoroacetic acid | 19 | Mast cell degranulation inducer | No Hemolysis at 16 μM | Human | Synthetic | NA | Non-hemolytic | ||
| 35812346 | 2022 | PRRRRSSSRPIRRRRPRRASRRRRRGGRRRR{nt:H}{ct:OH} | Protamine (sulfate) | OH | H | Linear | L | None | 31 | Mast cell degranulation inducer | No Hemolysis at 16 μM | Human | Synthetic | NA | Non-hemolytic | ||
| 2317508 | 1990 | FLPLIAGLLGKLF{ct:Amid} | Hemolytic protein B9 | Amidation | Free | Linear | L | None | 13 | Hemolytic | 4 % Hemolysis at 1nmol/ml | Human | Rana Esculenta (Edible Frog) (Pelophylax Esculentus) | α-Helix | NA | ||
| 2317508 | 1990 | FLPLIAGLLGKLF{ct:Amid} | Hemolytic protein B9 | Amidation | Free | Linear | L | None | 13 | Hemolytic | 5 % Hemolysis at 1.5nmol/ml | Human | Rana Esculenta (Edible Frog) (Pelophylax Esculentus) | α-Helix | NA | ||
| 2317508 | 1990 | FLPLIAGLLGKLF{ct:Amid} | Hemolytic protein B9 | Amidation | Free | Linear | L | None | 13 | Hemolytic | 17 % Hemolysis at 2nmol/ml | Human | Rana Esculenta (Edible Frog) (Pelophylax Esculentus) | α-Helix | NA | ||
| 2317508 | 1990 | FLPLIAGLLGKLF{ct:Amid} | Hemolytic protein B9 | Amidation | Free | Linear | L | None | 13 | Hemolytic | 20 % Hemolysis at 2.5nmol/ml | Human | Rana Esculenta (Edible Frog) (Pelophylax Esculentus) | α-Helix | NA | ||
| 2317508 | 1990 | FLPLIAGLLGKLF{ct:Amid} | Hemolytic protein B9 | Amidation | Free | Linear | L | None | 13 | Hemolytic | 35 % Hemolysis at 3nmol/ml | Human | Rana Esculenta (Edible Frog) (Pelophylax Esculentus) | α-Helix | NA | ||
| 2317508 | 1990 | FLPLIAGLLGKLF{ct:Amid} | Hemolytic protein B9 | Amidation | Free | Linear | L | None | 13 | Hemolytic | 90 % Hemolysis at 3.5nmol/ml | Human | Rana Esculenta (Edible Frog) (Pelophylax Esculentus) | α-Helix | NA | ||
| 2578459 | 1985 | IKITTMLAKLGKVLAHV{ct:Amid} | Bombolitin I | Amidation | Free | Linear | L | None | 17 | hemolytic | 50 % Hemolysis at 4μg/mL | Pig | American Common Bumblebee, Megabombus Pennsylvanicus | Helix | NA | ||
| 2578459 | 1985 | IKIMDILAKLGKVLAHV{ct:Amid} | Bombolitin III | Amidation | Free | Linear | L | None | 17 | hemolytic | 50 % Hemolysis at 2.8μg/mL | Pig | American Common Bumblebee, Megabombus Pennsylvanicus | Helix | NA | ||
| 2578459 | 1985 | INIKDILAKLVKVLGHV{ct:Amid} | Bombolitin IV | Amidation | Free | Linear | L | None | 17 | hemolytic | 50 % Hemolysis at 1.8μg/mL | Pig | American Common Bumblebee, Megabombus Pennsylvanicus | NA | NA | ||
| 2578459 | 1985 | INVLGILGLLGKALSHL{ct:Amid} | Bombolitin V | Amidation | Free | Linear | L | None | 17 | hemolytic | 50 % Hemolysis at 0.7μg/mL | Pig | American Common Bumblebee, Megabombus Pennsylvanicus | NA | NA | ||
| 2317508 | 1990 | FLPLIAGLIGKLF{ct:Amid} | Peptide B9 | Amidation | Free | Linear | L | None | 13 | Hemolytic | Hemolytic | Human | Frog Rana Esculenta, Europe | NA | NA | ||
| 16207177 | 2006 | GSVLNCGETCLLGTCYTTGCTCNKYRVCTKD{cyc:N-C} | Kalata B8 | Free | Free | Cyclic | L | None | 31 | Antiviral, Anti-HIV, Hemolytic | 0 % Hemolysis at 370µM | Human | Plant African Herb, Oldenlandia Affinis | Beta | Non-hemolytic | ||
| 16872274 | 2006 | GLPTCGETCFGGTCNTPGCTCDPWPVCTHN{cyc:N-C} | Cycloviolacin O24 | Free | Free | Cyclic | L | None | 30 | Antiviral, Anti-HIV, Hemolytic | 75 % Hemolytic at 25µg/ml | Human | Plant Viola Odorata | Bridge | NA | ||
| 22074926 | 2012 | GGSVPCGESCVFIPCITSLAGCSCKNKVCYYD{cyc:N-C} | Parigidin-br1 | Free | Free | Cyclic | L | None | 32 | Insecticidal, Hemolytic | 28 % Hemolytic at 20µM | Human | Plant Palicourea Rigida (Rubiaceae) | Bridge | NA | ||
| 22074926 | 2012 | GGSVPCGESCVFIPCITSLAGCSCKNKVCYYD{cyc:N-C} | Parigidin-br1 | Free | Free | Cyclic | L | None | 32 | Insecticidal, Hemolytic | 41 % Hemolytic at 40µM | Human | Plant Palicourea Rigida (Rubiaceae) | Bridge | NA | ||
| 29649486 | 2018 | MNRLIILCLVAATIYSTIALPMKEDISNEERPTSVNEKPVKKSVAVAGAVIQGAALAFQVLDKILTSLGGIGRKIAIGVDNESGMKWAARNVYFYSGTSDTVLPYSVPHSKAFLYGARKTRGSVRGAVGVLAYSMSDGNTLGILFSVPYDYNWYSNWWNIKVYRGYKRANKWMYHDLYYYARPHKGNNEWHEKSLGYGLKSKGFMTSSGQTKLEIRVSRA | Deep-sea actinoporin Cjtox I (DELTA-actitoxin-Cja1a) (DELTA-AITX-Cja1a) | Free | Free | Linear | L | None | 220 | Cytolytic | Hemolytic | Horse | Cribrinopsis Japonica (Deep-Sea Anemone) | NA | NA | ||
| 17761205 | 2007 | MNFKYSILFICFGTLDRGLIPECPFNEYDILFFVYTRQQRDGIVLTEETLQNYDLFKKSTISRQVVFIDHGFLSNGNNENFIAMAKALIEKDNFLVISVDWKKGACNAFASTLDYLGYSTAVGNTRHVGKYVADFTKLLVEQYKVSMSNIRLIGHSLGAHTSGFAGKEVQELKLNKYSNIDGLDPAGPSFDSNDCPERLCETDAEYVQIIHTSNILGVYSKIGTVDFYMNYGSHQPGCGRFFSPSCSHTKAVKYLTECIKHECCLIGTPWKKYFSTPKPISQCTKDTCVCVGLNAKSYPARGSFYVPVEATAPYCHNEGIKL | Phospholipase A1 (PLA1) (EC 3.1.1.32) (allergen Poly p 1) | Free | Free | Linear | L | None | 322 | Allergic | 17±4 % Hemolytic at 100µM | Rat | Polybia Paulista (Neotropical Social Wasp) (Swarm-Founding Polistine Wasp) | NA | NA | ||
| 17451767 | 2007 | NLVQFKTLIMKIAGRSVVYKYFYYGCYCGWGGIGQPRDATDRCCFVHD | Acidic phospholipase A2 (Bp-PLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) | Free | Free | Linear | L | None | 48 | Anticoagulation | High Hemolytic | mouse | Bothrops Pauloensis (Neuwied'S Lancehead) (Bothrops Neuwiedi Pauloensis) | NA | NA | ||
| 10930841 | 2000 | MRALWIVAVLLVGVEGSLFELGKMIWQETGKNPVKNYGLYGCNCGVGGRGEPLDATDRCCFVHKCCYKKLTDCDSKKDRYSYKWKNKAIVCGKNQPCMQEMCECDKAFAICLRENLDTYNKSFRYHLKPSCKKTSEQC | Basic phospholipase A2 homolog acutohaemolysin (svPLA2 homolog) (Dac-K49) | Free | Free | Linear | L | None | 138 | Hemolytic, Anticoagulant | 50 % Hemolytic at 100µg | Rabbit | Deinagkistrodon Acutus (Hundred-Pace Snake) (Agkistrodon Acutus) | NA | NA | ||
| 31295915 | 2019 | SAEVAGAVIEGAKLTFNVLQ | FraA | Free | Free | Linear | L | None | 20 | actinoporins | HC(50) % Hemolytic at 0.4 ± 0.02nM | Sheep | Actinia Fragacea (Strawberry Anemone) | β-sandwich flanked by two α-helices | NA | ||
| 31295915 | 2019 | SAEVAGAIIDGASLTFDVLQ | FraB | Free | Free | Linear | L | None | 20 | actinoporins | HC(50) % Hemolytic at 0.3 ± 0.02nM | Sheep | Actinia Fragacea (Strawberry Anemone) | β-sandwich flanked by two α-helices | NA | ||
| 31295915 | 2019 | SADVAGAVIDGAGLG | FraC d | Free | Free | Linear | L | None | 15 | actinoporins | HC(50) % Hemolytic at 1.6 ± 0.3nM | Sheep | Actinia Fragacea (Strawberry Anemone) | β-sandwich flanked by two α-helices | NA | ||
| 31295915 | 2019 | SVAVAGAVIKGAALTFNILQ | FraD | Free | Free | Linear | L | None | 20 | actinoporins | HC(50) % Hemolytic at 0.4 ± 0.3nM | Sheep | Actinia Fragacea (Strawberry Anemone) | β-sandwich flanked by two α-helices | NA | ||
| 31295915 | 2019 | SADVAGAVIDGAGLGFDVLK | FraE | Free | Free | Linear | L | None | 20 | actinoporins | HC(50) % Hemolytic at 1.6 ± 0.2nM | Sheep | Actinia Fragacea (Strawberry Anemone) | β-sandwich flanked by two α-helices | NA | ||
| 32092412 | 2021 | MRSLGALLLLLSACLAVSAGPVPTPPDNIQVQENFNISRIYGKWYNLAIGSTCPWLKKIMDRMTVSTLVLGEGATEAEISMTSTRWRKGVCEETSGAYEKTDTDGKFLYHKSKWNITMESYVVHTNYDEYAIFLTKKFSRHHGPTITAKLYGRAPQLRETLLQDFRVVAQGVGIPEDSIFTMADRGECVPGEQEPEPILIPRVRRAVLPQEEEGSGGGQLVTEVTKKEDSCQLGYSAGPCMGMTSRYFYNGTSMACETFQYGGCMGNGNNFVTEKECLQTCRTVAACNLPIVRGPCRAFIQLWAFDAVKGKCVLFPYGGCQGNGNKFYSEKECREYCGVPGDGDEELLRFSN | Protein AMBP (Protein HC) [Cleaved into: Alpha-1-microglobulin (EC 1.6.2.-) (Alpha-1 microglycoprotein) (Complex-forming glycoprotein heterogeneous in charge); Inter-alpha-trypsin inhibitor light chain (ITI-LC) (Bikunin) (EDC1) (HI-30) (Uronic-acid-rich protein); Trypstatin] | Free | Free | Linear | L | None | 352 | Antioxidant | Hemolytic | Human | Homo Sapiens (Human) | NA | NA | ||
| 10978735 | 2001 | ALAGTIIAGASLTFQVLDKVLEELGKVSRKIAVGIDNESGGTWTALNAYFRSGTTDVILPEFVPNTKALLYSGRKDTGPVATGAVAAFAYYMSSGNTLGVMFSVPFDYNWYSNWWDVKIYSGKRRADQGMYEDLYYGNPYRGDNGWHEKNLGYGLRMKGIMTSAGEAKMQIKISR | DELTA-stichotoxin-She4b (DELTA-SHTX-She4b) (Cytolysin III) (Sticholysin II) (St II) (St-II) (StII) (StnII) (Sticholysin-2) (STCH2) | Free | Free | Linear | L | None | 175 | Cytolytic | 50 % Hemolytic at 30-45ng/ml | Human | Stichodactyla Helianthus (Sun Anemone) (Stoichactis Helianthus) | NA | NA | ||
| 20624979 | 2010 | MKTRIVSSVTTTLLLGSILMNPVAGAADSDINIKTGTTDIGSNTTVKTGDLVTYDKENGMHKKVFYSFIDDKNHNKKLLVIRTKGTIAGQYRVYSEEGANKSGLAWPSAFKVQLQLPDNEVAQISDYYPRNSIDTKEYMSTLTYGFNGNVTGDDTGKIGGLIGANVSIGHTLKYVQPDFKTILESPTDKKVGWKVIFNNMVNQNWGPYDRDSWNPVYGNQLFMKTRNGSMKAADNFLDPNKASSLLSSGFSPDFATVITMDRKASKQQTNIDVIYERVRDDYQLHWTSTNWKGTNTKDKWTDRSSERYKIDWEKEEMTN | Alpha-hemolysin (Alpha-HL) (Alpha-toxin) | Free | Free | Linear | L | None | 319 | Cytolytic | Hemolytic | Human | Staphylococcus Aureus | β-barrel | NA | ||
| 20624979 | 2010 | MKTRIVSSVTTTLLLGSILMNPVAGAADSDINIKTGTTDIGSNTTVKTGDLVTYDKENGMHKKVFYSFIDDKNHNKKLLVIRTKGTIAGQYRVYSEEGANKSGLAWPSAFKVQLQLPDNEVAQISDYYPRNSIDTKEYMSTLTYGFNGNVTGDDTGKIGGLIGANVSIGHTLKYVQPDFKTILESPTDKKVGWKVIFNNMVNQNWGPYDRDSWNPVYGNQLFMKTRNGSMKAADNFLDPNKASSLLSSGFSPDFATVITMDRKASKQQTNIDVIYERVRDDYQLHWTSTNWKGTNTKDKWTDRSSERYKIDWEKEEMTN | Alpha-hemolysin (Alpha-HL) (Alpha-toxin) | Free | Free | Linear | L | None | 319 | Cytolytic | Hemolytic | Rabbit | Staphylococcus Aureus | β-barrel | NA | ||
| 8077197 | 1994 | MQQSHQAGYANAADRESGIPAAVLDGIKAVAKEKNATLMFRLVNPHSTSLIAEGVATKGLGVHAKSSDWGLQAGYIPVNPNLSKLFGRAPEVIARADNDVNSSLAHGHTAVDLTLSKERLDYLRQAGLVTGMADGVVASNHAGYEQFEFRVKETSDGRYAVQYRRKGGDDFEAVKVIGNAAGIPLTADIDMFAIMPHLSNFRDSARSSVTSGDSVTDYLARTRRAASEATGGLDRERIDLLWKIARAGARSAVGTEARRQFRYDGDMNIGVITDFELEVRNALNRRAHAVGAQDVVQHGTEQNNPFPEADEKIFVVSATGESQMLTRGQLKEYIGQQRGEGYVFYENRAYGVAGKSLFDDGLGAAPGVPSGRSKFSPDVLETVPASPGLRRPSLGAVERQDSGYDSLDGVGSRSFSLGEVSDMAAVEAAELEMTRQVLHAGARQDDAEPGVSGASAHWGQRALQGAQAVAAAQRLVHAIALMTQFGRAGSTNTPQEAASLSAAVFGLGEASSAVAETVSGFFRGSSRWAGGFGVAGGAMALGGGIAAAVGAGMSLTDDAPAGQKAAAGAEIALQLTGGTVELASSIALALAAARGVTSGLQVAGASAGAAAGALAAALSPMEIYGLVQQSHYADQLDKLAQESSAYGYEGDALLAQLYRDKTAAEGAVAGVSAVLSTVGAAVSIAAAASVVGAPVAVVTSLLTGALNGILRGVQQPIIEKLANDYARKIDELGGPQAYFEKNLQARHEQLANSDGLRKMLADLQAGWNASSVIGVQTTEISKSALELAAITGNADNLKSVDVFVDRFVQGERVAGQPVVLDVAAGGIDIASRKGERPALTFITPLAAPGEEQRRRTKTGKSEFTTFVEIVGKQDRWRIRDGAADTTIDLAKVVSQLVDANGVLKHSIKLDVIGGDGDDVVLANASRIHYDGGAGTNTVSYAALGRQDSITVSADGERFNVRKQLNNANVYREGVATQTTAYGKRTENVQYRHVELARVGQLVEVDTLEHVQHIIGGAGNDSITGNAHDNFLAGGSGDDRLDGGAGNDTLVGGEGQNTVIGGAGDDVFLQDLGVWSNQLDGGAGVDTVKYNVHQPSEERLERMGDTGIHADLQKGTVEKWPALNLFSVDHVKNIENLHGSRLNDRIAGDDQDNELWGHDGNDTIRGRGGDDILRGGLGLDTLYGEDGNDIFLQDDETVSDDIDGGAGLDTVDYSAMIHPGRIVAPHEYGFGIEADLSREWVRKASALGVDYYDNVRNVENVIGTSMKDVLIGDAQANTLMGQGGDDTVRGGDGDDLLFGGDGNDMLYGDAGNDTLYGGLGDDTLEGGAGNDWFGQTQAREHDVLRGGDGVDTVDYSQTGAHAGIAAGRIGLGILADLGAGRVDKLGEAGSSAYDTVSGIENVVGTELADRITGDAQANVLRGAGGADVLAGGEGDDVLLGGDGDDQLSGDAGRDRLYGEAGDDWFFQDAANAGNLLDGGDGRDTVDFSGPGRGLDAGAKGVFLSLGKGFASLMDEPETSNVLRNIENAVGSARDDVLIGDAGANVLNGLAGNDVLSGGAGDDVLLGDEGSDLLSGDAGNDDLFGGQGDDTYLFGVGYGHDTIYESGGGHDTIRINAGADQLWFARQGNDLEIRILGTDDALTVHDWYRDADHRVEIIHAANQAVDQAGIEKLVEAMAQYPDPGAAAAAPPAARVPDTLMQSLAVNWR | Bifunctional hemolysin/adenylate cyclase (AC-HLY) (ACT) (Cyclolysin) [Cleaved into: Calmodulin-sensitive adenylate cyclase (EC 4.6.1.1) (ATP pyrophosphate-lyase) (Adenylyl cyclase); Hemolysin] | Free | Free | Linear | L | None | 1706 | Enzymatic | Hemolytic | Sheep | Bordetella Pertussis (Strain Tohama I / Atcc Baa-589 / Nctc 13251) | NA | NA | ||
| 23499645 | 2013 | VVGGDECNINEHRSLVAIFNSTGFFCSGILLNQEWVLTASHCDSTNFQMK | Thrombin-like enzyme BpirSP27 (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) | Free | Free | Linear | L | None | 50 | Anticomplementary | 50 % Hemolytic | Rabbit | Bothrops Pirajai (Piraja'S Lancehead) | NA | NA | ||
| 23499645 | 2013 | VVGGDECDINEHPFLAFLYSHGYFCGLTLINQEWVLTAAHCDRRFMRIYL | Thrombin-like enzyme BpirSP41 (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) | Free | Free | Linear | L | None | 50 | Anticomplementary | 50 % Hemolytic | Rabbit | Bothrops Pirajai (Piraja'S Lancehead) | NA | NA | ||
| 23159790 | 2013 | MMNLKYLLFFCLVQALHYCYAYGDPSLSNELDRFNPCPYSDDTVKMIILTRENKKHDFYTLNTIKNHNEFKKSTIKHQVVFITHGFTSTATAENFLAMAEALLDKGNYLVILIDWRVAACTNEMAGVKLAYYSYAASNTRLVGNYIATVTKMLVQQYNVPMANIRLIGHSLGAHTSGFAGKKVQELRLGKYSEIIGLDPAGPSFKSQECSQRICETDANYVQIIHTSNHLGTLVTLGTVDFYMNNGYNQPGCGLPIIGETCSHTRAVKYFTECIRHECCLIGVPQSKNPQPVSKCTRNECVCVGLNAKTYPKTGSFYVPVESKAPYCNNKGKII | Phospholipase A1 1 (PLA1) (EC 3.1.1.32) (Allergen Ves a 1.01) (Vespapase) (allergen Vesp a 1) | Free | Free | Linear | L | None | 334 | Anticomplementary | Hemolytic | Rabbit | Vespa Affinis (Lesser Banded Hornet) | NA | NA | ||
| 23159790 | 2013 | MMNLKYLLFFCLVQALHYCYAYGDPSLSNELDRFNPCPYSDDTVKMIILTRENKKHDFYTLNTIKNHNEFKKSTIKHQVVFITHGFTSTATAENFLAMAEALLDKGNYLVILIDWRVAACTNEMAGVKLAYYSYAASNTRLVGNYIATVTKMLVQQYNVPMANIRLIGHSLGAHTSGFAGKKVQELRLGKYSEIIGLDPAGPSFKSQECSQRICETDANYVQIIHTSNHLGTLVTLGTVDFYMNNGYNQPGCGLPIIGETCSHTRAVKYFTECIRHECCLIGVPQSKNPQPVSKCTRNECVCVGLNAKTYPKTGSFYVPVESKAPYCNNKGKII | Phospholipase A1 1 (PLA1) (EC 3.1.1.32) (Allergen Ves a 1.01) (Vespapase) (allergen Vesp a 1) | Free | Free | Linear | L | None | 334 | Anticomplementary | Hemolytic | Sheep | Vespa Affinis (Lesser Banded Hornet) | NA | NA | ||
| 10484737 | 1999 | GLLPKVKLVPEQISFILSTRENR | Phospholipase A1 verutoxin-1 (PLA1) (VT-1) (EC 3.1.1.32) (EC 3.1.1.5) | Free | Free | Linear | L | None | 23 | Catalytic | 3 % Hemolytic at 3ug/ml | mouse | Vespa Velutina (Asian Yellow-Legged Hornet) | NA | NA | ||
| 10484737 | 1999 | FNPCPYSDDTVKMIILTRENKKHDF | Phospholipase A1 verutoxin-2a (PLA1) (VT-2a) (EC 3.1.1.32) (EC 3.1.1.5) | Free | Free | Linear | L | None | 25 | Catalytic | 98.8 % Hemolytic at 3ug/ml | mouse | Vespa Velutina (Asian Yellow-Legged Hornet) | NA | NA | ||
| 10484737 | 1999 | FNPCPYSDDTVKMIILTRENKKHDF | Phospholipase A1 verutoxin-2b (PLA1) (VT-2b) (EC 3.1.1.32) (EC 3.1.1.5) | Free | Free | Linear | L | None | 25 | Catalytic | 99.3 % Hemolytic at 3ug/ml | mouse | Vespa Velutina (Asian Yellow-Legged Hornet) | NA | NA | ||
| 24384926 | 2014 | NLYQFGKMINHMVGKSPIFSYGDYGCYCGWGGKGTPVDATDRCCFVHDCCYGRANGCDPKLSTYSYNFQNGNIVCGNKYGCLRHICECDRVAAICFGENVNTYDKKFLSSSRCRQTSEQC | Basic phospholipase A2 Cc2-PLA2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) | Free | Free | Linear | L | None | 120 | Anti-platelet | 43.34 ± 2.58 % Hemolytic | Sheep | Cerastes Cerastes (Horned Desert Viper) | NA | NA | ||
| 2403529 | 1989 | MREKVVLFLSIIMAIMLPVGNAAAAPVVHNPASTANRPVYAIAHRVLTTQGVDDAVAIGANALEIDFTAWGRGWWADHDGIPTSAGATAEEIFKHIADKRKQGANITFTWLDIKNPDYCRDARSVCSINALRDLARKYLEPAGVRVLYGFYKTVGGPAWKTITADLRDGEAVALSGPAQDVLNDFARSENKILTKQKIADYGYYNINQGFGNCYGTWNRTCDQLRKSSEARDQGKLGKTFGWTIATGQDARVNDLLGKANVDGLIFGFKITHFYRHADTENSFKAIKRWVDKHSATHHLATVADNPW | Phospholipase D (PLD) (EC 3.1.4.-) (Choline phosphatase) (SM/LPC-specific PLD) (Sphingomyelinase D) (SMaseD) (EC 3.1.4.41) | Free | Free | Linear | L | None | 307 | Enzymatic | Hemolytic | Sheep | Corynebacterium Pseudotuberculosis | NA | NA | ||
| 21593408 | 2011 | MAYVRLTSLAVLFFLAASVMKTEGGLPTCGETCTLGTCYVPDCSCSWPICMKNHIIAANAKTVNEHRLLCTSHEDCFKKGTGNYCASFPDSNIHFGWCFHAESEGYLLKDFMNMSKDDLKMPLESTN | Cyclotide cter-M | Free | Free | Linear | L | None | 127 | Anti-HIV | 50 % Hemolytic at >100µM | Human | Clitoria Ternatea (Butterfly Pea) | NA | Low hemolytic | ||
| 20854656 | 2010 | MARRARVDAELVRRGLARSRQQAAELIGAGKVRIDGLPAVKPATAVSDTTALTVVTDSERAWVSRGAHKLVGALEAFAIAVAGRRCLDAGASTGGFTEVLLDRGAAHVVAADVGYGQLAWSLRNDPRVVVLERTNARGLTPEAIGGRVDLVVADLSFISLATVLPALVGCASRDADIVPLVKPQFEVGKGQVGPGGVVHDPQLRARSVLAVARRAQELGWHSVGVKASPLPGPSGNVEYFLWLRTQTDRALSAKGLEDAVHRAISEGP | 16S/23S rRNA (cytidine-2'-O)-methyltransferase TlyA (EC 2.1.1.226) (EC 2.1.1.227) (16S rRNA (cytidine1409-2'-O)-methyltransferase) (23S rRNA (cytidine1920-2'-O)-methyltransferase) (Hemolysin TlyA) | Free | Free | Linear | L | None | 268 | Antibiotic | 50 % Hemolytic at 18μmug/ml | Rabbit | Mycobacterium Tuberculosis (Strain Atcc 25618 / H37Rv) | NA | NA | ||
| 23733617 | 2013 | MLFPTALIFGCWALVIEGADNRRPIWNMGHMVNEVYQIDEFVDLGANSIETDITFDDDAMAEYSYHGVPCDCRRWCHKWEYVNVFLDGLRRATTPGDSKYRPELTLVVFDLKTGDLSSSTAYKGGKLFAQKLLDRYWNGGNNGGRAYIIISIPDIDHYAFITGFREALKNANHEELLDKVGYDFSGNDDLSSTRTALNKAGVKDREHVWQSDGITNCILRGLDRVREAVRNRDSSNGYINKVYYWTIEKYVSVRDALDAGVDGIMTNEPDVIVNVLNEGNYRGRFRLANYDDNPWVTFK | Dermonecrotic toxin LiSicTox-alphaIVA1 (EC 4.6.1.-) (Dermonecrotic toxin 7) (DT7) (LiRecDT7) (Phospholipase D) (PLD) (Sphingomyelin phosphodiesterase D 7) (SMD 7) (SMase D 7) (Sphingomyelinase D 7) | Free | Free | Linear | L | None | 299 | Hemolytic | 100 % Hemolytic at 25ug/ml | Human | Loxosceles Intermedia (Brown Spider) | NA | NA | ||
| 2693022 | 1989 | MSKITLSSLKSSLQQGLKNGKNKLNQAGTTLKNGLTQTGHSLQNGAKKLILYIPQGYDSGQGNGVQDLVKAANDLGIEVWREERSNLDIAKTSFDTTQKILGFTDRGIVLFAPQLDNLLKKNPKIGNTLGSASSISQNIGKANTVLGGIQSILGSVLSGVNLNELLQNKDPNQLELAKAGLELTNELVGNIASSVQTVDAFAEQISKLGSHLQNVKGLGGLSNKLQNLPDLGKASLGLDIISGLLSGASAGLILADKEASTEKKAAAGVEFANQIIGNVTKAVSSYILAQRVASGLSSTGPVAALIASTVALAVSPLSFLNVADKFKQADLIKSYSERFQKLGYDGDRLLADFHRETGTIDASVTTINTALAAISGGVGAASAGSLVGAPVALLVAGVTGLITTILEYSKQAMFEHVANKVHDRIVEWEKKHNKNYFEQGYDSRHLADLQDNMKFLINLNKELQAERVVAITQQRWDNQIGDLAAISRRTDKISSGKAYVDAFEEGQHQSYDSSVQLDNKNGIINISNTNRKTQSVLFRTPLLTPGEENRERIQEGKNSYITKLHIQRVDSWTVTDGDASSSVDFTNVVQRIAVKFDDAGNIIESKDTKIIANLGAGNDNVFVGSSTTVIDGGDGHDRVHYSRGEYGALVIDATAETEKGSYSVKRYVGDSKALHETIATHQTNVGNREEKIEYRREDDRFHTGYTVTDSLKSVEEIIGSQFNDIFKGSQFDDVFHGGNGVDTIDGNDGDDHLFGGAGDDVIDGGNGNNFLVGGTGNDIISGGKDNDIYVHKTGDGNDSITDSGGQDKLAFSDVNLKDLTFKKVDSSLEIINQKGEKVRIGNWFLEDDLASTVANYKATNDRKIEEIIGKGGERITSEQVDKLIKEGNNQISAEALSKVVNDYNTSKDRQNVSNSLAKLISSVGSFTSSSDFRNNLGTYVPSSIDVSNNIQLARAA | RTX-II toxin determinant A (APX-IIA) (Cytolysin IIA) (CLY-IIA) (Hemolysin IIA) (HLY-IIA) | Free | Free | Linear | L | None | 956 | Antisera | Hemolytic | goat | Actinobacillus Pleuropneumoniae (Haemophilus Pleuropneumoniae) | NA | Low hemolytic | ||
| 15932999 | 2005 | MKSNVDTVLDGYTSVPVGVLDSTLANTDILTRITLVFPSSLSLSALQESWYALVRSWPILAARVRATPSTPSGLSYLIPTPATLESLETRSRNSASKPLEKHIVLLDQSSRSFSDYHPIVAKAVHSNLDRNNISIGGAPLVEHEKATICSNACTSWKQLIKQDQAFVTAQATKFADATTVTISFSHILGDAFTIKHIFQGWQTALNGQAVQELQDVGKDPFIKYLPKDTNDKKHKKNKKSEPAPDLPLQWFRYGLARKIKLISLLLWEVKVKKPEKTLGQYYIYLPQAKVDELMAQARSDLEQLRSSSATSATERDLNVSTFNVLFAWLLQNIHASTAIKPSKTSSVICIINAKTRPPAGHVPADYPRHQLWGGALGAPLRPLSAAEYVTLPLGQLALHIRESITEQVDPENIRKSVVMALKHSMWKKPSGELLFFSQNPNTYWCGCTEWRSAKFHTIDFSAAATPHHDAIQPTAAPAASVNPVAITTNMETPMTKRNRWALLGEANNGIWFTGGLTANEASNKNGFGRYIFVE | Acetyltransferase MATC1 (EC 2.3.1.-) (Mannosylerythritol lipids (MELs) biosynthesis cluster protein MAT1) | Free | Free | Linear | L | None | 534 | Biosurfactant | High Hemolytic | Sheep | Ustilago Maydis (Strain 521 / Fgsc 9021) (Corn Smut Fungus) | NA | NA | ||
| 15932999 | 2005 | MQADKHAWKEVSPNLAQRPLVGVEKLLNYAEYYQNGNFQLSAAIHLETNLTTEKLQQRFGLAVWNVRCLLPEIGTWTVGTTGDAAVDLDNATFTAIQTVEEAQKWIDETAVIVQDGTTAEELTILTTNHTIEPAGKQFRVYLVTNARQGSPAIIVNASHVLSGHRIAAQLCTIVQALVDARLVSLLQAEPDPRAALRSIFVPENLARLIGKLPISLNTAYHKRFNPTEGDLENGFEKLSERLANSALPSIGIPRLSSPATNPEYSLGTVNGEAMTIMNLRRTIGSNEYRLLIDAHKKLGITVPSVIYACIVNSIDRRCKSNTAQDAETPGANLAYSAHAKRWLPDETFMTRSPVNMAIVLGSAYVSPDELRSKQHGCDLSIDELIELAKTIRAKQDAYLDTPHIISAMEQVGDEVSAMIADTAIKQRQAGTDPHVALFENSPAICPPTLTSQGDIAFKRLYTAQGGSWDPEPAVAAGEYVYIGHSWNSGRTTDASVCFALVGFSGELRLTSYFDSRFFDAKLIESILDDVLSNLRMIATTVPVDAPEAKL | Acyl-CoA-dependent acyltransferase MAC2 (EC 2.-.-.-) (Mannosylerythritol lipids (MELs) biosynthesis cluster protein MAC2) | Free | Free | Linear | L | None | 550 | Biosurfactant | High Hemolytic | Sheep | Ustilago Maydis (Strain 521 / Fgsc 9021) (Corn Smut Fungus) | NA | NA | ||
| 15932999 | 2005 | MKVALLANPARGEINVLLATAYELIRLGHDVTFLTGSSFANAIAEFRSEQNDPILAARIHFSDLGNARAVEDFTRGMQSHLKGLRKPPGDYSSMEICQIVALVTEQEFRDAATMVRDRLLEIEPDMIAVDALSPNLVTGCRMTGLPWMFTVPCSPSLTATRKSLFDPHPMGRRRQRTLMSALENLKLTFIETYRNATKKDLYARRALLKNEFGLNSMGFNGDSAIVPPLWKDRNCVGGIHFNTPGLTDSIRQPHQIHFVGAGVTSDPENHDTPVFEAASFLKQLSPSSSTTFKPLFPPLSKTGRDLDVEWMDEAYAAGQLVVYLNMGSMFLWTDAEVRSCLRAFERLYEQSGGKIKLLFKLNKPKRTPNNTGASTPTAPISSPDFEEKQRTVMGSARPVGASNLVSEKLADAIKNVTPRRKTDADKGYSQFTLSEFEGLEYVRFTRWVHDQRSIYKHPALRVVIHHGGGNSFNEAVHYALPQMILSQWFDTHEYAILAERFGIGLRSKHAPKIDENDLVNTMTRLLQGPEAEKIRRNAKVWSIRSRNAGGAPAAARLIEAQAMLFNQQKQLELAASEVRAAVDTLSGKSSVADLESETAFTPNMLSGAASTVGSD | Erythritol-mannosyl-transferase 1 (EC 2.4.1.-) (Mannosylerythritol lipids (MELs) biosynthesis cluster protein EMT1) | Free | Free | Linear | L | None | 615 | Biosurfactant | High Hemolytic | Sheep | Ustilago Maydis (Strain 521 / Fgsc 9021) (Corn Smut Fungus) | NA | NA | ||
| 15932999 | 2005 | MINNALRTLISSATEQSLDDVLEHEFRTAVQLQQMDQFEWHQVEADLWKRTCLGHEASASFNQNIAHGHTELSLMTSWRVHQPSSSRITGSELELDQLVARVRQAWIQARYLRPEVGVELDTHTDPTVAQTMCYRLLRDEESIQEWLDETFVVKRLGDPGVATPAELCAYTYNRPLATKGKKSMLYLILPRLDDEQRTAYTIWNVSHAVTDGGSLAEVFNTLFQCVIDATPSEPYDSIYTPSAFELNVLPRMPRSVVMAYRQQYQPKPEEIAKAHKVAEVNMRMITEKMGESLALMPSTSWPERKHETVCLCRELEANEVRELLKFAKQVHSGITYLASAATILSAAETFPERKASSKGALVGMVRNARRWISATPLDASLGASTPLGSDAVFLWVPIDTHKTLEPSFSRMQELVTTARHIRHELDKHLTTPHCISSYPYVAESSIQGLNQQWSQIKAVQSPSSSSSQKEIAGIIGAQAPGFSSVGMMRIRPRFEPVSANARASGLWLERTDFTHTGRQINASPWISMFNVDGRIKLQLGFDTKFHEVEKMNQWLDRTVVWMRICAAAAATTSTSVSSTSVDATAPVFARL | Acyl-CoA-dependent acyltransferase MAC1 (EC 2.-.-.-) (Mannosylerythritol lipids (MELs) biosynthesis cluster protein MAC1) | Free | Free | Linear | L | None | 591 | Biosurfactant | High Hemolytic | Sheep | Ustilago Maydis (Strain 521 / Fgsc 9021) (Corn Smut Fungus) | NA | NA | ||
| 23933196 | 2018 | MSSDIIMAGLGRPFTLGFLYDARREKLIPGFSLFGDETLQKYATSTPQHSSDFQIVASDSVESKSNVMDIEASLGVSFLGGLVEVGGSAKYLNNTKKYQNQSRVTLQYKVTTTFKQFKAPPGKVNVQQTAISDKNVATHVVTAILFGANAFFVFDSDKVEDSNLQDIQGKMEAVIKKIPSVSIEGSGSVQLTDEEKSLASNLSCKFHGDFLLESLPTTFEEAVMTYQKLPELVGEEASDGVPMKVWLVPLTRFYSKADLLVRDISQGLVRKVHSILEDLHKLKRRANDSLEDDTVKLFPLLEKKLKNFQKNYSDYMTTFRRTISQKLQSIRKGDEDETAMLQLFEDRLRSPFNIDSLNMWMEITEREINVLRSCIDIIEETKHKAVLSQSQMVKDLLDSEVMHAVCYVFTYVTDKDHYLDALRDYLKSPNSRPARVRPVVTWVASNTVLETMREKAHLFRSLAKDMENRCVHFLVASIVNLKVEGAAIHYYRESVLIEPNFKHPIISAVEKIVDRRDLLWYDCELTLDPNTSHPSLYLSEGNKKAVTGTLRAFDNNPERFGLWQQVLCNKGLSRRHYWEVEWNGYVIVGVTYSSIGRKNIDIQSFIGFSETSWTLMFIPKNGVAVKGARRSVSYYFISDLAFPPLGLYHDCHASTLSFYKVSDNVLNHFHTIEIKPKLSEPVYAIIRIGDEDRPYHGTVRLL | Cytolytic toxin-alpha (Sp-CTx-alpha) | Free | Free | Linear | L | None | 702 | Cytolytic | 50 % Hemolytic at 25-56ng/mL | Rabbit | Scorpaena Plumieri (Spotted Scorpionfish) | NA | NA | ||
| 30734396 | 2019 | GLVSGLLNSVTGLLGNLAGGGL | Plasticin-TR (PTC-TR) | Free | Free | Linear | L | None | 22 | Anti-inflammatory | 50 % Hemolytic at >500µM | Mouse | Phyllomedusa Trinitatis (Trinidad Leaf Frog) | Helical | Non-hemolytic | ||
| 22342498 | 2012 | FLKGIIDTVSNWL{ct:Amid} | Amphipathic peptide CT1 (VsCT1) (Non-disulfide-bridged peptide 5.11) (NDBP-5.11) | Amidation | Free | Linear | L | None | 13 | hemolytic | 6 % Hemolytic at 50µM | Human | Mesomexovis Subcristatus (Scorpion) (Vaejovis Subcristatus) | Alpha Helix | Low hemolytic | ||
| 22342498 | 2012 | FLKGIIDTVSKLF{ct:Amid} | Amphipathic peptide CT2 (VsCT2) (Non-disulfide-bridged peptide 5.12) (NDBP-5.12) | Amidation | Free | Linear | L | None | 13 | hemolytic | 2 % Hemolytic at 50µM | Human | Mesomexovis Subcristatus (Scorpion) (Vaejovis Subcristatus) | Alpha Helix | Low hemolytic | ||
| 15274631 | 2004 | MSSSTVMADGFEEIEVDVVSVWKEGYAYENRGNSSVQQKITMTKGMKNLNSETKTLTATHTLGRTLKVGDPFEIASVEVSYTFSHQKSQVSMTQTEVYSSQVIEHTVTIPPNKKFTRWKLNADVGGTGIEYMYLIDEVTAIGADLTIPEVNKSRAKILVGRQIHLGETEIRIKHAERKEYMTVISRKSWPAATLGNSNLFKFVLFEDSSGIRIKTLNTMYPGYEWAYSSDQGGIYFDESSDNPKQRWALSKAMPLRHGDVVTFRNNFFTNSGMCYDDGPATNVYCLEKREDKWILEVVNT | Lysenin-related protein 1 (LRP-1) (Lysenin-2) (efL2) | Free | Free | Linear | L | None | 300 | Cytolytic | Hemolytic | Sheep | Eisenia Fetida (Red Wiggler Worm) | NA | NA | ||
| 15893660 | 2005 | SLETKDVITRAAYENLVNSGAIQGITMTKTIISNPILEEALVSHFNRKLG{cyc:N-C} | Tricyclon-A | Free | Free | Cyclic | L | None | 50 | Plant defense | 2 % Hemolytic at 500µM | Human | Viola Arvensis (European Field Pansy) (Field Violet) | Helix and Extended | NA | ||
| 20097251 | 2010 | MMKQQFFLFLAVIVMISSVIEAGRGREFMSNLKEKLSGVKEKMKNSWNRLTSMSEYACPVIEKWCEDHCQAKNAIGRCENTECKCLSK | Potassium channel toxin MeuTXKbeta3-meucin-24 [Cleaved into: Meucin-24 (Non-disulfide-bridged peptide 5.1) (NDBP-5.1); Potassium channel toxin MeuTXKbeta3] | Free | Free | Linear | L | None | 88 | Antiparasite | 0 % Hemolytic at 100µM | Mouse | Mesobuthus Eupeus (Lesser Asian Scorpion) (Buthus Eupeus) | NA | Non-hemolytic | ||
| 12236591 | 2002 | NLFQFAEMIVKMTGKEAVH | Neutral phospholipase A2 RVV-PFIIc' (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) | Free | Free | Linear | L | None | 19 | Hemolytic, Anticoagulant | 31 % Hemolytic at 2µg | Rabbit | Daboia Russelii (Russel'S Viper) (Vipera Russelii) | NA | NA | ||
| 34941722 | 2021 | ISEALKSIIVG{ct:Amid} | Annulatin (Linear alpha-helical peptide) | Amidation | Free | Linear | L | None | 11 | Histamine releasing activity from mast cells | 15.4 % Hemolytic at 12.5µmol/l | Human | Campsomeriella Annulata (Wasp) (Campsomeris Annulata) | Alpha Helix | Low hemolytic | ||
| 26456928 | 2016 | LKCNKLIPLAYKTCPAGKDLCYKMYMVSNKTVPVKRGCIDVCPKNSLLVKYECCNTDRCN | Cytotoxin 7 (CTX7) | Free | Free | Linear | L | None | 60 | Cytolytic | 50 % Hemolytic at 0.096µM | Human | Naja Naja (Indian Cobra) | NA | NA | ||
| 26456928 | 2016 | LQCNKLVPIASKTCPPGKNLCYKMFMVSDLTIPVKRGCIDVCPKNSLLVKYECCNTDRCN | Cytotoxin 2a (CTX2a) (Cytotoxin 2) (CTX2) | Free | Free | Linear | L | None | 60 | Cytolytic | 50 % Hemolytic at 1.024µM | Human | Naja Naja (Indian Cobra) | NA | NA | ||
| 26456928 | 2016 | LKCNKLIPLAYKTCPAGKDLCYKMYMVSDKTVPVKRGCIDVCPKNSLLVKYECCNTDRCN | Cytotoxin 8 (CTX8) | Free | Free | Linear | L | None | 60 | Cytolytic | 50 % Hemolytic at 0.074µM | Human | Naja Naja (Indian Cobra) | NA | NA | ||
| 26456928 | 2016 | LKCNKLVPLFYKTCPAGKDLCYKMYMVATPKVPVKRGCIDVCPKSSLLVKYVCCNTDRCN | Cytotoxin 10 (CTX10) | Free | Free | Linear | L | None | 60 | Cytolytic | 50 % Hemolytic at 0.162µM | Human | Naja Naja (Indian Cobra) | NA | NA | ||
| 12657318 | 2003 | GWPAYPGPNGIRSSVCQTKLGCGKKNLATKGVCKAFCLGRKRFWQKCGKNGSSGKGSRICNPVLAHAVEKAGKGLIKVTDMAVAAIVKYAGKK | Parbolysin P4 (Parbolysin 4) | Free | Free | Linear | L | None | 93 | Cytolysis | 50 % Hemolytic at 5.75μg/ml | Bovine | Parborlasia Corrugatus (Antarctic Nemertean Worm) | NA | NA |